All explAInations

All explAInations of medical conditions are found in alphabetical order below.

• 1A00/A00 Cholera
• 1A01/A04 Intestinal infection due to other Vibrio
• 1A02/A03 Intestinal infections due to Shigella
• 1A03.0/A04.0 Enteropathogenic Escherichia coli infection
• 1A03.1/A04.1 Enterotoxigenic Escherichia coli infection
• 1A03.2/A04.2 Enteroinvasive Escherichia coli infection
• 1A03.3/A04.3 Enterohaemorrhagic Escherichia coli infection
• 1A03/A04 Intestinal infections due to Escherichia coli
• 1A03.Y/A04.8 Intestinal infections due to other specified Escherichia coli
• 1A03.Z/A04 Intestinal infections due to Escherichia coli, unspecified
• 1A04/A04.7 Intestinal infections due to Clostridioides difficile
• 1A05/A04.6 Intestinal infections due to Yersinia enterocolitica
• 1A06/A04.5 Gastroenteritis due to Campylobacter
• 1A07.0/A01.0 Typhoid peritonitis
• 1A07/A01.0 Typhoid fever
• 1A07.Y/A01.0 Other specified typhoid fever
• 1A07.Z/A01.0 Typhoid fever, unspecified
• 1A08/A01 Paratyphoid fever
• 1A09.0/A02.0 Salmonella enteritis
• 1A09/A02 Infections due to other Salmonella
• 1A09.Y/A02.8 Infections due to other Salmonella in other organs
• 1A09.Z/A02 Salmonella infection, unspecified
• 1A0Y/A04.9 Other specified bacterial intestinal infections
• 1A0Z/A04.9 Bacterial intestinal infections, unspecified
• 1A10/A05.0 Foodborne staphylococcal intoxication
• 1A11.0/A05.1 Foodborne intoxication by botulinum toxin
• 1A11.1/A05.1 Other forms of botulism
• 1A11/A05.1 Botulism
• 1A11.Z/A05.1 Botulism, unspecified
• 1A12/A05.2 Foodborne Clostridium perfringens intoxication
• 1A13/A05.4 Foodborne Bacillus cereus intoxication
• 1A1Y/A05.9 Other specified bacterial foodborne intoxications
• 1A1Z/A05.9 Bacterial foodborne intoxications, unspecified
• 1A20/A08.2 Enteritis due to Adenovirus
• 1A21/A08.3 Gastroenteritis due to Astrovirus
• 1A22/A08.0 Gastroenteritis due to Rotavirus
• 1A23/A08.1 Enteritis due to Norovirus
• 1A24/A08.5 Intestinal infections due to Cytomegalovirus
• 1A2Y/A08 Other specified viral intestinal infections
• 1A2Z/A08 Viral intestinal infections, unspecified
• 1A30/A07.0 Infections due to Balantidium coli
• 1A31/A07.1 Giardiasis
• 1A32/A07.2 Cryptosporidiosis
• 1A33.0/A07.3 Cystoisosporiasis of small intestine
• 1A33.1/A07.3 Cystoisosporiasis of colon
• 1A33/A07.3 Cystoisosporiasis
• 1A33.Y/A07.3 Other specified cystoisosporiasis
• 1A33.Z/A07.3 Cystoisosporiasis, unspecified
• 1A34/A07.8 Sarcocystosis
• 1A35/A07.8 Blastocystosis
• 1A36.0/A07.8 Intestinal infections due to Entamoeba
• 1A36.00/A06.0 Acute amoebiasis
• 1A36.01/A06.3 Amoeboma of intestine
• 1A36.0Z/A07.8 Intestinal infections due to Entamoeba, unspecified
• 1A36.1/A06 Extraintestinal infections due to Entamoeba
• 1A36.10/A06.4 Amoebic liver abscess
• 1A36.11/A06.5 Amoebic lung abscess
• 1A36.12/A06.7 Cutaneous amoebiasis
• 1A36.1Y/A06 Amoebiasis of other specified sites
• 1A36/A06 Amoebiasis
• 1A36.Z/A06 Amoebiasis, unspecified
• 1A3Y/A08.5 Other specified protozoal intestinal infections
• 1A3Z/A08.5 Protozoal intestinal infections, unspecified
• 1A40.0/A09.9 Gastroenteritis or colitis without specification of origin
• 1A40/A09 Gastroenteritis or colitis without specification of infectious agent
• 1A40.Z/A09 Infectious gastroenteritis or colitis without specification of infectious agent
• 1A60.0/A50.0 Early congenital syphilis, symptomatic
• 1A60.1/A50.1 Early congenital syphilis, latent
• 1A60.2/A50.3 Late congenital syphilitic oculopathy
• 1A60.3/A50.4 Late congenital neurosyphilis
• 1A60.4/A50 Other late congenital syphilis, symptomatic
• 1A60.5/A50.6 Late congenital syphilis, latent
• 1A60/A50 Congenital syphilis
• 1A60.Z/A50 Congenital syphilis, unspecified
• 1A61.0/A51.0 Primary genital syphilis
• 1A61.1/A51.1 Primary anal syphilis
• 1A61.2/A51.2 Primary syphilis of other sites
• 1A61.3/A51.3 Secondary syphilis of skin or mucous membranes
• 1A61.4/A51.4 Secondary syphilis of other sites
• 1A61.5/A51.5 Latent early syphilis
• 1A61/A51 Early syphilis
• 1A61.Y/A51 Other specified early syphilis
• 1A61.Z/A51 Early syphilis, unspecified
• 1A62.0/A52 Neurosyphilis
• 1A62.00/A52.2 Asymptomatic neurosyphilis
• 1A62.01/A52.1 Symptomatic late neurosyphilis
• 1A62.0Z/A52 Neurosyphilis, unspecified
• 1A62.1/A52.0 Cardiovascular late syphilis
• 1A62.2/A52.7 Symptomatic late syphilis of other sites
• 1A62.20/A52.7 Ocular late syphilis
• 1A62.21/A52.7 Late syphilis involving the musculoskeletal system
• 1A62.22/A52.7 Late syphilis of skin or mucous membranes
• 1A62.2Y/A52.7 Symptomatic late syphilis of other specified sites
• 1A62.2Z/A52.7 Symptomatic late syphilis of unspecified site
• 1A62/A52 Late syphilis
• 1A62.Y/A52.8 Other specified late syphilis
• 1A62.Z/A52 Late syphilis, unspecified
• 1A63/A53.0 Latent syphilis, unspecified as early or late
• 1A6Z/A50-A64 Syphilis, unspecified
• 1A70.0/A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
• 1A70.00/A54.0 Gonorrhoea of penis
• 1A70.0Y/A54.0 Other specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
• 1A70.0Z/A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess, unspecified
• 1A70.1/A54.1 Gonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess
• 1A70/A54 Gonococcal genitourinary infection
• 1A70.Y/A54 Gonococcal infection of other specified genitourinary organ
• 1A70.Z/A54 Gonococcal genitourinary infection, unspecified
• 1A71/A54 Gonococcal pelviperitonitis
• 1A72.0/A54.4 Gonococcal infection of musculoskeletal system
• 1A72.1/A54.6 Gonococcal infection of rectum
• 1A72.2/A54.6 Gonococcal infection of anus
• 1A72.3/A54.5 Gonococcal pharyngitis
• 1A72.4/A54.3 Gonococcal infection of eye
• 1A72/A54 Gonococcal infection of other sites
• 1A72.Y/A54 Gonococcal infection of other specified sites
• 1A73/A54 Disseminated gonococcal infection
• 1A7Z/A54 Gonococcal infection, unspecified
• 1A80/A55 Chlamydial lymphogranuloma
• 1A81.0/A56.0 Chlamydial infection of lower genitourinary tract
• 1A81.1/A56.1 Chlamydial infection of internal reproductive organs
• 1A81/A56 Non-ulcerative sexually transmitted chlamydial infection
• 1A81.Y/A56.8 Non-ulcerative sexually transmitted chlamydial infection of other specified site
• 1A81.Z/A56 Non-ulcerative sexually transmitted chlamydial infection of unspecified site
• 1A8Y/A50-A64 Other specified sexually transmissible infections due to chlamydia
• 1A8Z/A50-A64 Sexually transmissible infections due to chlamydia, unspecified
• 1A90/A57 Chancroid
• 1A91/A58 Granuloma inguinale
• 1A92/A59 Trichomoniasis
• 1A93/A63.8 Sexually transmissible infestations
• 1A94.0/A60.0 Herpes simplex infection of genitalia or urogenital tract
• 1A94.1/A60.1 Herpes simplex infection of perianal skin or rectum
• 1A94/A60 Anogenital herpes simplex infection
• 1A94.Z/A60 Anogenital herpes simplex infection without further specification
• 1A95.0/A63.0 Anal warts
• 1A95.1/A63.0 Genital warts
• 1A95.2/A63.0 Extragenital condylomata acuminata
• 1A95/A63.0 Anogenital warts
• 1A9Y/A50-A64 Other specified predominantly sexually transmitted infections
• 1A9Z/A50-A64 Predominantly sexually transmitted infections, unspecified
• 1B10.0/A15 Respiratory tuberculosis, confirmed
• 1B10.1/A16 Respiratory tuberculosis, not confirmed
• 1B10/A16 Tuberculosis of the respiratory system
• 1B10.Z/A16 Respiratory tuberculosis, without mention of bacteriological or histological confirmation
• 1B11.0/A17.0 Tuberculous meningitis
• 1B11.1/A17.8 Tuberculous meningoencephalitis
• 1B11.2/A17.1 Meningeal tuberculoma
• 1B11.3/A17 Tuberculous granuloma of brain
• 1B11.4/A17 Tuberculous granuloma of the meninges
• 1B11/A17 Tuberculosis of the nervous system
• 1B11.Y/A17.8 Tuberculosis of other specified part of nervous system
• 1B11.Z/A17 Tuberculosis of the nervous system, unspecified
• 1B12.0/A18 Tuberculosis of heart
• 1B12.1/A18.5 Tuberculosis of eye
• 1B12.2/A18.6 Tuberculosis of ear
• 1B12.3/A18 Tuberculosis of endocrine glands
• 1B12.4/A18 Tuberculosis of the musculoskeletal system
• 1B12.40/M90.0 Tuberculosis of bones or joints
• 1B12.41/A18 Tuberculous myositis
• 1B12.4Y/A18 Tuberculosis of other specified part of the musculoskeletal system
• 1B12.4Z/A18 Tuberculosis of the musculoskeletal system, unspecified
• 1B12.5/A18.1 Tuberculosis of the genitourinary system
• 1B12.6/A18.2 Tuberculous peripheral lymphadenopathy
• 1B12.7/K93.0 Tuberculosis of the digestive system
• 1B12.8/A18.4 Cutaneous tuberculosis
• 1B12/A18 Tuberculosis of other systems and organs
• 1B12.Y/A18.8 Tuberculosis of other specified organ or site
• 1B13.0/A19.0 Acute miliary tuberculosis of a single specified site
• 1B13.1/A19.1 Acute miliary tuberculosis of multiple sites
• 1B13.2/A19 Acute miliary tuberculosis, unspecified site
• 1B13/A19 Miliary tuberculosis
• 1B13.Y/A19.8 Other specified miliary tuberculosis
• 1B13.Z/A19 Miliary tuberculosis, unspecified
• 1B14/Z22.7 Latent tuberculosis
• 1B1Y/A15-A19 Other specified tuberculosis
• 1B1Z/A15-A19 Tuberculosis, unspecified
• 1B20.0/A30 Paucibacillary leprosy
• 1B20.1/A30 Multibacillary leprosy
• 1B20.2/A30 Leprosy reactions
• 1B20.20/A30 Type I leprosy reaction
• 1B20.21/A30 Type II leprosy reaction
• 1B20.3/A30 Complications of leprosy
• 1B20/A30 Leprosy
• 1B20.Z/A30 Leprosy, unspecified
• 1B21.0/A31.0 Pulmonary infection due to non-tuberculous mycobacterium
• 1B21.1/A31 Non-tuberculous mycobacterial lymphadenitis
• 1B21.2/A31 Cutaneous non-tuberculous mycobacterial infection
• 1B21.20/A31 Mycobacterium ulcerans infection
• 1B21.2Y/A31 Cutaneous infection due to other specified non-tuberculous mycobacteria
• 1B21.2Z/A31 Cutaneous infection due to unspecified non-tuberculous mycobacteria
• 1B21.3/A31 Disseminated non-tuberculous mycobacterial infection
• 1B21.4/A31 Gastrointestinal non-tuberculous mycobacterial infection
• 1B21/A31 Infections due to non-tuberculous mycobacteria
• 1B21.Y/A31.8 Non-tuberculous mycobacterial infection of other specified site
• 1B21.Z/A31 Non-tuberculous mycobacterial infection of unspecified site
• 1B2Y/I Other specified mycobacterial diseases
• 1B2Z/I Mycobacterial diseases, unspecified
• 1B40.0/I00 Rheumatic arthritis, acute or subacute
• 1B40/I00 Acute rheumatic fever without mention of heart involvement
• 1B40.Y/I00 Other specified acute rheumatic fever without mention of heart involvement
• 1B40.Z/I00 Acute rheumatic fever without mention of heart involvement, unspecified
• 1B41.0/I01.0 Acute rheumatic pericarditis
• 1B41.1/I01.1 Acute rheumatic endocarditis
• 1B41.10/I01.1 Rheumatic aortitis
• 1B41.1Y/I01.1 Other specified acute rheumatic endocarditis
• 1B41.1Z/I01.1 Acute rheumatic endocarditis, unspecified
• 1B41.2/I01.2 Acute rheumatic myocarditis
• 1B41/I01 Acute rheumatic fever with heart involvement
• 1B41.Y/I01.8 Other acute rheumatic heart disease
• 1B41.Z/I01 Acute rheumatic heart disease, unspecified
• 1B42/I02 Rheumatic chorea
• 1B50/A38 Scarlet fever
• 1B51/J02.0 Streptococcal pharyngitis
• 1B53/G00.2 Meningitis due to Streptococcus
• 1B54/G00.3 Meningitis due to Staphylococcus
• 1B5Y/I Other specified staphylococcal or streptococcal diseases
• 1B5Z/I Staphylococcal or streptococcal diseases, unspecified
• 1B70.0/A46 Erysipelas
• 1B70.00/A46 Erysipelas of face
• 1B70.01/A46 Erysipelas of external ear
• 1B70.02/A46 Erysipelas of lower limb
• 1B70.0Y/A46 Erysipelas of other specified site
• 1B70.1/L03 Streptococcal cellulitis of skin
• 1B70.2/L03 Staphylococcal cellulitis of skin
• 1B70.3/No Mapping Ascending bacterial lymphangitis
• 1B70/No Mapping Bacterial cellulitis, erysipelas or lymphangitis
• 1B70.Y/No Mapping Bacterial cellulitis or lymphangitis due to other specified bacterium
• 1B70.Z/No Mapping Bacterial cellulitis or lymphangitis due to unspecified bacterium
• 1B71.0/M72.6 Streptococcal necrotising fasciitis
• 1B71.1/M72.6 Polymicrobial necrotising fasciitis
• 1B71.2/M72.6 Neonatal necrotising fasciitis
• 1B71/M72.6 Necrotising fasciitis
• 1B71.Y/M72.6 Necrotising fasciitis due to other specified bacterial infection
• 1B71.Z/M72.6 Necrotising fasciitis, unspecified
• 1B72.0/L01 Bullous impetigo
• 1B72.1/L01 Non-bullous impetigo
• 1B72.2/L01.1 Secondary impetiginisation of the skin
• 1B72/L01 Impetigo
• 1B72.Y/L01 Other specified impetigo
• 1B72.Z/L01 Impetigo, unspecified
• 1B73.0/B08.0 Streptococcal ecthyma
• 1B73.1/B08.0 Staphylococcal ecthyma
• 1B73.2/B08.0 Ecthyma gangrenosum
• 1B73/B08.0 Ecthyma
• 1B73.Y/B08.0 Other specified ecthyma
• 1B73.Z/B08.0 Ecthyma, unspecified
• 1B74.0/No Mapping Staphylococcus aureus superficial folliculitis
• 1B74/No Mapping Superficial bacterial folliculitis
• 1B74.Y/No Mapping Superficial bacterial folliculitis due to other specified organism
• 1B74.Z/No Mapping Superficial bacterial folliculitis due to unspecified organism
• 1B75.0/L02 Furuncle
• 1B75.1/L02 Carbuncle
• 1B75.2/L02 Furunculosis
• 1B75.3/L02 Pyogenic abscess of the skin
• 1B75.4/No Mapping Chronic deep bacterial folliculitis
• 1B75/No Mapping Deep bacterial folliculitis or pyogenic abscess of the skin
• 1B7Y/No Mapping Other specified pyogenic bacterial infection of skin and subcutaneous tissue
• 1B90.0/A25.0 Spirillosis
• 1B90.1/A25.1 Streptobacillosis
• 1B90/A25 Rat-bite fevers
• 1B91/A27 Leptospirosis
• 1B92/A24.0 Glanders
• 1B93.0/A20.0 Bubonic plague
• 1B93.1/A20.1 Cellulocutaneous plague
• 1B93.2/A20.2 Pneumonic plague
• 1B93.3/A20.3 Plague meningitis
• 1B93/A20 Plague
• 1B93.Y/A20.8 Other specified plague
• 1B93.Z/A20 Plague, unspecified
• 1B94.0/A21.0 Ulceroglandular tularaemia
• 1B94/A21 Tularaemia
• 1B94.Y/A21.8 Other specified tularaemia
• 1B94.Z/A21 Tularaemia, unspecified
• 1B95/A23 Brucellosis
• 1B96/A26 Erysipeloid
• 1B97/A22 Anthrax
• 1B98/A28.1 Cat-scratch disease
• 1B99/A28.0 Pasteurellosis
• 1B9A/A28.2 Extraintestinal yersiniosis
• 1B9Z/A28.8 Unspecified zoonotic bacterial disease
• 1C10.0/A42.0 Pulmonary actinomycosis
• 1C10.1/A42.1 Abdominal actinomycosis
• 1C10.2/A42.2 Cervicofacial actinomycosis
• 1C10.3/A42 Primary cutaneous actinomycosis
• 1C10/A42 Actinomycosis
• 1C10.Y/A42.8 Other specified forms of actinomycosis
• 1C10.Z/A42 Actinomycosis, unspecified
• 1C11.0/A44 Carrion disease
• 1C11.00/A44.0 Oroya fever
• 1C11.01/A44.1 Verruga peruana
• 1C11.1/A79.0 Trench fever
• 1C11/A44 Bartonellosis
• 1C11.Y/A44.8 Other forms of bartonellosis
• 1C12.0/A37.0 Whooping cough due to Bordetella pertussis
• 1C12.1/A37.1 Whooping cough due to Bordetella parapertussis
• 1C12/A37 Whooping cough
• 1C12.Y/A37.8 Other specified whooping cough
• 1C12.Z/A37 Whooping cough, unspecified
• 1C13/A35 Tetanus
• 1C14/A34 Obstetrical tetanus
• 1C15/A33 Tetanus neonatorum
• 1C16/A48.0 Gas gangrene
• 1C17.0/A36.0 Pharyngeal or tonsillar diphtheria
• 1C17.00/A36.0 Postdiphtheritic paralysis of uvula
• 1C17.0Y/A36.0 Other specified pharyngeal or tonsillar diphtheria
• 1C17.0Z/A36.0 Pharyngeal or tonsillar diphtheria, unspecified
• 1C17.1/A36.1 Nasal diphtheria
• 1C17.2/A36.2 Laryngeal diphtheria
• 1C17.3/A36.3 Cutaneous diphtheria
• 1C17/A36 Diphtheria
• 1C17.Y/A36.8 Other specified diphtheria
• 1C17.Z/A36 Diphtheria, unspecified
• 1C18/A48.4 Brazilian purpuric fever
• 1C19.0/A48.2 Nonpneumonic Legionnaires’ disease
• 1C19.1/A48.1 Legionnaires disease
• 1C19/A48.1 Legionellosis
• 1C1A.0/A32.0 Cutaneous listeriosis
• 1C1A.1/A32.1 Listerial meningitis or meningoencephalitis
• 1C1A/A32 Listeriosis
• 1C1A.Y/A32.8 Other specified listeriosis
• 1C1A.Z/A32 Listeriosis, unspecified
• 1C1B.0/A43.0 Pulmonary nocardiosis
• 1C1B.1/A43.1 Cutaneous nocardiosis
• 1C1B/A43 Nocardiosis
• 1C1B.Y/A43.8 Other specified forms of nocardiosis
• 1C1B.Z/A43 Nocardiosis, unspecified
• 1C1C.0/A39.0 Meningococcal meningitis
• 1C1C.1/A39.1 Waterhouse-Friderichsen syndrome
• 1C1C.2/A39 Meningococcaemia
• 1C1C.20/A39.2 Acute meningococcaemia
• 1C1C.2Y/A39 Other specified meningococcaemia
• 1C1C.2Z/A39 Meningococcaemia, unspecified
• 1C1C/A39 Meningococcal disease
• 1C1C.Y/A39.8 Other specified meningococcal disease
• 1C1C.Z/A39 Meningococcal disease, unspecified
• 1C1D.0/A66.0 Primary yaws
• 1C1D.1/A66.7 Secondary yaws
• 1C1D.2/A66 Tertiary yaws
• 1C1D.3/A66.8 Latent yaws
• 1C1D/A66 Yaws
• 1C1E.0/A67.0 Primary lesions of pinta
• 1C1E.1/A67.1 Intermediate lesions of pinta
• 1C1E.2/A67.2 Late lesions of pinta
• 1C1E.3/A67.3 Mixed lesions of pinta
• 1C1E/A67 Pinta
• 1C1F/A65 Endemic non-venereal syphilis
• 1C1G.0/A69.2 Early cutaneous Lyme borreliosis
• 1C1G.1/A69.2 Disseminated Lyme borreliosis
• 1C1G.10/A69.2 Lyme neuroborreliosis
• 1C1G.11/A69.2 Lyme carditis
• 1C1G.12/A69.2 Ophthalmic Lyme borreliosis
• 1C1G.13/M01.2 Lyme arthritis
• 1C1G.14/A69.2 Late cutaneous Lyme borreliosis
• 1C1G.1Y/A69.2 Other specified disseminated Lyme borreliosis
• 1C1G.1Z/A69.2 Disseminated Lyme borreliosis, unspecified
• 1C1G/A69.2 Lyme borreliosis
• 1C1G.Y/A69.2 Other specified Lyme borreliosis
• 1C1H.0/A69.0 Other Vincent infections
• 1C1H/A69.0 Necrotising ulcerative gingivitis
• 1C1H.Y/A69.0 Other specified necrotising ulcerative gingivitis
• 1C1H.Z/A69.0 Necrotising ulcerative gingivitis, unspecified
• 1C1J.0/A68.1 Tick-borne relapsing fever
• 1C1J.1/A68.0 Louse-borne relapsing fever
• 1C1J/A68 Relapsing fever
• 1C20/A74.0 Chlamydial conjunctivitis
• 1C21/K67.0 Chlamydial peritonitis
• 1C22/A70 Infections due to Chlamydia psittaci
• 1C23.0/A71.0 Initial stage of trachoma
• 1C23.1/A71.1 Active stage of trachoma
• 1C23/A71 Trachoma
• 1C23.Y/A71 Other specified trachoma
• 1C23.Z/A71 Trachoma, unspecified
• 1C2Y/A74.9 Other specified diseases due to chlamydiae
• 1C2Z/A74.9 Diseases due to chlamydiae, unspecified
• 1C30.0/A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii
• 1C30.1/A75.1 Recrudescent typhus
• 1C30.2/A75.2 Typhus fever due to Rickettsia typhi
• 1C30.3/A75.3 Typhus fever due to Orientia tsutsugamushi
• 1C30/A75 Typhus fever
• 1C30.Y/A75 Other specified typhus fever
• 1C30.Z/A75 Typhus fever, unspecified
• 1C31.0/A77.0 Spotted fever due to Rickettsia rickettsii
• 1C31.1/A77.1 Spotted fever due to Rickettsia conorii
• 1C31.2/A77.2 Spotted fever due to Rickettsia sibirica
• 1C31.3/A77.3 Spotted fever due to Rickettsia australis
• 1C31/A77 Spotted fever
• 1C31.Y/A77.8 Other specified spotted fever
• 1C31.Z/A77 Spotted fever, unspecified
• 1C32/A79.1 Rickettsialpox
• 1C33/A78 Q fever
• 1C3Y/A79.8 Other specified rickettsioses
• 1C3Z/A79 Rickettsioses, unspecified
• 1C40/B96.8 Campylobacteriosis
• 1C41/A49 Bacterial infection of unspecified site
• 1C42/A24 Melioidosis
• 1C43/B47.1 Actinomycetoma
• 1C44/L08.8 Non-pyogenic bacterial infections of the skin
• 1C45.0/A48.3 Streptococcal toxic shock syndrome
• 1C45.1/A48.3 Staphylococcal toxic shock syndrome
• 1C45/A48.3 Toxic shock syndrome
• 1C45.Y/A48.3 Toxic shock syndrome due to other specified infectious agent
• 1C45.Z/A48.3 Toxic shock syndrome without specified infectious agent
• 1C4Y/B96.8 Other specified bacterial diseases
• 1C4Z/B96.8 Unspecified bacterial disease
• 1C60.0/B20-B24 HIV disease clinical stage 1 associated with tuberculosis
• 1C60.1/B20-B24 HIV disease clinical stage 2 associated with tuberculosis
• 1C60.2/B20-B24 HIV disease clinical stage 3 associated with tuberculosis
• 1C60.3/B22.7 HIV disease clinical stage 4 associated with tuberculosis
• 1C60.30/B22.7 Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis
• 1C60.3Y/B22.7 Other specified HIV disease clinical stage 4 associated with tuberculosis
• 1C60.3Z/B22.7 HIV disease clinical stage 4 associated with tuberculosis, unspecified
• 1C60/B20-B24 Human immunodeficiency virus disease associated with tuberculosis
• 1C60.Z/B20-B24 Human immunodeficiency virus disease associated with tuberculosis, clinical stage unspecified
• 1C61.0/B20-B24 HIV disease clinical stage 1 associated with malaria
• 1C61.1/B20-B24 HIV disease clinical stage 2 associated with malaria
• 1C61.2/B20-B24 HIV disease clinical stage 3 associated with malaria
• 1C61.3/B22.7 HIV disease clinical stage 4 associated with malaria
• 1C61.30/B22.7 Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria
• 1C61.3Y/B22.7 Other specified HIV disease clinical stage 4 associated with malaria
• 1C61.3Z/B22.7 HIV disease clinical stage 4 associated with malaria, unspecified
• 1C61/B20-B24 Human immunodeficiency virus disease associated with malaria
• 1C61.Z/B20-B24 Human immunodeficiency virus disease associated with malaria, clinical stage unspecified
• 1C62.0/B20-B24 HIV disease clinical stage 1 without mention of tuberculosis or malaria
• 1C62.1/B20-B24 HIV disease clinical stage 2 without mention of tuberculosis or malaria
• 1C62.2/B20-B24 HIV disease clinical stage 3 without mention of tuberculosis or malaria
• 1C62.3/B22.7 HIV disease clinical stage 4 without mention of tuberculosis or malaria
• 1C62/B20-B24 Human immunodeficiency virus disease without mention of tuberculosis or malaria
• 1C62.Z/B20-B24 Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
• 1C80/A80-A89 Viral encephalitis not elsewhere classified
• 1C81/A80 Acute poliomyelitis
• 1C82/A82 Rabies
• 1C83/A83.1 Western equine encephalitis
• 1C84/A83.2 Eastern equine encephalitis
• 1C85/A83.0 Japanese encephalitis
• 1C86/A83.3 St Louis encephalitis
• 1C87/A83.6 Rocio viral encephalitis
• 1C88/A83.4 Murray Valley encephalitis
• 1C89/A84.0 Far Eastern tick-borne encephalitis
• 1C8A/A84.1 Central European tick-borne encephalitis
• 1C8B/A83.5 California encephalitis
• 1C8C/A92.2 Venezuelan equine encephalitis
• 1C8D/A83.5 La Crosse encephalitis
• 1C8E.1/A87.0 Enteroviral meningitis
• 1C8E.2/A87.1 Meningitis due to adenovirus
• 1C8E/G02.0 Viral meningitis not elsewhere classified
• 1C8E.Y/G02.0 Other specified viral meningitis not elsewhere classified
• 1C8E.Z/G02.0 Viral meningitis not elsewhere classified, unspecified
• 1C8F/A87.2 Lymphocytic choriomeningitis
• 1C8Y/A80-A89 Other specified viral infections of the central nervous system
• 1C8Z/A80-A89 Viral infections of the central nervous system, unspecified
• 1D00.0/G04.2 Bacterial encephalitis
• 1D00.1/G04 Fungal encephalitis
• 1D00.2/G04 Parasitic or protozoal encephalitis
• 1D00/G04 Infectious encephalitis not elsewhere classified
• 1D00.Y/G04.8 Other specified infectious encephalitis not elsewhere classified
• 1D00.Z/G04 Infectious encephalitis not elsewhere classified, unspecified
• 1D01.0/G00 Bacterial meningitis
• 1D01.00/G00.0 Meningitis due to Haemophilus influenzae
• 1D01.0Y/G00.8 Other specified bacterial meningitis
• 1D01.0Z/G00 Bacterial meningitis, unspecified
• 1D01.1/G02.1 Fungal meningitis
• 1D01.10/G02.1 Meningitis due to Cryptococcus neoformans
• 1D01.1Y/G02.1 Other specified fungal meningitis
• 1D01.1Z/G02.1 Fungal meningitis, unspecified
• 1D01.2/G00-G09 Parasitic or protozoal meningitis
• 1D01.3/G03.2 Benign recurrent meningitis
• 1D01/G00-G09 Infectious meningitis not elsewhere classified
• 1D01.Y/G00-G09 Other specified infectious meningitis not elsewhere classified
• 1D01.Z/G00-G09 Infectious meningitis not elsewhere classified, unspecified
• 1D02.0/G04.2 Bacterial myelitis
• 1D02.1/G04 Viral myelitis
• 1D02.2/G04 Fungal myelitis
• 1D02.3/G04 Parasitic myelitis
• 1D02/G04 Infectious myelitis not elsewhere classified
• 1D02.Y/G04.8 Other specified infectious myelitis not elsewhere classified
• 1D02.Z/G04 Infectious myelitis not elsewhere classified, unspecified
• 1D03.0/G00-G09 Intraspinal intramedullary abscess
• 1D03.1/G00-G09 Intraspinal subdural abscess
• 1D03.2/G00-G09 Intraspinal extradural abscess
• 1D03.3/G06.0 Intracranial abscess
• 1D03.30/G06.0 Deep cerebral hemispheric abscess
• 1D03.31/G06.0 Abscess of the corpus callosum
• 1D03.32/G06.0 Pituitary abscess
• 1D03.33/G06.0 Multiple or widespread intracranial abscess
• 1D03.3Y/G06.0 Other specified intracranial abscess
• 1D03.3Z/G06.0 Intracranial abscess, unspecified
• 1D03.4/G00-G09 Intraspinal epidural abscess
• 1D03.5/G00-G09 Spinal cord abscess
• 1D03/G00-G09 Infectious abscess of the central nervous system
• 1D03.Y/G00-G09 Other specified site of infectious abscess of the central nervous system
• 1D03.Z/G00-G09 Infectious abscess of the central nervous system, site unspecified
• 1D04.0/G00-G09 Parasitic intracerebral granuloma
• 1D04.1/G06.0 Intracranial granuloma
• 1D04.10/G06.0 Fungal intracranial granuloma
• 1D04.1Y/G06.0 Other specified intracranial granuloma
• 1D04.1Z/G06.0 Intracranial granuloma, unspecified
• 1D04.2/G00-G09 Intraspinal intramedullary granuloma
• 1D04.3/G00-G09 Intraspinal subdural granuloma
• 1D04.4/G00-G09 Intraspinal extradural granuloma
• 1D04.5/G00-G09 Intraspinal epidural granuloma
• 1D04/G00-G09 Infectious granulomas of the central nervous system
• 1D04.Y/G00-G09 Other specified site of infectious granulomas of the central nervous system
• 1D04.Z/G00-G09 Infectious granulomas of the central nervous system, site unspecified
• 1D05.0/G00-G09 Epidural infectious cyst
• 1D05.1/G00-G09 Subdural infectious cyst
• 1D05/G00-G09 Infectious cysts of the central nervous system
• 1D05.Y/G00-G09 Other specified infectious cysts of the central nervous system
• 1D05.Z/G00-G09 Infectious cysts of the central nervous system, unspecified
• 1D0Y/G00-G09 Other specified non-viral and unspecified infections of the central nervous system
• 1D0Z/G00-G09 Non-viral and unspecified infections of the central nervous system, unspecified
• 1D20/A97.0 Dengue without warning signs
• 1D21/A97.1 Dengue with warning signs
• 1D22/A97.2 Severe dengue
• 1D2Z/A97 Dengue fever, unspecified
• 1D40/A92.0 Chikungunya virus disease
• 1D41/A93.2 Colorado tick fever
• 1D42/A92.1 O’nyong-nyong fever
• 1D43/A93.0 Oropouche virus disease
• 1D44/A92.4 Rift Valley fever
• 1D45/A93.1 Sandfly fever
• 1D46/A92.3 West Nile virus infection
• 1D47/A95 Yellow fever
• 1D48/A92.5 Zika virus disease
• 1D49/A98.0 Crimean-Congo haemorrhagic fever
• 1D4A/A98.1 Omsk haemorrhagic fever
• 1D4B/A98.2 Kyasanur Forest disease
• 1D4C/A92-A99 Alkhurma haemorrhagic fever
• 1D4D/B33.1 Ross River disease
• 1D4E/A92-A99 Severe fever with thrombocytopenia syndrome
• 1D4Y/A92-A99 Other specified arthropod-borne viral fevers
• 1D4Z/A92-A99 Arthropod-borne viral fever, virus unspecified
• 1D60.0/I Ebola disease
• 1D60.00/I Bundibugyo virus disease
• 1D60.01/A98.4 Ebola virus disease
• 1D60.02/I Sudan virus disease
• 1D60.03/I Atypical Ebola disease
• 1D60.0Y/I Other specified Ebola disease
• 1D60.0Z/I Ebola disease, virus unspecified
• 1D60.1/A98.3 Marburg disease
• 1D60.10/A98.3 Marburg virus disease
• 1D60.11/A98.3 Atypical Marburg disease
• 1D60.1Y/A98.3 Other specified Marburg disease
• 1D60.1Z/A98.3 Marburg disease, virus unspecified
• 1D60/I Filovirus disease
• 1D60.Y/I Other specified filovirus disease
• 1D60.Z/I Filovirus disease, virus unspecified
• 1D61.0/A96.0 Argentinian haemorrhagic fever
• 1D61.1/A96.1 Bolivian haemorrhagic fever
• 1D61.2/A96.2 Lassa fever
• 1D61.3/A96 Venezuelan haemorrhagic fever
• 1D61/I Arenavirus disease
• 1D61.Y/I Other specified arenavirus disease
• 1D61.Z/I Arenavirus disease, unspecified
• 1D62.0/A98.5 Haemorrhagic fever with renal syndrome
• 1D62.1/B33.4 Hantavirus pulmonary syndrome
• 1D62.2/I Atypical hantavirus disease
• 1D62/I Hantavirus disease
• 1D62.Y/I Other specified hantavirus disease
• 1D62.Z/I Hantavirus disease, unspecified
• 1D63/I Henipavirus encephalitis
• 1D64/J12.9 Middle East respiratory syndrome
• 1D65/U04 Severe acute respiratory syndrome
• 1D6Y/I Other specified zoonotic viral diseases
• 1D6Z/I Zoonotic viral disease, virus unspecified
• 1D80.0/B26.9 Mumps without complication
• 1D80.1/B26.0 Orchitis due to mumps virus
• 1D80.2/B26.1 Meningitis due to mumps virus
• 1D80.3/B26.2 Encephalitis due to mumps virus
• 1D80.4/B26.3 Pancreatitis due to mumps virus
• 1D80/B26 Mumps
• 1D80.Y/B26.8 Other specified mumps
• 1D81.0/B27 Mononucleosis due to Epstein-Barr virus
• 1D81.1/B27.1 Mononucleosis due to cytomegalovirus
• 1D81/B27 Infectious mononucleosis
• 1D81.Y/B27.8 Other specified infectious mononucleosis
• 1D81.Z/B27 Infectious mononucleosis, unspecified
• 1D82.0/B25.1 Cytomegaloviral hepatitis
• 1D82.1/B25.2 Cytomegaloviral pancreatitis
• 1D82/B25 Cytomegaloviral disease
• 1D82.Y/B25.8 Other specified cytomegaloviral disease
• 1D82.Z/B25 Cytomegaloviral disease, unspecified
• 1D83/B33.0 Epidemic myalgia
• 1D84.0/B30.1 Conjunctivitis due to adenovirus
• 1D84.1/B30.3 Acute epidemic haemorrhagic conjunctivitis
• 1D84/B30.9 Viral conjunctivitis
• 1D84.Y/B30.9 Other specified viral conjunctivitis
• 1D84.Z/B30.9 Viral conjunctivitis, unspecified
• 1D85.0/B33.2 Dilated cardiomyopathy secondary to viral myocarditis
• 1D85.1/B33.2 Acute viral carditis
• 1D85.2/B33.2 Chronic viral carditis
• 1D85.3/B33.2 Aseptic myocarditis of newborn
• 1D85.4/B33.2 Coxsackie carditis
• 1D85/B33.2 Viral carditis
• 1D85.Y/B33.2 Other specified viral carditis
• 1D85.Z/B33.2 Viral carditis, unspecified
• 1D86/B33 Viral haemorrhagic fever, not elsewhere classified
• 1D90/B34.0 Adenovirus infection of unspecified site
• 1D91/B34.1 Enterovirus infection of unspecified site
• 1D92/B34.2 Coronavirus infection, unspecified site
• 1D93/B34.3 Parvovirus infection of unspecified site
• 1D9Y/B34.8 Other viral infections of unspecified site
• 1D9Z/B34 Unspecified viral infection of unspecified site
• 1E1Y/B33.8 Other specified viral diseases
• 1E1Z/B33 Unspecified viral disease
• 1E30/J10 Influenza due to identified seasonal influenza virus
• 1E31/J09 Influenza due to identified zoonotic or pandemic influenza virus
• 1E32/J11 Influenza, virus not identified
• 1E50.0/B15 Acute hepatitis A
• 1E50.1/B16 Acute hepatitis B
• 1E50.2/B17.1 Acute hepatitis C
• 1E50.3/B17.0 Acute hepatitis D
• 1E50.4/B17.2 Acute hepatitis E
• 1E50/B15-B19 Acute viral hepatitis
• 1E50.Y/B15-B19 Other specified acute viral hepatitis
• 1E50.Z/B15-B19 Acute viral hepatitis, unspecified
• 1E51.0/B18 Chronic hepatitis B
• 1E51.00/B18 Chronic hepatitis B with human immunodeficiency virus co-infection
• 1E51.0Y/B18 Other specified chronic hepatitis B
• 1E51.0Z/B18 Chronic hepatitis B, unspecified
• 1E51.1/B18.2 Chronic hepatitis C
• 1E51.2/B18 Chronic hepatitis D
• 1E51.3/B18 Chronic hepatitis E
• 1E51/B18 Chronic viral hepatitis
• 1E51.Y/B18.8 Other specified chronic viral hepatitis
• 1E51.Z/B18 Chronic viral hepatitis, unspecified
• 1E5Z/B15-B19 Viral hepatitis, unspecified
• 1E70/B03 Smallpox
• 1E71/B04 Monkeypox
• 1E72/B08.0 Cowpox
• 1E73/B08.0 Vaccinia
• 1E74/B08.0 Buffalopox
• 1E75/B08.0 Orf
• 1E76/B08.1 Molluscum contagiosum
• 1E7Y/B08.8 Other specified infections due to poxvirus
• 1E7Z/B08.8 Infections due to poxvirus, unspecified
• 1E80.0/B07 Digital or periungual warts
• 1E80.1/B07 Plantar warts
• 1E80/B07 Common warts
• 1E80.Y/B07 Other specified common warts
• 1E81/B07 Plane warts
• 1E82.0/B00-B09 Focal epithelial hyperplasia of oral mucous membranes
• 1E82/B00-B09 Warts of lips or oral cavity
• 1E83/B07 Wart virus proliferation in immune-deficient states
• 1E8Z/B00-B09 Viral warts, not elsewhere classified
• 1E90.0/B01.9 Varicella without complication
• 1E90.1/B01.0 Varicella meningitis
• 1E90.2/B01.1 Varicella encephalitis
• 1E90/B01 Varicella
• 1E90.Y/B01.8 Varicella with other specified complication
• 1E91.0/B02 Zoster without complications
• 1E91.1/B02.3 Ophthalmic zoster
• 1E91.2/B02.7 Disseminated zoster
• 1E91.3/B02.2 Zoster with central nervous system involvement
• 1E91.4/B02.2 Acute neuropathy of cranial nerve due to zoster
• 1E91.40/B02.2 Acute trigeminal zoster neuropathy
• 1E91.41/B02.2 Acute herpetic geniculate ganglionitis
• 1E91.4Y/B02.2 Other specified acute neuropathy of cranial nerve due to zoster
• 1E91.5/B02 Postherpetic polyneuropathy
• 1E91/B02 Zoster
• 1E91.Y/B02.8 Zoster with other specified complications
• 1E91.Z/B02 Zoster, unspecified
• 1F00.0/B00 Herpes simplex infection of skin or mucous membrane
• 1F00.00/B00.9 Herpes simplex infection of skin
• 1F00.01/B00.8 Herpes simplex labialis
• 1F00.02/B00.2 Herpes simplex gingivostomatitis
• 1F00.03/B00.7 Disseminated cutaneous herpes simplex infection complicating other skin diseases
• 1F00.0Y/B00 Other specified herpes simplex infection of skin or mucous membrane
• 1F00.1/B00.5 Herpes simplex infection of the eye
• 1F00.10/B00.5 Herpes simplex keratitis
• 1F00.11/B00.5 Herpes simplex infection of eyelid
• 1F00.1Y/B00.5 Other specified herpes simplex infection of the eye
• 1F00.1Z/B00.5 Herpes simplex infection of the eye, unspecified
• 1F00.2/B00 Herpes simplex infection of central nervous system
• 1F00.20/B00.3 Herpes simplex meningitis
• 1F00.21/B00.4 Encephalitis due to herpes simplex virus
• 1F00.3/B00.7 Disseminated herpes simplex infection
• 1F00/B00 Herpes simplex infections
• 1F00.Y/B00.8 Other specified herpes simplex infections
• 1F00.Z/B00 Herpes simplex infections, unspecified
• 1F01/B08.2 Roseola infantum
• 1F02.0/B06 Rubella with neurological complications
• 1F02.1/M01.4 Rubella arthritis
• 1F02.2/B06.9 Rubella without complication
• 1F02/B06 Rubella
• 1F02.Y/B06.8 Rubella with other specified complication
• 1F03.0/B05.9 Measles without complication
• 1F03.1/B05.0 Measles complicated by encephalitis
• 1F03.2/B05.1 Measles complicated by meningitis
• 1F03/B05 Measles
• 1F03.Y/B05.8 Measles with other complications
• 1F04/B08.3 Erythema infectiosum
• 1F05.0/B08.4 Enteroviral vesicular stomatitis
• 1F05.1/B08.5 Enteroviral vesicular pharyngitis
• 1F05.2/A88.0 Enteroviral exanthematous fever
• 1F05.3/B08.8 Foot and mouth disease
• 1F05/B00-B09 Picornavirus infections presenting in the skin or mucous membranes
• 1F05.Y/B00-B09 Other specified picornavirus infections presenting in the skin or mucous membranes
• 1F0Y/B00-B09 Other specified viral infections characterised by skin or mucous membrane lesions
• 1F0Z/B00-B09 Viral infections characterised by skin or mucous membrane lesions, unspecified
• 1F20.0/B44 Invasive aspergillosis
• 1F20.00/B44.8 Invasive aspergillosis of the digestive tract
• 1F20.01/B44.8 Invasive cerebral aspergillosis
• 1F20.02/B44.7 Disseminated aspergillosis
• 1F20.0Y/B44 Invasive aspergillosis of other specified site
• 1F20.1/B44 Non-invasive aspergillosis
• 1F20.10/B44.8 Aspergillus otomycosis
• 1F20.11/B44.8 Chronic aspergillosis of the paranasal sinuses
• 1F20.12/B44.1 Chronic pulmonary aspergillosis
• 1F20.13/B44.2 Tonsillar aspergillosis
• 1F20.14/B44 Aspergillus bronchitis
• 1F20.15/B44 Obstructing aspergillus tracheobronchitis
• 1F20.1Y/B44 Other specified non-invasive aspergillosis
• 1F20/B44 Aspergillosis
• 1F20.Z/B44 Aspergillosis, unspecified
• 1F21/B46.8 Basidiobolomycosis
• 1F22/B40 Blastomycosis
• 1F23.0/B37.0 Candidosis of lips or oral mucous membranes
• 1F23.1/B37 Candidosis of skin or mucous membranes
• 1F23.10/B37.3 Vulvovaginal candidosis
• 1F23.11/B37.4 Candida balanoposthitis
• 1F23.12/B37 Flexural or intertriginous candidosis
• 1F23.13/B37 Candidosis of nail or paronychium
• 1F23.14/B37 Chronic mucocutaneous candidosis
• 1F23.15/B37 Disseminated cutaneous candidosis
• 1F23.16/B37 Candida otomycosis
• 1F23.1Y/B37 Candidosis of skin or mucous membrane of other specified site
• 1F23.1Z/B37 Candidosis of skin or mucous membranes, unspecified
• 1F23.2/B37 Candidosis of gastrointestinal tract
• 1F23.3/B37 Systemic or invasive candidosis
• 1F23.30/B37.5 Candida meningitis
• 1F23.31/B37.1 Pulmonary candidosis
• 1F23.3Y/B37 Other specified systemic or invasive candidosis
• 1F23.3Z/B37 Systemic or invasive candidosis, unspecified
• 1F23/B37 Candidosis
• 1F23.Y/B37.8 Other specified candidosis
• 1F23.Z/B37 Candidosis, unspecified
• 1F24/B43 Chromoblastomycosis
• 1F25.0/B38 Pulmonary coccidioidomycosis
• 1F25.00/B38 Acute pulmonary coccidioidomycosis
• 1F25.01/B38 Chronic pulmonary coccidioidomycosis
• 1F25.1/B38 Extrathoracic coccidioidomycosis
• 1F25.10/B38.7 Disseminated coccidioidomycosis
• 1F25.11/B38.3 Primary cutaneous coccidioidomycosis
• 1F25.12/B38.4 Coccidioides meningitis
• 1F25.1Y/B38 Other specified extrathoracic coccidioidomycosis
• 1F25/B38 Coccidioidomycosis
• 1F25.Z/B38 Coccidioidomycosis, unspecified
• 1F26/B46.8 Conidiobolomycosis
• 1F27.0/B45.0 Pulmonary cryptococcosis
• 1F27.1/B45.1 Cerebral cryptococcosis
• 1F27.2/B45.7 Disseminated cryptococcosis
• 1F27/B45 Cryptococcosis
• 1F27.Y/B45.8 Other specified cryptococcosis
• 1F27.Z/B45 Cryptococcosis, unspecified
• 1F28.0/B35 Dermatophytosis of scalp
• 1F28.1/B35.1 Dermatophytosis of nail
• 1F28.2/B35.3 Dermatophytosis of foot
• 1F28.3/B35.6 Genitocrural dermatophytosis
• 1F28.4/B35.8 Kerion
• 1F28.5/B35.8 Disseminated dermatophytosis
• 1F28/B35 Dermatophytosis
• 1F28.Y/B35.8 Other specified dermatophytosis
• 1F28.Z/B35 Dermatophytosis, unspecified
• 1F29/B47.0 Eumycetoma
• 1F2A.0/B39.2 Pulmonary histoplasmosis capsulati
• 1F2A.1/B39.5 Histoplasmosis due to Histoplasma duboisii
• 1F2A/B39 Histoplasmosis
• 1F2A.Y/B39 Other specified histoplasmosis
• 1F2A.Z/B39 Histoplasmosis, unspecified
• 1F2B/B48.0 Lobomycosis
• 1F2C/B46 Mucormycosis
• 1F2D.0/B36.0 Pityriasis versicolor
• 1F2D.1/B36 Malassezia folliculitis
• 1F2D.2/B36.2 White piedra
• 1F2D.3/B36.3 Black piedra
• 1F2D.4/B36.1 Tinea nigra
• 1F2D.5/B36 Onychomycosis due to non-dermatophyte mould
• 1F2D/B36 Non-dermatophyte superficial dermatomycoses
• 1F2D.Y/B36.8 Other specified non-dermatophyte superficial dermatomycoses
• 1F2E.0/B41.0 Pulmonary paracoccidioidomycosis
• 1F2E.1/B41.7 Disseminated paracoccidioidomycosis
• 1F2E/B41 Paracoccidioidomycosis
• 1F2E.Y/B41.8 Other specified paracoccidioidomycosis
• 1F2E.Z/B41 Paracoccidioidomycosis, unspecified
• 1F2F/B48.8 Phaeohyphomycosis
• 1F2G.0/B48.5 Pulmonary pneumocystosis
• 1F2G/B48.5 Pneumocystosis
• 1F2G.Z/B48.5 Pneumocystosis, unspecified
• 1F2H/B48.2 Scedosporiosis
• 1F2J.0/B42.1 Lymphocutaneous sporotrichosis
• 1F2J.1/B42.8 Fixed cutaneous sporotrichosis
• 1F2J.2/B42.0 Pulmonary sporotrichosis
• 1F2J.3/B42.7 Disseminated sporotrichosis
• 1F2J/B42 Sporotrichosis
• 1F2J.Y/B42.8 Other specified sporotrichosis
• 1F2J.Z/B42 Sporotrichosis, unspecified
• 1F2K/B48.4 Talaromycosis
• 1F2L.0/B35-B49 Disseminated adiaspiromycosis
• 1F2L.1/B35-B49 Pulmonary adiaspiromycosis
• 1F2L/B35-B49 Emmonsiosis
• 1F2L.Y/B35-B49 Other specified emmonsiosis
• 1F2L.Z/B35-B49 Emmonsiosis, unspecified
• 1F2Y/B35-B49 Other specified mycoses
• 1F2Z/B35-B49 Mycoses, unspecified
• 1F40.0/B50.0 Plasmodium falciparum malaria with cerebral complications
• 1F40/B50 Malaria due to Plasmodium falciparum
• 1F40.Y/B50.8 Other severe and complicated Plasmodium falciparum malaria
• 1F40.Z/B50 Malaria due to Plasmodium falciparum, unspecified
• 1F41.0/B51.0 Plasmodium vivax malaria with rupture of spleen
• 1F41/B51 Malaria due to Plasmodium vivax
• 1F41.Y/B51.8 Malaria due to Plasmodium vivax with other complications
• 1F41.Z/B51 Plasmodium vivax malaria without complication
• 1F42.0/B52.0 Plasmodium malariae malaria with nephropathy
• 1F42/B52.9 Malaria due to Plasmodium malariae
• 1F42.Y/B52.9 Malaria due to Plasmodium malariae with other complications
• 1F42.Z/B52.9 Plasmodium malariae malaria without complication
• 1F43/B53.0 Malaria due to Plasmodium ovale
• 1F44/B53 Other parasitologically confirmed malaria
• 1F45/B54 Malaria without parasitological confirmation
• 1F4Z/B50-B64 Malaria, unspecified
• 1F50/B60.1 Acanthamoebiasis
• 1F51.0/B56.0 Gambiense trypanosomiasis
• 1F51.00/B56.0 Meningitis in Gambiense trypanosomiasis
• 1F51.0Y/B56.0 Other specified gambiense trypanosomiasis
• 1F51.0Z/B56.0 Gambiense trypanosomiasis, unspecified
• 1F51.1/B56.1 Rhodesiense trypanosomiasis
• 1F51.10/B56.1 Meningitis in Rhodesiense trypanosomiasis
• 1F51.1Y/B56.1 Other specified rhodesiense trypanosomiasis
• 1F51.1Z/B56.1 Rhodesiense trypanosomiasis, unspecified
• 1F51/B56 African trypanosomiasis
• 1F51.Y/B56 Other specified african trypanosomiasis
• 1F51.Z/B56 African trypanosomiasis, unspecified
• 1F52/B60.0 Babesiosis
• 1F53.1/B57.1 Acute Chagas disease without heart involvement
• 1F53.2/B57.2 Chronic Chagas disease with heart involvement
• 1F53.3/B57.3 Chagas disease with digestive system involvement
• 1F53.4/B57.4 Meningitis in Chagas disease
• 1F53/B57 Chagas disease
• 1F53.Y/B57 Other specified Chagas disease
• 1F53.Z/B57 Chagas disease, unspecified
• 1F54.0/B55.0 Visceral leishmaniasis
• 1F54.1/B55.1 Cutaneous leishmaniasis
• 1F54.2/B55.2 Mucocutaneous leishmaniasis
• 1F54/B55 Leishmaniasis
• 1F54.Z/B55 Leishmaniasis, unspecified
• 1F55/B60.2 Naegleriasis
• 1F56/B48.1 Rhinosporidiosis
• 1F57.0/B58.1 Hepatitis due to Toxoplasma gondii
• 1F57.1/B58.2 Meningoencephalitis due to Toxoplasma gondii
• 1F57.2/B58.3 Pulmonary toxoplasmosis due to Toxoplasma gondii
• 1F57.3/B58.0 Eye disease due to Toxoplasma gondii
• 1F57/B58 Toxoplasmosis
• 1F57.Y/B58.8 Other specified toxoplasmosis
• 1F57.Z/B58 Toxoplasmosis, unspecified
• 1F58/B60.8 Microsporidiosis
• 1F5Z/B60.8 Unspecified protozoal disease
• 1F60.0/B65-B83 Eosinophilic meningitis due to Angiostrongylus cantonensis
• 1F60.1/B81.3 Intestinal angiostrongyliasis
• 1F60/B65-B83 Angiostrongyliasis
• 1F60.Y/B65-B83 Other specified angiostrongyliasis
• 1F60.Z/B65-B83 Angiostrongyliasis, unspecified
• 1F61/B81.0 Anisakiasis
• 1F62/B77 Ascariasis
• 1F63.0/B81.1 Capillariasis of the intestine
• 1F63/B65-B83 Capillariasis
• 1F63.Y/B65-B83 Other specified capillariasis
• 1F63.Z/B65-B83 Capillariasis, unspecified
• 1F64/B72 Dracunculiasis
• 1F65/B80 Enterobiasis
• 1F66.0/B74.3 Loiasis
• 1F66.1/B74.4 Mansonelliasis
• 1F66.2/B74 Filariasis due to Brugia species
• 1F66.3/B74 Lymphatic filariasis
• 1F66.30/B74.0 Filariasis due to Wuchereria bancrofti
• 1F66.31/B74.1 Filariasis due to Brugia malayi
• 1F66.32/B74.2 Filariasis due to Brugia timori
• 1F66.3Z/B74 Lymphatic filariasis, unspecified
• 1F66.4/B74.8 Subcutaneous dirofilariasis
• 1F66/B74 Filariasis
• 1F66.Y/B74.8 Other specified filariasis
• 1F66.Z/B74 Filariasis, unspecified
• 1F67/B83.1 Gnathostomiasis
• 1F68.0/B76 Ancylostomiasis
• 1F68.1/B76.1 Necatoriasis
• 1F68.2/B76 Cutaneous larva migrans
• 1F68/B76 Hookworm diseases
• 1F69/B81.8 Oesophagostomiasis
• 1F6A.0/B73 Onchocerciasis of the eye
• 1F6A.1/B73 Onchocerciasis of the skin
• 1F6A/B73 Onchocerciasis
• 1F6A.Y/B73 Other specified onchocerciasis
• 1F6B/B78 Strongyloidiasis
• 1F6C/B83.3 Syngamosis
• 1F6D/B83.0 Toxocariasis
• 1F6E/B75 Trichinosis
• 1F6F/B81.2 Trichostrongyliasis
• 1F6G/B79 Trichuriasis
• 1F6H/B65-B83 Uncinariosis
• 1F6Y/B65-B83 Other specified diseases due to nematodes
• 1F6Z/B65-B83 Diseases due to nematodes, unspecified
• 1F70.0/B69.0 Cysticercosis of central nervous system
• 1F70.00/B69.0 Meningitis due to Cysticercosis
• 1F70.1/B69.1 Cysticercosis of eye
• 1F70/B69 Cysticercosis
• 1F70.Y/B69.8 Other specified cysticercosis
• 1F70.Z/B69 Cysticercosis, unspecified
• 1F71/B70.0 Diphyllobothriasis
• 1F72/B71.1 Dipylidiasis
• 1F73.0/B67.8 Echinococcus infection of liver
• 1F73.1/B67.7 Echinococcus infection of lung
• 1F73.2/B67.7 Echinococcus infection of bone
• 1F73.3/B67.7 Echinococcus infection of central nervous system
• 1F73/B67.7 Echinococcosis
• 1F73.Y/B67.7 Other specified echinococcosis
• 1F73.Z/B67.7 Echinococcosis, unspecified
• 1F74/B71.0 Hymenolepiasis
• 1F75/B70.1 Sparganosis
• 1F76.0/B68.0 Taeniasis due to Taenia solium
• 1F76.1/B68.1 Taeniasis due to Taenia saginata
• 1F76/B68 Taeniasis
• 1F76.Y/B68 Other specified taeniasis
• 1F76.Z/B68 Taeniasis, unspecified
• 1F7Y/B71.8 Other specified diseases due to cestodes
• 1F7Z/B71 Diseases due to cestodes, unspecified
• 1F80/B66.1 Clonorchiasis
• 1F81/B66.2 Dicrocoeliasis
• 1F82/B66.3 Fascioliasis
• 1F83/B66.5 Fasciolopsiasis
• 1F84/B66.0 Opisthorchiasis
• 1F85/B66.4 Paragonimiasis
• 1F86.0/B65.0 Schistosomiasis due to Schistosoma haematobium
• 1F86.1/B65.1 Schistosomiasis due to Schistosoma mansoni
• 1F86.2/B65.2 Schistosomiasis due to Schistosoma japonicum
• 1F86.3/B65 Other schistosomiases
• 1F86.4/B65.3 Cercarial dermatitis
• 1F86.5/B65 Schistosomal pneumonitis
• 1F86/B65 Schistosomiasis
• 1F86.Z/B65 Schistosomiasis due to unspecified or unknown Schistosoma species
• 1F8Y/B66.8 Other specified diseases due to trematodes
• 1F8Z/B66 Diseases due to trematodes, unspecified
• 1F90.0/B82.9 Mixed intestinal helminthiases
• 1F90.1/B82.9 Intestinal parasitic infestation not otherwise specified
• 1F90.2/B82.0 Intestinal helminthiasis, unspecified
• 1F90/B82.9 Other and unspecified infestation by parasitic worms
• 1F90.Y/B82.9 Other specified other and unspecified infestation by parasitic worms
• 1F90.Z/B82.9 Other and unspecified infestation by parasitic worms, unspecified
• 1F91/B65-B83 Diphyllobothriasis and sparganosis
• 1F9Z/B65-B83 Helminthiases, unspecified
• 1G00.0/B85.0 Pediculosis capitis
• 1G00.1/B85.1 Pediculosis corporis
• 1G00/B85.2 Pediculosis
• 1G00.Z/B85.2 Pediculosis of unspecified site or type
• 1G01.0/B87.2 Ocular myiasis
• 1G01.1/B87.3 Nasopharyngeal myiasis
• 1G01.2/B87 Laryngeal myiasis
• 1G01.3/B87.0 Cutaneous myiasis
• 1G01/B87 Myiasis
• 1G01.Y/B87.8 Other specified myiasis
• 1G01.Z/B87 Myiasis, unspecified
• 1G02/B88.3 External hirudiniasis
• 1G03/B85.3 Pthiriasis
• 1G04.0/B86 Classical scabies
• 1G04.1/B86 Crusted scabies
• 1G04/B86 Scabies
• 1G04.Y/B86 Other and unspecified scabies
• 1G05/B88.1 Tungiasis
• 1G06/B88.8 Cimicosis
• 1G07.0/B88.0 Infestation by Demodex
• 1G07/B88.9 Infestation by mites
• 1G07.Y/B88.9 Infestation of the skin by other specified parasitic mites
• 1G0Y/B85-B89 Infestation by other specified ectoparasite
• 1G0Z/B85-B89 Infestation by unknown or unspecified ectoparasite
• 1G2Y/I Other specified parasitic diseases
• 1G2Z/I Unspecified parasitic diseases
• 1G40/A30-A49 Sepsis without septic shock
• 1G41/R57.2 Sepsis with septic shock
• 1G60.0/B47 Mycetoma of unknown or unspecified type
• 1G60.1/I Pythiosis
• 1G60.2/I Protothecosis
• 1G60/I Certain other disorders of infectious origin
• 1G60.Y/I Other specified disorders of infectious origin not elsewhere classified
• 1G80/B90 Sequelae of tuberculosis
• 1G81/I Sequelae of trachoma
• 1G82/B92 Sequelae of leprosy
• 1G83/B91 Sequelae of poliomyelitis
• 1G84/I Sequelae of viral encephalitis
• 1G85/I Sequelae of diphtheria
• 1G8Y/I Sequelae of other specified infectious diseases
• 1H0Z/I Infection, unspecified
• 2A00.0/C69-C72 Gliomas of brain
• 2A00.00/C71 Glioblastoma of brain
• 2A00.0Y/C69-C72 Other specified gliomas of brain
• 2A00.0Z/C69-C72 Gliomas of brain, unspecified
• 2A00.1/C69-C72 Embryonal tumours of brain
• 2A00.10/C71.6 Medulloblastoma of brain
• 2A00.11/C71 Central primitive neuroectodermal tumour
• 2A00.1Y/C69-C72 Other specified embryonal tumours of brain
• 2A00.1Z/C69-C72 Embryonal tumours of brain, unspecified
• 2A00.2/C69-C72 Tumours of neuroepithelial tissue of brain
• 2A00.20/C69-C72 Tumours of the pineal gland or pineal region
• 2A00.21/D33.2 Mixed neuronal-glial tumours
• 2A00.22/D33 Choroid plexus tumours
• 2A00.2Y/C69-C72 Other specified tumours of neuroepithelial tissue of brain
• 2A00.2Z/C69-C72 Tumours of neuroepithelial tissue of brain, unspecified
• 2A00.3/C71.6 Central neurocytoma of brain
• 2A00.4/C69-C72 Astroblastoma of the brain
• 2A00.5/C69-C72 Primary neoplasm of brain of unknown or unspecified type
• 2A00/C69-C72 Primary neoplasms of brain
• 2A01.0/C69-C72 Meningiomas
• 2A01.00/C70 Primary malignant meningioma
• 2A01.0Y/C69-C72 Other specified meningiomas
• 2A01.0Z/C69-C72 Meningiomas, unspecified
• 2A01.1/C70 Mesenchymal tumours of meninges
• 2A01.2/C70.0 Primary neoplasm of meninges of unknown or unspecified type
• 2A01/C69-C72 Primary neoplasms of meninges
• 2A02.0/C72 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system
• 2A02.00/C72 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system
• 2A02.0Y/C72 Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system
• 2A02.0Z/C72 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified
• 2A02.1/C72 Tumours of cranial or paraspinal nerves
• 2A02.10/C47.9 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves
• 2A02.11/C72 Paraspinal neuroblastoma
• 2A02.12/C72.3 Malignant neoplasm of the optic nerve
• 2A02.1Y/C72 Other specified tumours of cranial or paraspinal nerves
• 2A02.1Z/C72 Tumours of cranial or paraspinal nerves, unspecified
• 2A02.2/C72 Primary neoplasm of spinal cord of unknown or unspecified type
• 2A02.3/D33.3 Benign neoplasm of cranial nerves
• 2A02.4/D33.4 Benign neoplasm of spinal cord
• 2A02/C72 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system
• 2A0Z/C69-C72 Other and unspecified neoplasms of brain or central nervous system
• 2A20.0/C92.1 Chronic myelogenous leukaemia, BCR-ABL1-positive
• 2A20.00/C92.1 Chronic myelogenous leukaemia with blast crisis
• 2A20.01/C92.1 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive
• 2A20.02/C92.1 Chronic myelogenous leukaemia, t(9:22)(q34; q11)
• 2A20.03/C92.1 Naegeli-type monocytic leukaemia
• 2A20.0Y/C92.1 Other specified chronic myelogenous leukaemia, BCR-ABL1-positive
• 2A20.0Z/C92.1 Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified
• 2A20.1/D47.1 Chronic neutrophilic leukaemia
• 2A20.2/D47.4 Primary myelofibrosis
• 2A20.3/D47.5 Chronic eosinophilic leukaemia, not elsewhere classified
• 2A20.4/D45 Polycythaemia vera
• 2A20.5/D47.7 Non mast cell myeloproliferative neoplasm, unclassifiable
• 2A20/D47.7 Non mast cell myeloproliferative neoplasms
• 2A20.Y/D47.7 Other specified non mast cell myeloproliferative neoplasms
• 2A20.Z/D47.7 Non mast cell myeloproliferative neoplasms, unspecified
• 2A21.0/C96.2 Systemic mastocytosis
• 2A21.00/C94.3 Mast cell leukaemia
• 2A21.0Y/C96.2 Other specified systemic mastocytosis
• 2A21.0Z/C96.2 Systemic mastocytosis, unspecified
• 2A21.1/C96.2 Cutaneous mastocytosis
• 2A21.10/C96.2 Urticaria pigmentosa
• 2A21.1Y/C96.2 Other specified cutaneous mastocytosis
• 2A21.2/C96.2 Mast cell sarcoma
• 2A21.3/C96.2 Extracutaneous mastocytoma
• 2A21/C96.2 Mastocytosis
• 2A21.Y/C96.2 Other specified mastocytosis
• 2A21.Z/C96.2 Mastocytosis, unspecified
• 2A22/D47.1 Other and unspecified myeloproliferative neoplasms
• 2A30/D46 Refractory anaemia
• 2A31/D46 Refractory neutropaenia
• 2A32/D46 Refractory thrombocytopenia
• 2A33/D46.1 Refractory anaemia with ring sideroblasts
• 2A34/D46.5 Refractory cytopenia with multi-lineage dysplasia
• 2A35/D46.2 Refractory anaemia with excess of blasts
• 2A36/D46.6 Myelodysplastic syndrome with isolated del(5q)
• 2A37/D46 Myelodysplastic syndrome, unclassifiable
• 2A38/D46 Refractory cytopenia of childhood
• 2A3Y/D46 Other specified myelodysplastic syndromes
• 2A3Z/D46 Myelodysplastic syndromes, unspecified
• 2A40/C93.1 Chronic myelomonocytic leukaemia
• 2A41/C92.2 Atypical chronic myeloid leukaemia, BCR-ABL1- negative
• 2A42.0/C93.3 Juvenile myelomonocytic leukaemia in complete remission
• 2A42/C93.3 Juvenile myelomonocytic leukaemia
• 2A42.Y/C93.3 Other specified juvenile myelomonocytic leukaemia
• 2A42.Z/C93.3 Juvenile myelomonocytic leukaemia, unspecified
• 2A43/D37-D48 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis
• 2A44/C94.6 Myeloproliferative and myelodysplastic disease, unclassifiable
• 2A4Y/C81-C96 Other specified myelodysplastic and myeloproliferative neoplasms
• 2A4Z/C81-C96 Myelodysplastic and myeloproliferative neoplasms, unspecified
• 2A50/C92.7 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement
• 2A51/C92.7 Myeloid neoplasm associated with PDGFRB rearrangement
• 2A52/C92.7 Myeloid or lymphoid neoplasms with FGFR1 abnormalities
• 2A5Z/C94.7 Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified
• 2A60.0/C92.9 Acute myeloid leukaemia with recurrent genetic abnormalities
• 2A60.1/C92.7 Acute myeloid leukaemia with myelodysplasia-related changes
• 2A60.2/D47.1 Therapy-related myeloid neoplasms
• 2A60.20/C92.7 Therapy related acute myeloid leukaemia or myelodysplastic syndrome
• 2A60.2Y/D47.1 Other specified therapy-related myeloid neoplasms
• 2A60.2Z/D47.1 Therapy-related myeloid neoplasms, unspecified
• 2A60.3/C92.0 Acute myeloid leukaemia, not elsewhere classified by criteria of other types
• 2A60.30/C92.0 Acute myeloid leukaemia with minimal differentiation
• 2A60.31/C92.0 Acute myeloid leukaemia without maturation
• 2A60.32/C92.0 Acute myeloid leukaemia with maturation
• 2A60.33/C92.5 Acute myelomonocytic leukaemia
• 2A60.34/C93.0 Acute monoblastic or monocytic leukaemia
• 2A60.35/C94.0 Acute erythroid leukaemia
• 2A60.36/C94.2 Acute megakaryoblastic leukaemia
• 2A60.37/C92.0 Acute basophilic leukaemia
• 2A60.38/C94.4 Acute panmyelosis with myelofibrosis
• 2A60.39/C92.3 Myeloid sarcoma
• 2A60.3Y/C92.0 Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types
• 2A60.3Z/C92.0 Acute myeloid leukaemia, unspecified
• 2A60.4/C92.7 Myeloid proliferation associated with Down syndrome
• 2A60.40/D61.9 Transient abnormal myelopoiesis
• 2A60.41/C92.7 Myeloid leukaemia associated with Down syndrome
• 2A60.4Y/C92.7 Other specified myeloid proliferation associated with Down syndrome
• 2A60.4Z/C92.7 Myeloid proliferation associated with Down syndrome, unspecified
• 2A60.5/C86.4 Blastic plasmacytoid dendritic cell neoplasm
• 2A60/C81-C96 Acute myeloid leukaemias and related precursor neoplasms
• 2A60.Y/C81-C96 Other specified acute myeloid leukaemias and related precursor neoplasms
• 2A60.Z/C81-C96 Acute myeloid leukaemias and related precursor neoplasms, unspecified
• 2A61/C94 Acute leukaemias of ambiguous lineage
• 2A70.0/C81-C96 B Lymphoblastic leukaemia or lymphoma, not elsewhere classified
• 2A70.1/C81-C96 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1
• 2A70/C81-C96 Precursor B-lymphoblastic neoplasms
• 2A70.Y/C81-C96 Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities
• 2A71/C81-C96 Precursor T-lymphoblastic neoplasms
• 2A7Z/C81-C96 Precursor lymphoid neoplasms, unspecified
• 2A80.0/C82.0 Follicular lymphoma grade 1
• 2A80.1/C82.1 Follicular lymphoma grade 2
• 2A80.2/C82.2 Follicular lymphoma grade 3
• 2A80.3/C82.6 Primary cutaneous follicle centre lymphoma
• 2A80.4/C82.9 Paediatric type follicular lymphoma
• 2A80.5/C82.9 Follicular lymphoma in situ
• 2A80.6/C82.9 Follicular lymphoma of small intestine
• 2A80/C82.9 Follicular lymphoma
• 2A80.Y/C82.9 Other specified follicular lymphoma
• 2A80.Z/C82.9 Follicular lymphoma, unspecified
• 2A81.0/C85.2 Primary mediastinal large B-cell lymphoma
• 2A81.1/C83.3 Intravascular large B-cell lymphoma
• 2A81.2/C83.3 Plasmablastic lymphoma
• 2A81.3/C83.3 Lymphomatoid granulomatosis
• 2A81.4/C83.3 T-cell/histiocyte rich large B-cell lymphoma
• 2A81.5/C83.3 Primary diffuse large B-cell lymphoma of central nervous system
• 2A81.6/C83.3 Epstein-Barr Virus-positive diffuse large B cell lymphoma of the elderly
• 2A81.7/C83.3 Diffuse large B-cell lymphoma associated with chronic inflammation
• 2A81.8/C83.3 ALK-positive large B-cell lymphoma
• 2A81.9/C83.3 Primary effusion lymphoma
• 2A81.A/C83.3 Primary cutaneous diffuse large B-cell lymphoma, leg type
• 2A81/C83.3 Diffuse large B-cell lymphomas
• 2A81.Y/C83.3 Other specified diffuse large B-cell lymphomas
• 2A81.Z/C83.3 Diffuse large B-cell lymphoma, not otherwise specified
• 2A82.0/C91.7 Chronic lymphocytic leukaemia or small lymphocytic lymphoma
• 2A82.00/C91.1 Chronic lymphocytic leukaemia of B-cell type
• 2A82.0Y/C91.7 Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma
• 2A82.0Z/C91.7 Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified
• 2A82.1/C91.3 B-cell prolymphocytic leukaemia
• 2A82.10/C91.3 B-cell prolymphocytic leukaemia in complete remission
• 2A82.1Y/C91.3 Other specified b-cell prolymphocytic leukaemia
• 2A82.1Z/C91.3 B-cell prolymphocytic leukaemia, unspecified
• 2A82.2/C91.4 Hairy-cell leukaemia
• 2A82.3/C91.7 Splenic B-cell lymphoma or leukaemia, unclassifiable
• 2A82/C91.7 Mature B-cell neoplasm with leukaemic behaviour
• 2A82.Y/C91.7 Other specified mature B-cell neoplasm with leukaemic behaviour
• 2A82.Z/C91.7 Mature B-cell neoplasm with leukaemic behaviour, unspecified
• 2A83.0/D47.2 Monoclonal gammopathy of undetermined significance
• 2A83.1/C90.0 Plasma cell myeloma
• 2A83.2/C90.3 Solitary plasmacytoma
• 2A83.3/C90 Extraosseous plasmacytoma
• 2A83.4/C90.1 Plasma cell leukaemia
• 2A83.5/C90 Monoclonal immunoglobulin deposition disease
• 2A83.50/D47.7 Heavy chain deposition disease
• 2A83.51/D47.7 Light and heavy chain deposition disease
• 2A83.52/D47.7 Light chain deposition disease
• 2A83/C90 Plasma cell neoplasms
• 2A83.Y/C90 Other specified multiple myeloma and plasma cell neoplasms
• 2A83.Z/C90 Plasma cell neoplasm, unspecified
• 2A84.0/C88 Alpha heavy chain disease
• 2A84.1/C88 Gamma heavy chain disease
• 2A84.2/C88 Mu heavy chain disease
• 2A84/C88 Heavy chain diseases or malignant immunoproliferative diseases
• 2A84.Y/C88 Other specified malignant immunoproliferative diseases
• 2A84.Z/C88 Heavy chain diseases, unspecified
• 2A85.0/C88.7 Nodal marginal zone lymphoma
• 2A85.1/C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach
• 2A85.2/C88.7 Extranodal marginal zone B-cell lymphoma, primary site skin
• 2A85.3/C85.7 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin
• 2A85.4/C88.0 Lymphoplasmacytic lymphoma
• 2A85.5/C83.1 Mantle cell lymphoma
• 2A85.6/C83.7 Burkitt lymphoma including Burkitt leukaemia
• 2A85/C85.1 Other specified mature B-cell neoplasms or lymphoma
• 2A85.Y/C85.1 Further specified mature B-cell neoplasms or lymphoma
• 2A86.0/C85.1 Malignant lymphoma of B cell type, not elsewhere classified
• 2A86.1/C85.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma
• 2A86.2/C85.1 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
• 2A86/C81-C96 B-cell lymphoma, mixed features
• 2A86.Y/C81-C96 Other specified B-cell lymphoma, mixed features
• 2A86.Z/C81-C96 B-cell lymphoma, mixed features, unspecified
• 2A8Z/C81-C96 Mature B-cell neoplasms, unspecified
• 2A90.0/C91.6 T-cell prolymphocytic leukaemia
• 2A90.1/C86 T-cell large granular lymphocytic leukaemia
• 2A90.2/C86 Chronic lymphoproliferative disorders of NK-cells
• 2A90.3/C86 Aggressive NK cell leukaemia
• 2A90.4/C86 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood
• 2A90.5/C91.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated
• 2A90.6/C86.0 Extranodal NK/T-cell lymphoma, nasal type
• 2A90.7/C86.2 Enteropathy associated T-cell lymphoma
• 2A90.8/C86.1 Hepatosplenic T-cell lymphoma
• 2A90.9/C86.5 Angioimmunoblastic T-cell lymphoma
• 2A90.A/C84.6 Anaplastic large cell lymphoma, ALK-positive
• 2A90.B/C84.7 Anaplastic large cell lymphoma, ALK-negative
• 2A90.C/C84.4 Peripheral T-cell lymphoma, not otherwise specified
• 2A90/C86 Mature T-cell lymphoma, specified types, nodal or systemic
• 2B00/C86.3 Subcutaneous panniculitis-like T-cell lymphoma
• 2B01/C84.0 Mycosis fungoides
• 2B02/C84.1 Sézary syndrome
• 2B03.0/C86.6 Primary cutaneous CD30 positive anaplastic large cell lymphoma
• 2B03.1/C84 Lymphomatoid papulosis
• 2B03/C84 Primary cutaneous CD-30 positive T-cell lymphoproliferative disorders
• 2B0Y/C84 Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders
• 2B0Z/C84 Primary cutaneous T-cell lymphoma of undetermined or unspecified type
• 2B2Y/C84.8 Other specified mature T-cell or NK-cell neoplasms
• 2B2Z/C84 Mature T-cell or NK-cell neoplasms, unspecified
• 2B30.0/C81.0 Nodular lymphocyte predominant Hodgkin lymphoma
• 2B30.1/C81.7 Classical Hodgkin lymphoma
• 2B30.10/C81.1 Nodular sclerosis classical Hodgkin lymphoma
• 2B30.11/C81.4 Lymphocyte-rich classical Hodgkin lymphoma
• 2B30.12/C81.2 Mixed cellularity classical Hodgkin lymphoma
• 2B30.13/C81.3 Lymphocyte depleted classical Hodgkin lymphoma
• 2B30.1Z/C81.7 Classical Hodgkin lymphoma, unspecified
• 2B30/C81 Hodgkin lymphoma
• 2B30.Z/C81 Hodgkin lymphoma, unspecified
• 2B31.0/D76.3 Juvenile xanthogranuloma
• 2B31.1/C96.8 Histiocytic sarcoma
• 2B31.2/C81-C96 Langerhans cell histiocytosis
• 2B31.20/C96.6 Langerhans cell histiocytosis involving the skin
• 2B31.2Y/C81-C96 Other specified Langerhans cell histiocytosis
• 2B31.3/C96.4 Langerhans cell sarcoma
• 2B31.4/C96.4 Interdigitating dendritic cell sarcoma
• 2B31.5/C96.4 Follicular dendritic cell sarcoma
• 2B31.6/C96.4 Indeterminate cell histiocytosis
• 2B31.7/C96.4 Fibroblastic reticular cell tumour
• 2B31/C81-C96 Histiocytic or dendritic cell neoplasms
• 2B31.Y/C81-C96 Other specified histiocytic or dendritic cell neoplasms
• 2B31.Z/C81-C96 Histiocytic or dendritic cell neoplasms, unspecified
• 2B32.0/D47.7 Post-transplant lymphoproliferative disorder, early lesion
• 2B32.1/D75.8 Reactive plasmacytic hyperplasia
• 2B32.2/D47.7 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like
• 2B32.3/D47.7 Polymorphic post-transplant lymphoproliferative disorder
• 2B32/D47.9 Immunodeficiency-associated lymphoproliferative disorders
• 2B32.Y/D47.9 Other specified immunodeficiency-associated lymphoproliferative disorders
• 2B32.Z/D47.9 Immunodeficiency-associated lymphoproliferative disorders, unspecified
• 2B33.0/C95.0 Acute leukaemia, not elsewhere classified
• 2B33.1/C92 Myeloid leukaemia
• 2B33.2/C96.9 Chronic myeloid leukaemia, not elsewhere classified
• 2B33.3/C91.0 Lymphoid leukaemia, not elsewhere classified
• 2B33.4/C95.9 Leukaemia, unspecified
• 2B33.5/C85.9 Malignant lymphoma, not elsewhere classified
• 2B33/C96.9 Malignant haematopoietic neoplasms without further specification
• 2B33.Y/C96.9 Other malignant haematopoietic neoplasms without further specification
• 2B3Z/C81-C96 Neoplasms of haematopoietic or lymphoid tissues, unspecified
• 2B50.0/C40 Chondrosarcoma of bone or articular cartilage of limbs
• 2B50.1/C41.9 Chondrosarcoma of bone or articular cartilage of pelvis
• 2B50.2/C41.3 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle
• 2B50/C41.9 Chondrosarcoma, primary site
• 2B50.Y/C41.9 Chondrosarcoma of bone or articular cartilage of other specified sites
• 2B50.Z/C41.9 Chondrosarcoma of bone or articular cartilage of unspecified sites
• 2B51.0/C41.1 Osteosarcoma of bone or articular cartilage of jaw
• 2B51.1/C40 Osteosarcoma of bone or articular cartilage of limbs
• 2B51.2/C41.4 Osteosarcoma of bone or articular cartilage of pelvis
• 2B51/C41.9 Osteosarcoma, primary site
• 2B51.Y/C41.9 Osteosarcoma of bone and articular cartilage of other specified sites
• 2B51.Z/C41.9 Osteosarcoma of bone and articular cartilage of unspecified sites
• 2B52.0/C40 Ewing sarcoma of bone or articular cartilage of limbs
• 2B52.1/C41.4 Ewing sarcoma of bone or articular cartilage of pelvis
• 2B52.2/C41.3 Ewing sarcoma of bone or articular cartilage of ribs
• 2B52.3/C41.9 Ewing sarcoma of soft tissue
• 2B52/C41.9 Ewing sarcoma, primary site
• 2B52.Y/C41.9 Ewing sarcoma of bone and articular cartilage of other specified sites
• 2B52.Z/C41.9 Ewing sarcoma of bone and articular cartilage of unspecified sites
• 2B53.0/C41.9 Myxofibrosarcoma, primary site
• 2B53.1/C41.9 Fibroblastic or myofibroblastic tumour of skin
• 2B53/C41.9 Fibroblastic or myofibroblastic tumour, primary site
• 2B53.Y/C41.9 Other specified fibroblastic or myofibroblastic tumour, primary site
• 2B53.Z/C41.9 Fibroblastic or myofibroblastic tumour, primary site, unspecified
• 2B54.0/C41.9 Unclassified pleomorphic sarcoma of skin
• 2B54.1/C41.9 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum
• 2B54/C41.9 Unclassified pleomorphic sarcoma, primary site
• 2B54.Y/C41.9 Unclassified pleomorphic sarcoma, primary site, other specified site
• 2B54.Z/C41.9 Unclassified pleomorphic sarcoma, primary site, unspecified site
• 2B55.0/C41.9 Rhabdomyosarcoma of the oral cavity or pharynx
• 2B55.1/C41.9 Rhabdomyosarcoma of respiratory or intrathoracic organs
• 2B55.2/C41.9 Rhabdomyosarcoma of male genital organs
• 2B55/C41.9 Rhabdomyosarcoma, primary site
• 2B55.Y/C41.9 Rhabdomyosarcoma, other specified primary site
• 2B55.Z/C41.9 Rhabdomyosarcoma, unspecified primary site
• 2B56.0/C41.9 Angiosarcoma of heart
• 2B56.1/C41.9 Angiosarcoma of skin
• 2B56.2/C41.9 Angiosarcoma of breast
• 2B56.3/C22.3 Angiosarcoma of liver
• 2B56/C41.9 Angiosarcoma, primary site
• 2B56.Y/C41.9 Angiosarcoma, other specified primary site
• 2B56.Z/C41.9 Angiosarcoma, unspecified primary site
• 2B57.0/C46 Kaposi sarcoma of lung
• 2B57.1/C46.0 Kaposi sarcoma of skin
• 2B57.2/C46 Kaposi sarcoma of gastrointestinal sites
• 2B57/C46 Kaposi sarcoma, primary site
• 2B57.Y/C46.8 Kaposi sarcoma of other specified primary sites
• 2B57.Z/C46 Kaposi sarcoma of unspecified primary site
• 2B58.0/C41.9 Leiomyosarcoma of retroperitoneum or peritoneum
• 2B58.1/C41.9 Leiomyosarcoma of uterus
• 2B58.2/C41.9 Leiomyosarcoma of stomach
• 2B58/C41.9 Leiomyosarcoma, primary site
• 2B58.Y/C41.9 Leiomyosarcoma, other specified primary site
• 2B58.Z/C41.9 Leiomyosarcoma, unspecified primary site
• 2B59.0/C41.9 Liposarcoma of soft tissue of limb
• 2B59.1/C41.9 Liposarcoma of retroperitoneum or peritoneum
• 2B59.2/C41.9 Liposarcoma of male genital organs
• 2B59/C41.9 Liposarcoma, primary site
• 2B59.Y/C41.9 Liposarcoma, other specified primary site
• 2B59.Z/C41.9 Liposarcoma, unspecified primary site
• 2B5A.0/C41.9 Synovial sarcoma of soft tissues of limb
• 2B5A.1/C41.9 Synovial sarcoma of respiratory or intra-thoracic organs
• 2B5A/C41.9 Synovial sarcoma, primary site
• 2B5A.Y/C41.9 Synovial sarcoma, other specified primary site
• 2B5A.Z/C41.9 Synovial sarcoma, unspecified primary site
• 2B5B.0/C41.9 Gastrointestinal stromal tumour of stomach
• 2B5B.1/C41.9 Gastrointestinal stromal tumour of small intestine
• 2B5B/C41.9 Gastrointestinal stromal tumour, primary site
• 2B5B.Y/C41.9 Gastrointestinal stromal tumour of other gastrointestinal sites
• 2B5B.Z/C41.9 Gastrointestinal stromal tumour of unspecified gastrointestinal sites
• 2B5C/C41.9 Endometrial stromal sarcoma, primary site
• 2B5D.0/C41.9 Malignant mixed epithelial mesenchymal tumour of ovary
• 2B5D.1/C41.9 Malignant mixed epithelial and mesenchymal tumour of corpus uteri
• 2B5D/C41.9 Malignant mixed epithelial mesenchymal tumour, primary site
• 2B5D.Y/C41.9 Malignant mixed epithelial mesenchymal tumour, other specified primary site
• 2B5D.Z/C41.9 Malignant mixed epithelial mesenchymal tumour, unspecified primary site
• 2B5E/C41.9 Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
• 2B5F.0/C41.9 Sarcoma, not elsewhere classified of uterus
• 2B5F.1/C41.9 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum
• 2B5F.10/C48.1 Myosarcomas of omentum
• 2B5F.1Y/C41.9 Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum
• 2B5F.1Z/C41.9 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified
• 2B5F.2/C41.9 Sarcoma, not elsewhere classified of other specified sites
• 2B5F.3/C41.9 Sarcoma, not elsewhere classified, primary site unknown
• 2B5F/C41.9 Sarcoma, not elsewhere classified, primary site
• 2B5G/C41.9 Myosarcoma of uterus, part not specified
• 2B5H/C41.9 Well differentiated lipomatous tumour, primary site
• 2B5J/C41.9 Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
• 2B5K/C49 Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
• 2B5Y/C41.9 Other specified malignant mesenchymal neoplasms
• 2B5Z/C41.9 Malignant mesenchymal neoplasm of unspecified type
• 2B60.0/C00 Basal cell carcinoma of lip
• 2B60.1/C00 Squamous cell carcinoma of lip
• 2B60/C00 Malignant neoplasms of lip
• 2B60.Y/C00.8 Other specified malignant neoplasms of lip
• 2B60.Z/C00 Malignant neoplasms of lip, unspecified
• 2B61.0/C01 Squamous cell carcinoma of the base of the tongue
• 2B61/C01 Malignant neoplasms of base of tongue
• 2B61.Y/C01 Other specified malignant neoplasms of base of tongue
• 2B61.Z/C01 Malignant neoplasms of base of tongue, unspecified
• 2B62.0/C02 Squamous cell carcinoma of other or unspecified parts of tongue
• 2B62.1/C02.4 Malignant neoplasms of lingual tonsil
• 2B62.10/C02.4 Squamous cell carcinoma of lingual tonsil
• 2B62/C02 Malignant neoplasms of other or unspecified parts of tongue
• 2B62.Y/C02.8 Other specified malignant neoplasms of other and unspecified parts of tongue
• 2B62.Z/C02 Malignant neoplasms of other or unspecified parts of tongue, unspecified
• 2B63.0/C03 Squamous cell carcinoma of gum
• 2B63/C03 Malignant neoplasms of gum
• 2B63.Y/C03 Other specified malignant neoplasm of gum
• 2B63.Z/C03 Malignant neoplasms of gum, unspecified
• 2B64.0/C04 Squamous cell carcinoma of floor of mouth
• 2B64/C04 Malignant neoplasms of floor of mouth
• 2B64.Y/C04.8 Other specified malignant neoplasm of floor of mouth
• 2B64.Z/C04 Malignant neoplasms of floor of mouth, unspecified
• 2B65.0/C05 Adenocarcinoma of palate
• 2B65.1/C05 Squamous cell carcinoma of palate
• 2B65/C05 Malignant neoplasms of palate
• 2B65.Y/C05.8 Other specified malignant neoplasm of palate
• 2B65.Z/C05 Malignant neoplasms of palate, unspecified
• 2B66.0/C06 Squamous cell carcinoma of other or unspecified parts of mouth
• 2B66/C06 Malignant neoplasms of other or unspecified parts of mouth
• 2B66.Y/C06.8 Other specified malignant neoplasms of other and unspecified parts of mouth
• 2B66.Z/C06 Malignant neoplasms of other or unspecified parts of mouth, unspecified
• 2B67.0/C07 Adenocarcinoma of parotid gland
• 2B67.1/C07 Squamous cell carcinoma of parotid gland
• 2B67/C07 Malignant neoplasms of parotid gland
• 2B67.Y/C07 Other specified malignant neoplasms of parotid gland
• 2B67.Z/C07 Malignant neoplasms of parotid gland, unspecified
• 2B68.0/C08 Adenocarcinoma of submandibular or sublingual glands
• 2B68.1/C08 Squamous cell carcinoma of submandibular or sublingual glands
• 2B68.2/C08 Other specified malignant neoplasms of submandibular or sublingual glands
• 2B68/C08 Malignant neoplasms of submandibular or sublingual glands
• 2B68.Z/C08 Malignant neoplasms of submandibular or sublingual glands, unspecified
• 2B69.0/C09 Squamous cell carcinoma of tonsil
• 2B69.1/C09 Other specified malignant neoplasms of tonsil
• 2B69/C09 Malignant neoplasms of tonsil
• 2B69.Z/C09 Malignant neoplasms of tonsil, unspecified
• 2B6A.0/C10 Squamous cell carcinoma of oropharynx
• 2B6A/C10 Malignant neoplasms of oropharynx
• 2B6A.Y/C10.8 Other specified malignant neoplasms of oropharynx
• 2B6A.Z/C10 Malignant neoplasms of oropharynx, unspecified
• 2B6B.0/C11 Squamous cell carcinoma of nasopharynx
• 2B6B.1/C11 Malignant epithelial neoplasms of nasopharynx, unspecified type
• 2B6B.2/C11 Malignant neoplasms of pharyngeal tonsil
• 2B6B.20/C11 Squamous cell carcinoma of pharyngeal tonsil
• 2B6B.21/C11 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil
• 2B6B.2Y/C11 Other specified malignant neoplasms of pharyngeal tonsil
• 2B6B.2Z/C11 Malignant neoplasm of pharyngeal tonsil without mention of type
• 2B6B/C11 Malignant neoplasms of nasopharynx
• 2B6B.Y/C11.8 Other specified malignant neoplasms of nasopharynx
• 2B6B.Z/C11 Malignant neoplasms of nasopharynx, unspecified
• 2B6C.0/C12 Squamous cell carcinoma of piriform sinus
• 2B6C/C12 Malignant neoplasms of piriform sinus
• 2B6C.Y/C12 Other specified malignant neoplasms of piriform sinus
• 2B6C.Z/C12 Malignant neoplasms of piriform sinus, unspecified
• 2B6D.0/C13 Squamous cell carcinoma of hypopharynx and variants
• 2B6D/C13 Malignant neoplasms of hypopharynx
• 2B6D.Y/C13.8 Other specified malignant neoplasms of hypopharynx
• 2B6D.Z/C13 Malignant neoplasms of hypopharynx, unspecified
• 2B6E.0/C14 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
• 2B6E/C14 Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
• 2B6E.Y/C14.8 Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
• 2B6E.Z/C14 Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified
• 2B6Y/C00-C14 Other specified malignant neoplasms of lip, oral cavity or pharynx
• 2B6Z/C00-C14 Malignant neoplasms of lip, oral cavity or pharynx, unspecified
• 2B70.0/C15 Adenocarcinoma of oesophagus
• 2B70.00/C15 Barrett adenocarcinoma
• 2B70.0Y/C15 Other specified adenocarcinoma of oesophagus
• 2B70.0Z/C15 Adenocarcinoma of oesophagus, unspecified
• 2B70.1/C15 Squamous cell carcinoma of oesophagus
• 2B70/C15 Malignant neoplasms of oesophagus
• 2B70.Y/C15.8 Other specified malignant neoplasms of oesophagus
• 2B70.Z/C15 Malignant neoplasms of oesophagus, unspecified
• 2B71.0/C15-C26 Adenocarcinoma of oesophagogastric junction
• 2B71/C15-C26 Malignant neoplasms of oesophagogastric junction
• 2B71.Y/C15-C26 Other specified malignant neoplasm of oesophagogastric junction
• 2B71.Z/C15-C26 Malignant neoplasms of oesophagogastric junction, unspecified
• 2B72.0/C16 Adenocarcinoma of stomach
• 2B72.1/C16 Malignant neuroendocrine neoplasm of stomach
• 2B72/C16 Malignant neoplasms of stomach
• 2B72.Y/C16.8 Other specified malignant neoplasms of stomach
• 2B72.Z/C16 Malignant neoplasms of stomach, unspecified
• 2B80.0/C17.0 Malignant neoplasms of duodenum
• 2B80.00/C17.0 Adenocarcinoma of duodenum
• 2B80.01/C17.0 Neuroendocrine neoplasm of duodenum
• 2B80.0Y/C17.0 Other specified malignant neoplasms of the duodenum
• 2B80.0Z/C17.0 Malignant neoplasms of duodenum, unspecified
• 2B80.1/C17 Malignant neoplasms of jejunum or ileum
• 2B80.10/C17 Adenocarcinoma of jejunum or ileum
• 2B80.11/C17 Neuroendocrine neoplasms of jejunum or ileum
• 2B80.1Y/C17 Other specified malignant neoplasms of jejunum or ileum
• 2B80.1Z/C17 Malignant neoplasms of jejunum or ileum, unspecified
• 2B80.2/C17 Malignant neoplasms of small intestine, site unspecified
• 2B80.20/C17 Adenocarcinoma of small intestine, site unspecified
• 2B80.21/C17 Neuroendocrine neoplasms of small intestine, site unspecified
• 2B80.2Y/C17 Other specified malignant neoplasms of small intestine, site unspecified
• 2B80/C17 Malignant neoplasms of small intestine
• 2B80.Y/C17.8 Other specified malignant neoplasms of small intestine
• 2B80.Z/C17 Malignant neoplasms of small intestine, unspecified
• 2B81.0/C18.1 Adenocarcinoma of appendix
• 2B81.1/C18.1 Mucinous adenocarcinoma of appendix
• 2B81.2/C18.1 Neuroendocrine neoplasms of appendix
• 2B81/C18.1 Malignant neoplasms of appendix
• 2B81.Y/C18.1 Other specified malignant neoplasms of appendix
• 2B81.Z/C18.1 Malignant neoplasms of appendix, unspecified
• 2B90.0/C18 Malignant neoplasm of ascending colon and right flexure of colon
• 2B90.00/C18 Adenocarcinoma of ascending colon or right flexure of colon
• 2B90.0Y/C18 Other specified malignant neoplasm of ascending colon and right flexure of colon
• 2B90.0Z/C18 Malignant neoplasm of ascending colon and right flexure of colon, unspecified
• 2B90.1/C18 Malignant neoplasm of descending colon and splenic flexure of colon
• 2B90.10/C18 Adenocarcinoma of descending colon or splenic flexure of colon
• 2B90.1Y/C18 Other specified malignant neoplasm of descending colon and splenic flexure of colon
• 2B90.1Z/C18 Malignant neoplasm of descending colon and splenic flexure of colon, unspecified
• 2B90.2/C18.4 Malignant neoplasm of transverse colon
• 2B90.20/C18.4 Adenocarcinoma of transverse colon
• 2B90.2Y/C18.4 Other specified malignant neoplasm of transverse colon
• 2B90.2Z/C18.4 Malignant neoplasm of transverse colon, unspecified
• 2B90.3/C18.7 Malignant neoplasm of sigmoid colon
• 2B90.30/C18.7 Adenocarcinoma of sigmoid colon
• 2B90.3Y/C18.7 Other specified malignant neoplasm of sigmoid colon
• 2B90.3Z/C18.7 Malignant neoplasm of sigmoid colon, unspecified
• 2B90/C18 Malignant neoplasms of colon
• 2B90.Y/C18.8 Other specified malignant neoplasms of colon
• 2B90.Z/C18 Malignant neoplasms of colon, unspecified
• 2B91.0/C19 Adenocarcinoma of rectosigmoid junction
• 2B91/C19 Malignant neoplasms of rectosigmoid junction
• 2B91.Y/C19 Other specified malignant neoplasms of rectosigmoid junction
• 2B91.Z/C19 Malignant neoplasms of rectosigmoid junction, unspecified
• 2B92.0/C20 Adenocarcinomas of rectum
• 2B92.1/C20 Neuroendocrine neoplasms of rectum
• 2B92/C20 Malignant neoplasms of rectum
• 2B92.Y/C20 Other specified malignant neoplasms of rectum
• 2B92.Z/C20 Malignant neoplasms of rectum, unspecified
• 2B93.0/C15-C26 Adenocarcinoma of large intestine, site unspecified
• 2B93/C15-C26 Malignant neoplasms of large intestine, site unspecified
• 2B93.Y/C15-C26 Other specified malignant neoplasms of large intestine, site unspecified
• 2B93.Z/C15-C26 Malignant neoplasms of large intestine, site and type unspecified
• 2B9Y/C15-C26 Other specified malignant neoplasms of large intestine
• 2C00.0/C21 Adenocarcinoma of anus or anal canal
• 2C00.1/C21 Melanoma of anus or anal canal
• 2C00.2/C21 Neuroendocrine neoplasm of anus or anal canal
• 2C00.3/C21 Squamous cell carcinoma of anus or anal canal
• 2C00/C21 Malignant neoplasms of anus or anal canal
• 2C00.Y/C21.8 Other specified malignant neoplasms of anus and anal canal
• 2C00.Z/C21 Malignant neoplasms of anus or anal canal, unspecified
• 2C0Y/C15-C26 Other specified malignant neoplasms of intestine
• 2C0Z/C15-C26 Malignant neoplasms of intestine, unspecified
• 2C10.0/C25 Adenocarcinoma of pancreas
• 2C10.1/C25.4 Neuroendocrine neoplasms of pancreas
• 2C10/C25 Malignant neoplasm of pancreas
• 2C10.Y/C25.8 Other specified malignant neoplasms of pancreas
• 2C10.Z/C25 Malignant neoplasm of pancreas, unspecified
• 2C11.0/C26 Adenocarcinoma of other or ill-defined digestive organs
• 2C11.1/C26 Mucinous carcinoma of other or ill-defined digestive organs
• 2C11.2/C26 Other specified malignant neoplasms of other or ill-defined digestive organs
• 2C11/C26 Malignant neoplasms of other or ill-defined digestive organs
• 2C11.Z/C26 Malignant neoplasms of other or ill-defined digestive organs, unspecified
• 2C12.0/C22 Malignant neoplasm of liver
• 2C12.00/C22 Combined hepatocellular-cholangiocarcinoma
• 2C12.01/C22.2 Hepatoblastoma
• 2C12.02/C22.0 Hepatocellular carcinoma of liver
• 2C12.03/C22 Mesothelial carcinoma of liver
• 2C12.0Y/C22 Other specified malignant neoplasm of liver
• 2C12.1/C22 Malignant neoplasm of intrahepatic bile ducts
• 2C12.10/C22.1 Intrahepatic cholangiocarcinoma
• 2C12.1Y/C22 Other specified malignant neoplasms of intrahepatic bile ducts
• 2C12/C22 Malignant neoplasms of liver or intrahepatic bile ducts
• 2C12.Z/C22 Malignant neoplasms of liver or intrahepatic bile ducts, unspecified
• 2C13.0/C23 Adenocarcinoma of the gallbladder
• 2C13/C23 Malignant neoplasms of gallbladder
• 2C13.Y/C23 Other specified malignant neoplasm of gallbladder
• 2C13.Z/C23 Malignant neoplasms of gallbladder, unspecified
• 2C14.0/C24.0 Adenocarcinoma of proximal biliary tract, cystic duct
• 2C14.1/C24.0 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct
• 2C14.2/C24.0 Neuroendocrine neoplasms of cystic duct
• 2C14/C24.0 Malignant neoplasms of proximal biliary tract, cystic duct
• 2C14.Y/C24.0 Other specified malignant neoplasms of biliary tract, cystic duct
• 2C14.Z/C24.0 Malignant neoplasms of proximal biliary tract, cystic duct, unspecified
• 2C15.0/C24.0 Adenocarcinoma of biliary tract, distal bile duct
• 2C15.1/C24.0 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct
• 2C15.2/C24.0 Neuroendocrine neoplasms of distal bile duct
• 2C15/C24.0 Malignant neoplasms of biliary tract, distal bile duct
• 2C15.Y/C24.0 Other specified malignant neoplasms of biliary tract, distal bile duct
• 2C15.Z/C24.0 Malignant neoplasms of biliary tract, distal bile duct, unspecified
• 2C16.0/C24.1 Adenocarcinoma of ampulla of Vater
• 2C16.1/C24.1 Neuroendocrine neoplasms of ampulla of Vater
• 2C16/C24.1 Malignant neoplasms of ampulla of Vater
• 2C16.Y/C24.1 Other specified malignant neoplasms of ampulla of Vater
• 2C16.Z/C24.1 Malignant neoplasms of ampulla of Vater, unspecified
• 2C17.0/C24 Adenocarcinoma of other or unspecified parts of biliary tract
• 2C17.1/C24 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract
• 2C17.2/C24 Neuroendocrine neoplasms of other or unspecified parts of biliary tract
• 2C17/C24 Malignant neoplasms of other or unspecified parts of biliary tract
• 2C17.Y/C24.8 Other specified malignant neoplasms of overlapping lesion of biliary tract
• 2C17.Z/C24 Malignant neoplasms of other or unspecified parts of biliary tract, unspecified
• 2C18.0/C15-C26 Hilar cholangiocarcinoma
• 2C18.1/C15-C26 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct
• 2C18.2/C15-C26 Neuroendocrine neoplasm of perihilar bile duct
• 2C18/C15-C26 Malignant neoplasms of perihilar bile duct
• 2C18.Y/C15-C26 Other specified malignant neoplasms of perihilar bile duct
• 2C18.Z/C15-C26 Malignant neoplasms of perihilar bile duct, unspecified
• 2C1Z/C15-C26 Malignant neoplasms of digestive organs, unspecified
• 2C20.0/C30.0 Adenocarcinoma of nasal cavity
• 2C20.1/C30.0 Malignant neuroepitheliomatous neoplasm of nasal cavity
• 2C20.2/C30.0 Melanoma of nasal cavity
• 2C20.3/C30.0 Olfactory neuroblastoma
• 2C20.4/C30.0 Squamous cell carcinoma of nasal cavity
• 2C20/C30.0 Malignant neoplasms of nasal cavity
• 2C20.Y/C30.0 Other specified malignant neoplasm of nasal cavity
• 2C20.Z/C30.0 Malignant neoplasms of nasal cavity, unspecified
• 2C21.0/C30.1 Adenocarcinoma of middle ear
• 2C21.1/C30.1 Squamous cell carcinoma of middle ear
• 2C21.2/C30.1 Unspecified malignant epithelial neoplasm of middle ear
• 2C21/C30.1 Malignant neoplasms of middle ear
• 2C21.Y/C30.1 Other specified malignant neoplasm of middle ear
• 2C21.Z/C30.1 Malignant neoplasms of middle ear, unspecified
• 2C22.0/C31 Adenocarcinoma of accessory sinuses
• 2C22.1/C31 Squamous cell carcinoma of accessory sinuses
• 2C22.10/C31 Squamous cell carcinoma of sphenoidal sinus
• 2C22.1Y/C31 Squamous cell carcinoma of other specified accessory sinuses
• 2C22.2/C31 Malignant epithelial neoplasms of accessory sinuses, unspecified type
• 2C22.3/C31 Melanomas of accessory sinuses
• 2C22/C31 Malignant neoplasms of accessory sinuses
• 2C22.Y/C31.8 Other specified malignant neoplasms of accessory sinuses
• 2C22.Z/C31 Malignant neoplasms of accessory sinuses, unspecified
• 2C23.1/C32.0 Malignant neoplasms of glottis of larynx
• 2C23.10/C32.0 Squamous cell carcinoma of larynx, glottis
• 2C23.1Y/C32.0 Other specified malignant neoplasms of larynx, glottis
• 2C23.2/C32.1 Malignant neoplasms of supraglottis of larynx
• 2C23.20/C32.1 Squamous cell carcinoma of larynx, supraglottis
• 2C23.2Y/C32.1 Other specified malignant neoplasms of larynx, supraglottis
• 2C23.3/C32.2 Malignant neoplasms of subglottis of larynx
• 2C23.30/C32.2 Squamous cell carcinoma of larynx, subglottis
• 2C23.31/C32.2 Adenocarcinoma of larynx, subglottis
• 2C23.3Y/C32.2 Other specified malignant neoplasms of larynx, subglottis
• 2C23.4/C32 Malignant neoplasm of laryngeal cartilage
• 2C23.5/C32 Malignant neoplasm of overlapping lesion of larynx
• 2C23/C32 Malignant neoplasms of larynx
• 2C23.Z/C32 Malignant neoplasms of larynx, unspecified
• 2C24.0/C33 Adenocarcinoma of trachea
• 2C24.1/C33 Squamous cell carcinoma of trachea
• 2C24.2/C33 Malignant epithelial neoplasms of trachea, unspecified type
• 2C24/C33 Malignant neoplasms of trachea
• 2C24.Y/C33 Other specified malignant neoplasms of trachea
• 2C24.Z/C33 Malignant neoplasms of trachea, unspecified
• 2C25.0/C34 Adenocarcinoma of bronchus or lung
• 2C25.1/C34 Small cell carcinoma of bronchus or lung
• 2C25.2/C34 Squamous cell carcinoma of bronchus or lung
• 2C25.3/C34 Large cell carcinoma of bronchus or lung
• 2C25.4/C34 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung
• 2C25.5/C34 Unspecified malignant epithelial neoplasm of bronchus or lung
• 2C25/C34 Malignant neoplasms of bronchus or lung
• 2C25.Y/C34.8 Other specified malignant neoplasms of bronchus or lung
• 2C25.Z/C34 Malignant neoplasms of bronchus or lung, unspecified
• 2C26.0/C45.0 Mesothelioma of pleura
• 2C26/C38.4 Malignant neoplasms of the pleura
• 2C26.Y/C38.4 Other specified malignant neoplasms of the pleura
• 2C26.Z/C38.4 Malignant neoplasms of the pleura, unspecified
• 2C27.0/C37 Carcinoma of thymus
• 2C27.1/C37 Carcinoid tumour or other neuroendocrine neoplasms of thymus
• 2C27.2/C37 Malignant thymoma
• 2C27/C37 Malignant neoplasms of thymus
• 2C27.Y/C37 Other specified malignant neoplasms of thymus
• 2C27.Z/C37 Malignant neoplasms of thymus, unspecified
• 2C28.0/C38 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura
• 2C28.1/C38 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura
• 2C28/C38 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura
• 2C28.Z/C38 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified
• 2C29.0/C39 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs
• 2C29.1/C39 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
• 2C29/C39 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
• 2C29.Z/C39 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified
• 2C2Y/C00-C75 Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs
• 2C2Z/C00-C75 Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified
• 2C30.0/C43.9 Superficial spreading melanoma, primary
• 2C30.1/C43.9 Nodular melanoma, primary
• 2C30.2/C43.9 Lentigo maligna melanoma, primary
• 2C30.3/C43.9 Acral lentiginous melanoma, primary
• 2C30/C43.9 Melanoma of skin
• 2C30.Y/C43.9 Other specified melanoma of skin
• 2C30.Z/C43.9 Melanoma of skin, unspecified
• 2C31.0/C44 Verrucous squamous cell carcinoma of skin
• 2C31.1/C44 Keratoacanthoma
• 2C31/C44 Squamous cell carcinoma of skin
• 2C31.Z/C44 Cutaneous squamous cell carcinoma
• 2C32.0/C44 Nodular basal cell carcinoma of skin
• 2C32.1/C44 Sclerosing basal cell carcinoma of skin
• 2C32.2/C44 Superficial basal cell carcinoma of skin
• 2C32/C44 Basal cell carcinoma of skin
• 2C32.Y/C44.8 Other specified basal cell carcinoma of skin
• 2C32.Z/C44 Basal cell carcinoma of skin, unspecified
• 2C33/C44 Adnexal carcinoma of skin
• 2C34/C43-C44 Cutaneous neuroendocrine carcinoma
• 2C35/C44 Cutaneous sarcoma
• 2C3Y/C43-C44 Other specified malignant neoplasms of skin
• 2C3Z/C43-C44 Malignant neoplasm of skin of unknown or unspecified type
• 2C40/C47 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system
• 2C41/C47 Malignant perineurioma
• 2C4Y/C47.8 Other specified malignant neoplasms of peripheral nerves and autonomic nervous system
• 2C4Z/C47 Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified
• 2C50.0/C48.0 Cystic, mucinous or serous carcinoma of retroperitoneum
• 2C50/C48.0 Malignant neoplasms of retroperitoneum
• 2C50.Y/C48.0 Other specified malignant neoplasms of retroperitoneum
• 2C50.Z/C48.0 Malignant neoplasms of retroperitoneum, unspecified
• 2C51.0/C48.2 Adenocarcinomas of peritoneum
• 2C51.1/C48.2 Cystic, mucinous or serous carcinoma of peritoneum
• 2C51.2/C45.1 Mesotheliomas of peritoneum
• 2C51.20/C45.1 Mesothelioma of mesocolon
• 2C51.21/C45.1 Mesothelioma of mesentery
• 2C51.2Y/C45.1 Mesotheliomas of other specified sites of peritoneum
• 2C51.2Z/C45.1 Mesotheliomas of peritoneum, site unspecified
• 2C51/C48.2 Malignant neoplasms of peritoneum
• 2C51.Y/C48.2 Other specified malignant neoplasms of peritoneum
• 2C51.Z/C48.2 Malignant neoplasms of peritoneum, unspecified
• 2C52.0/C48.1 Cystic, mucinous or serous carcinoma of omentum
• 2C52/C45-C49 Malignant neoplasms of omentum
• 2C52.Y/C45-C49 Other specified malignant neoplasms of omentum
• 2C52.Z/C45-C49 Malignant neoplasms of omentum, unspecified
• 2C53.0/C48.8 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum
• 2C53.1/C45 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum
• 2C53/C45-C49 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
• 2C53.Y/C45-C49 Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
• 2C53.Z/C45-C49 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified
• 2C5Y/C45-C49 Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum
• 2C5Z/C45-C49 Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified
• 2C60/C50-C50 Carcinoma of breast, specialised type
• 2C61.0/C50-C50 Invasive ductal carcinoma of breast
• 2C61.1/C50-C50 Invasive lobular carcinoma of breast
• 2C61.2/C50-C50 Invasive pleomorphic lobular carcinoma of breast
• 2C61.3/C50-C50 Invasive carcinoma of breast with mixed ductal and lobular features
• 2C61.4/C50-C50 Invasive carcinoma of breast, unidentifiable type
• 2C61/C50-C50 Invasive carcinoma of breast
• 2C62/C50-C50 Inflammatory carcinoma of breast
• 2C63/C50-C50 Malignant phyllodes tumour of breast
• 2C64/C50-C50 Solid papillary carcinoma of breast with evidence of invasion
• 2C65/C50 Hereditary breast and ovarian cancer syndrome
• 2C6Y/C50-C50 Other specified malignant neoplasms of breast
• 2C6Z/C50-C50 Malignant neoplasms of breast, unspecified
• 2C70.0/C51 Basal cell carcinoma of vulva
• 2C70.1/C51 Melanoma of vulva
• 2C70.2/C51 Squamous cell carcinoma of vulva
• 2C70/C51 Malignant neoplasms of vulva
• 2C70.Y/C51.8 Other specified malignant neoplasms of vulva
• 2C70.Z/C51 Malignant neoplasms of vulva, unspecified
• 2C71.0/C52 Adenocarcinoma of vagina
• 2C71.1/C52 Melanoma of vagina
• 2C71.2/C52 Squamous cell carcinoma of vagina
• 2C71/C52 Malignant neoplasms of vagina
• 2C71.Y/C52 Other specified malignant neoplasms of vagina
• 2C71.Z/C52 Malignant neoplasms of vagina, unspecified
• 2C72.0/C51-C58 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa
• 2C72.1/C51-C58 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa
• 2C72.3/C51-C58 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa
• 2C72/C51-C58 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa
• 2C72.Y/C51-C58 Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa
• 2C72.Z/C51-C58 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified
• 2C73.0/C56 Carcinomas of ovary
• 2C73.00/C56 Clear cell adenocarcinoma of ovary
• 2C73.01/C56 Endometrioid adenocarcinoma of ovary
• 2C73.02/C56 Low grade serous adenocarcinoma of ovary
• 2C73.03/C56 High grade serous adenocarcinoma of ovary
• 2C73.04/C56 Mucinous adenocarcinoma of ovary
• 2C73.0Y/C56 Other specified carcinomas of ovary
• 2C73.0Z/C56 Carcinomas of ovary, unspecified
• 2C73.1/C56 Dysgerminoma of ovary
• 2C73.2/C56 Granulosa cell malignant tumour of ovary
• 2C73.3/C56 Malignant teratoma of ovary
• 2C73.4/C56 Serous cystadenoma, borderline malignancy of ovary
• 2C73.5/C56 Endodermal sinus tumour, unspecified site, female
• 2C73/C56 Malignant neoplasms of ovary
• 2C73.Y/C56 Other specified malignant neoplasms of the ovary
• 2C73.Z/C56 Malignant neoplasms of ovary, unspecified
• 2C74.0/C57.0 Adenocarcinoma of fallopian tube
• 2C74/C57.0 Malignant neoplasms of fallopian tube
• 2C74.Y/C57.0 Other specified malignant neoplasms of fallopian tube
• 2C74.Z/C57.0 Malignant neoplasms of fallopian tube, unspecified
• 2C75.0/C58 Malignant trophoblastic neoplasms of placenta
• 2C75/C58 Malignant neoplasms of placenta
• 2C75.Y/C58 Other specified malignant neoplasms of placenta
• 2C75.Z/C58 Malignant neoplasms of placenta, unspecified
• 2C76.0/C54 Endometrial endometrioid adenocarcinoma
• 2C76.1/C54 Endometrial mucinous adenocarcinoma
• 2C76.2/C54 Endometrial clear cell adenocarcinoma
• 2C76.3/C54 Endometrial serous adenocarcinoma
• 2C76.4/C54 Endometrial mixed adenocarcinoma
• 2C76.40/C54 Endometrial squamous cell carcinoma
• 2C76.41/C54 Endometrial small cell carcinoma
• 2C76.42/C54 Endometrial undifferentiated carcinoma
• 2C76.43/C54 Carcinosarcoma of uterus
• 2C76/C54 Malignant neoplasms of corpus uteri
• 2C76.Y/C54.8 Other specified malignant neoplasms of corpus uteri
• 2C76.Z/C54 Malignant neoplasms of corpus uteri, unspecified
• 2C77.0/C53.9 Squamous cell carcinoma of cervix uteri
• 2C77.1/C53.9 Adenocarcinoma of cervix uteri
• 2C77.2/C53.9 Adenosquamous carcinoma of cervix uteri
• 2C77.3/C53.9 Neuroendocrine carcinoma of cervix uteri
• 2C77/C53.9 Malignant neoplasms of cervix uteri
• 2C77.Y/C53.9 Other specified malignant neoplasms of cervix uteri
• 2C77.Z/C53.9 Malignant neoplasms of cervix uteri, unspecified
• 2C78/C55 Malignant neoplasms of uterus, part not specified
• 2C79/C57.8 Malignant neoplasm involving overlapping sites of female genital organs
• 2C7Y/C51-C58 Other specified malignant neoplasms of female genital organs
• 2C7Z/C51-C58 Malignant neoplasms of female genital organs, unspecified
• 2C80.2/C62.9 Germ cell tumour of testis
• 2C80/C62.9 Malignant neoplasms of testis
• 2C80.Y/C62.9 Other specified malignant neoplasms of testis
• 2C80.Z/C62.9 Malignant neoplasms of testis, unspecified
• 2C81.0/C60 Squamous cell carcinoma of penis
• 2C81.1/C60 Melanoma of penis
• 2C81/C60 Malignant neoplasms of penis
• 2C81.Y/C60.8 Other specified malignant neoplasm of penis
• 2C81.Z/C60 Malignant neoplasms of penis, unspecified
• 2C82.0/C61 Adenocarcinoma of prostate
• 2C82/C61 Malignant neoplasms of prostate
• 2C82.Y/C61 Other specified malignant neoplasms of prostate
• 2C82.Z/C61 Malignant neoplasms of prostate, unspecified
• 2C83.0/C63.2 Squamous cell carcinoma of scrotum
• 2C83/C63.2 Malignant neoplasms of scrotum
• 2C83.Y/C63.2 Other specified malignant neoplasms of scrotum
• 2C83.Z/C63.2 Malignant neoplasms of scrotum, unspecified
• 2C84/C63 Malignant neoplasms of other specified male genital organs
• 2C8Z/C60-C63 Malignant neoplasms of male genital organs, unspecified
• 2C90.0/C64 Renal cell carcinoma of kidney, except renal pelvis
• 2C90/C64 Malignant neoplasms of kidney, except renal pelvis
• 2C90.Y/C64 Other specified malignant neoplasms of kidney, except renal pelvis
• 2C90.Z/C64 Malignant neoplasms of kidney, except renal pelvis, unspecified
• 2C91.0/C65 Urothelial carcinoma of renal pelvis
• 2C91/C65 Malignant neoplasms of renal pelvis
• 2C91.Y/C65 Other specified malignant neoplasms of renal pelvis
• 2C91.Z/C65 Malignant neoplasms of renal pelvis, unspecified
• 2C92.0/C66 Urothelial carcinoma of ureter
• 2C92/C66 Malignant neoplasms of ureter
• 2C92.Y/C66 Other specified malignant neoplasms of ureter
• 2C92.Z/C66 Malignant neoplasms of ureter, unspecified
• 2C93.0/C68 Adenocarcinoma of urethra or paraurethral gland
• 2C93.1/C68 Squamous cell carcinoma of urethra or paraurethral gland
• 2C93.2/C68 Urothelial carcinoma of urethra or paraurethral gland
• 2C93/C68 Malignant neoplasms of urethra or paraurethral gland
• 2C93.Y/C68.8 Other specified malignant neoplasms of urethra and paraurethral gland
• 2C93.Z/C68 Malignant neoplasms of urethra or paraurethral gland, unspecified
• 2C94.0/C67 Adenocarcinoma of bladder
• 2C94.1/C67 Squamous cell carcinoma of bladder
• 2C94.2/C67 Urothelial carcinoma of bladder
• 2C94/C67 Malignant neoplasms of bladder
• 2C94.Y/C67.8 Other specified malignant neoplasms of bladder
• 2C94.Z/C67 Malignant neoplasms of bladder, unspecified
• 2C95.0/C68.8 Adenocarcinoma involving overlapping sites of urinary organs
• 2C95.1/C68.8 Squamous cell carcinomas involving overlapping sites of urinary organs
• 2C95.2/C68.8 Urothelial carcinoma involving overlapping sites of urinary organs
• 2C95/C68.8 Malignant neoplasm involving overlapping sites of urinary organs
• 2C95.Y/C68.8 Other specified malignant neoplasms of overlapping lesion of urinary organs
• 2C95.Z/C68.8 Malignant neoplasm involving overlapping sites of urinary organs, unspecified
• 2C9Y/C64-C68 Other specified malignant neoplasms of urinary tract
• 2C9Z/C64-C68 Malignant neoplasms of urinary tract, unspecified
• 2D00.0/C69.0 Melanoma of conjunctiva
• 2D00.1/C69.0 Malignant neoplasm of caruncle
• 2D00.2/C69.0 Squamous cell carcinoma of conjunctiva
• 2D00/C69.0 Malignant neoplasm of conjunctiva
• 2D00.Y/C69.0 Other specified malignant neoplasm of conjunctiva
• 2D00.Z/C69.0 Malignant neoplasm of conjunctiva, unspecified
• 2D01.0/C69.1 Melanoma of cornea
• 2D01.1/C69.1 Squamous cell carcinoma of cornea
• 2D01/C69.1 Malignant neoplasm of cornea
• 2D01.Y/C69.1 Other specified malignant neoplasms of cornea
• 2D01.Z/C69.1 Malignant neoplasm of cornea, unspecified
• 2D02.0/C69.2 Adenocarcinoma of retinal pigment epithelium
• 2D02.1/C69.2 Malignant neuroepithelial tumours of retina
• 2D02.2/C69.2 Retinoblastoma
• 2D02/C69.2 Malignant neoplasm of retina
• 2D02.Y/C69.2 Other specified malignant neoplasm of retina
• 2D02.Z/C69.2 Malignant neoplasm of retina, unspecified
• 2D03.0/C69.5 Adenocarcinoma of the lacrimal apparatus
• 2D03.1/C69.5 Mucoepidermoid carcinoma of lacrimal apparatus
• 2D03.2/C69.5 Squamous cell carcinoma of the lacrimal apparatus
• 2D03/C69.5 Malignant neoplasm of lacrimal apparatus
• 2D03.Y/C69.5 Other specified malignant neoplasm of lacrimal apparatus
• 2D03.Z/C69.5 Malignant neoplasm of lacrimal apparatus, unspecified
• 2D04/C69.6 Malignant neoplasm of orbit
• 2D05.0/C69.3 Melanoma of choroid
• 2D05/C69.3 Malignant neoplasm of choroid
• 2D05.Y/C69.3 Other specified malignant neoplasm of choroid
• 2D05.Z/C69.3 Malignant neoplasm of choroid, unspecified
• 2D06.0/C69.4 Adenocarcinoma of ciliary epithelium
• 2D06.1/C69.4 Malignant medulloepithelioma of ciliary body
• 2D06.3/C69.4 Malignant neuroepithelial tumours of ciliary body
• 2D06.4/C69.4 Melanoma of ciliary body
• 2D06/C69.4 Malignant neoplasm of ciliary body
• 2D06.Y/C69.4 Other specified malignant neoplasm of ciliary body
• 2D06.Z/C69.4 Malignant neoplasm of ciliary body, unspecified
• 2D07.0/C69 Adenocarcinoma of iris epithelium
• 2D07.1/C69 Malignant neuroepithelial tumours of iris
• 2D07.2/C69 Melanoma of iris
• 2D07/C69 Malignant neoplasm of iris
• 2D07.Y/C69 Other specified malignant neoplasm of iris
• 2D07.Z/C69 Malignant neoplasm of iris, unspecified
• 2D0Y/C69.8 Other specified malignant neoplasms of eye and ocular adnexa
• 2D0Z/C69 Malignant neoplasms of eye or ocular adnexa, unspecified
• 2D10.0/C73 Follicular carcinoma of thyroid gland
• 2D10.1/C73 Papillary carcinoma of thyroid gland
• 2D10.2/C73 Poorly differentiated carcinoma of thyroid gland
• 2D10.3/C73 Undifferentiated carcinoma of thyroid gland
• 2D10.4/C73 Medullary carcinoma of thyroid gland
• 2D10/C73 Malignant neoplasms of thyroid gland
• 2D10.Y/C73 Other specified malignant neoplasms of thyroid gland
• 2D10.Z/C73 Malignant neoplasms of thyroid gland, unspecified
• 2D11.0/C74 Adenocarcinoma of adrenal gland
• 2D11.1/C74 Malignant phaeochromocytoma of adrenal gland
• 2D11.2/C74 Neuroblastoma of adrenal gland
• 2D11/C74 Malignant neoplasms of adrenal gland
• 2D11.Y/C74 Other specified malignant neoplasms of adrenal gland
• 2D11.Z/C74 Malignant neoplasms of adrenal gland, unspecified
• 2D12.0/C75 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type
• 2D12.1/C75 Adenocarcinoma of other endocrine glands or related structures
• 2D12/C75 Malignant neoplasms of other endocrine glands or related structures
• 2D12.Y/C75.8 Other specified malignant neoplasms of other endocrine glands or related structures
• 2D12.Z/C75 Malignant neoplasms of other endocrine glands or related structures, unspecified
• 2D1Z/C73-C75 Malignant neoplasms of endocrine glands, unspecified
• 2D3Y/C00-C75 Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
• 2D3Z/C00-C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
• 2D40/C80.9 Adenocarcinoma of unspecified site
• 2D41/C80.9 Unspecified carcinoma of unspecified site
• 2D42/C76.7 Malignant neoplasms of ill-defined sites
• 2D43/C97-C97 Malignant neoplasms of independent, multiple primary sites
• 2D4Y/C80.9 Other specified malignant neoplasms of ill-defined or unspecified primary sites
• 2D4Z/C80.9 Unspecified malignant neoplasms of ill-defined or unspecified sites
• 2D50/C79.3 Malignant neoplasm metastasis in brain
• 2D51/C79.3 Malignant neoplasm metastasis in meninges
• 2D52/C79.4 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system
• 2D60.0/C77.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck
• 2D60.1/C77.1 Malignant neoplasm metastasis in intrathoracic lymph nodes
• 2D60.2/C77.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes
• 2D60.3/C77.3 Malignant neoplasm metastasis in axillary lymph nodes
• 2D60.4/C77.4 Malignant neoplasm metastasis in inguinal lymph nodes
• 2D60.5/C77.5 Malignant neoplasm metastasis in intrapelvic lymph nodes
• 2D60/C77 Malignant neoplasm metastasis in lymph node of a single region
• 2D60.Y/C77 Other specified malignant neoplasm metastasis in lymph node of a single region
• 2D60.Z/C77 Malignant neoplasm metastasis in lymph node of a single region, unspecified
• 2D61/C77.8 Malignant neoplasm metastases in lymph nodes of multiple regions
• 2D6Z/C77 Metastatic malignant neoplasm to unspecified lymph node
• 2D70/C78.0 Malignant neoplasm metastasis in lung
• 2D71/C78.1 Malignant neoplasm metastasis in mediastinum
• 2D72/C78.2 Malignant neoplasm metastasis in pleura
• 2D73/C78.3 Malignant neoplasm metastasis in upper respiratory tract organs
• 2D7Y/C78.8 Malignant neoplasm metastasis in other specified thoracic organs
• 2D7Z/C78 Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified
• 2D80.0/C78.7 Malignant neoplasm metastasis in liver
• 2D80.1/C78.7 Malignant neoplasm metastasis in intrahepatic bile duct
• 2D80/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct
• 2D80.Y/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct, other specified site
• 2D80.Z/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct, unspecified site
• 2D81/C76-C80 Malignant neoplasm metastasis in pancreas
• 2D82/C76-C80 Malignant neoplasm metastasis in extrahepatic bile ducts
• 2D83/C76-C80 Malignant neoplasm metastasis in ampulla of Vater
• 2D84/C78.4 Malignant neoplasm metastasis in the small intestine
• 2D85/C78.5 Malignant neoplasm metastasis in large intestine
• 2D86/C76-C80 Malignant neoplasm metastasis in anus
• 2D8Y/C76-C80 Malignant neoplasm metastasis in other specified digestive system organ
• 2D8Z/C76-C80 Malignant neoplasm metastasis in unspecified digestive system organ
• 2D90/C78.6 Malignant neoplasm metastasis in retroperitoneum
• 2D91/C78.6 Malignant neoplasm metastasis in peritoneum
• 2E00/C79.0 Malignant neoplasm metastasis in kidney or renal pelvis
• 2E01/C79.1 Malignant neoplasm metastasis in bladder
• 2E02/C76-C80 Malignant neoplasm metastasis in other or unspecified urinary system organs
• 2E03/C79.5 Malignant neoplasm metastasis in bone or bone marrow
• 2E04/C76-C80 Malignant neoplasm metastasis in soft tissue
• 2E05.0/C79.6 Malignant neoplasm metastasis in ovary
• 2E05/C76-C80 Malignant neoplasm metastasis in female reproductive system
• 2E05.Y/C76-C80 Malignant neoplasm metastasis in other female reproductive system organs
• 2E05.Z/C76-C80 Malignant neoplasm metastasis in female reproductive system, unspecified
• 2E06/C76-C80 Malignant neoplasm metastasis in male genital organs
• 2E07/C79.7 Malignant neoplasm metastasis in adrenal gland
• 2E08/C79.2 Metastatic malignant neoplasm involving skin
• 2E09/C79.4 Malignant neoplasm metastasis in peripheral nervous system
• 2E0Y/C76-C80 Malignant neoplasm metastasis in other specified sites
• 2E2Z/C76-C80 Malignant neoplasm metastasis, unspecified
• 2E60.0/D00.0 Carcinoma in situ of lip, oral cavity or pharynx
• 2E60.1/D00.1 Carcinoma in situ of oesophagus
• 2E60.2/D00.2 Carcinoma in situ of stomach
• 2E60/D00 Carcinoma in situ of oral cavity, oesophagus or stomach
• 2E61.0/D01.0 Carcinoma in situ of colon
• 2E61.1/D01.2 Carcinoma in situ of rectum
• 2E61.2/D01.3 Carcinoma in situ of anal canal
• 2E61.3/D01.5 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater
• 2E61/D01 Carcinoma in situ of other or unspecified digestive organs
• 2E61.Y/D01 Carcinoma in situ of other specified digestive organs
• 2E61.Z/D01 Carcinoma in situ of unspecified digestive organs
• 2E62.0/D02.0 Carcinoma in situ of larynx
• 2E62.1/D02.1 Carcinoma in situ of trachea
• 2E62.2/D02.2 Carcinoma in situ of bronchus or lung
• 2E62/D02 Carcinoma in situ of middle ear or respiratory system
• 2E62.Y/D02 Carcinoma in situ of other specified sites of middle ear and respiratory system
• 2E62.Z/D02 Carcinoma in situ of unspecified sites of middle ear and respiratory system
• 2E63.0/D03.9 Melanoma in situ of skin
• 2E63.00/D03.9 Lentigo maligna
• 2E63.0Z/D03.9 Melanoma in situ of skin, unspecified
• 2E63.1/D03.9 Melanoma in situ of conjunctiva
• 2E63/D03.9 Melanoma in situ neoplasms
• 2E63.Y/D03.9 Melanoma in situ neoplasms, other specified site
• 2E63.Z/D03.9 Melanoma in situ neoplasms, unspecified site
• 2E64.0/D04.9 Intraepidermal squamous cell carcinoma
• 2E64.00/D04.9 Bowen disease of skin
• 2E64.01/D04.9 Actinic intraepidermal squamous cell carcinoma
• 2E64.0Y/D04.9 Other specified intraepidermal squamous cell carcinoma
• 2E64.0Z/D04.9 Intraepidermal squamous cell carcinoma, unspecified
• 2E64.1/D04.9 Extramammary Paget disease of skin
• 2E64.2/D04.9 Carcinoma in situ of anal margin or perianal skin
• 2E64/D04.9 Carcinoma in situ of skin
• 2E64.Y/D04.9 Other specified carcinoma in situ of skin
• 2E64.Z/D04.9 Carcinoma in situ of skin, unspecified
• 2E65.0/D05.0 Lobular carcinoma in situ of breast
• 2E65.1/D05 Lobular carcinoma in situ of breast, pleomorphic subtype
• 2E65.2/D05.1 Ductal carcinoma in situ of breast
• 2E65.3/D05 Ductal carcinoma in situ of breast, comedo subtype
• 2E65.4/D05 Mixed ductal and lobular carcinoma in situ of breast
• 2E65.5/D05 Paget disease of nipple
• 2E65/D05 Carcinoma in situ of breast
• 2E65.Y/D05 Other specified carcinoma in situ of breast
• 2E65.Z/D05 Carcinoma in situ of breast, unspecified
• 2E66.2/D06 High grade squamous intraepithelial lesion of cervix uteri
• 2E66/D06 Carcinoma in situ of cervix uteri
• 2E66.Y/D06 Other specified carcinoma in situ of cervix uteri
• 2E66.Z/D06 Carcinoma in situ of cervix uteri, unspecified
• 2E67.0/D07.0 Carcinoma in situ of endometrium
• 2E67.1/D07.1 Carcinoma in situ of vulva
• 2E67.11/D07.1 Vulvar Paget disease
• 2E67.12/D07.1 Vulvar intraepithelial neoplasia, HPV-independent
• 2E67.13/D07.1 High grade squamous intraepithelial lesion of vulva , HPV-associated
• 2E67.2/D07.2 Carcinoma in situ of vagina
• 2E67.22/D07.2 High grade squamous intraepithelial lesion of vagina
• 2E67.2Y/D07.2 Other specified carcinoma in situ of vagina
• 2E67.2Z/D07.2 Carcinoma in situ of vagina, unspecified
• 2E67.3/D07.3 Carcinoma in situ of other or unspecified female genital organs
• 2E67.4/D07.4 Carcinoma in situ of penis
• 2E67.40/D07.4 Squamous cell carcinoma in situ of skin of penis
• 2E67.41/D07.4 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis
• 2E67.5/D07.5 High grade intraepithelial lesion of prostate
• 2E67.6/D07.6 Carcinoma in situ of other or unspecified male genital organs
• 2E67/D07 Carcinoma in situ of other or unspecified genital organs
• 2E68/D09.0 Carcinoma in situ of bladder
• 2E69/D09.1 Carcinoma in situ of other or unspecified urinary organs
• 2E6A.0/D09.9 Carcinoma in situ of the conjunctiva
• 2E6A.1/D09.9 Carcinoma in situ of the cornea
• 2E6A/D09.9 Carcinoma in situ of the eye or ocular adnexa
• 2E6A.Y/D09.9 Carcinoma in situ of other and unspecified part of the eye and adnexa
• 2E6B/D09.3 Carcinoma in situ of thyroid and other endocrine glands
• 2E6Y/D09.9 Carcinoma in situ of other specified site
• 2E6Z/D09.9 Carcinoma in situ of unspecified site
• 2E80.0/D17 Lipoma
• 2E80.00/D17 Superficial subcutaneous lipoma
• 2E80.01/D17 Deep subfascial lipoma
• 2E80.02/D17 Deep internal or visceral lipoma
• 2E80.0Y/D17 Lipoma, other specified site
• 2E80.0Z/D17 Lipoma, unspecified site
• 2E80.1/D17 Lipoblastoma
• 2E80/D17 Benign lipomatous neoplasm
• 2E80.Y/D17 Other specified benign lipomatous neoplasm
• 2E80.Z/D17 Benign lipomatous neoplasm, unspecified
• 2E81.0/D18.0 Neoplastic haemangioma
• 2E81.00/D18.0 Umbilical cord haemangioma
• 2E81.01/D18.0 Conjunctival haemangioma or haemolymphangioma
• 2E81.0Y/D18.0 Neoplastic haemangioma of other specified site
• 2E81.0Z/D18.0 Neoplastic haemangioma, unspecified site
• 2E81.1/D18.1 Benign lymphatic neoplasms
• 2E81.10/D18.1 Disseminated lymphangiomatosis
• 2E81.11/D18.1 Acquired progressive lymphangioma
• 2E81.1Y/D18.1 Other specified benign lymphatic neoplasms
• 2E81.1Z/D18.1 Benign lymphatic neoplasms, unspecified
• 2E81.2/D18 Benign vascular neoplasms of infancy and childhood
• 2E81.20/D18 Focal infantile haemangioma
• 2E81.21/D18 Multifocal infantile haemangioma
• 2E81.2Y/D18 Other specified benign vascular neoplasms of infancy and childhood
• 2E81.2Z/D18 Benign vascular neoplasms of infancy and childhood, unspecified
• 2E81/D18 Benign vascular neoplasms
• 2E81.Y/D18 Other specified benign vascular neoplasms
• 2E81.Z/D18 Benign vascular neoplasms, unspecified
• 2E82.0/D10-D36 Benign chondrogenic tumours of bone or articular cartilage of limbs
• 2E82.1/D10-D36 Benign chondrogenic tumours of bone or articular cartilage of other specified sites
• 2E82/D10-D36 Benign chondrogenic tumours
• 2E82.Z/D10-D36 Benign chondrogenic tumours, site unspecified
• 2E83.0/D16.4 Benign osteogenic tumours of bone or articular cartilage of skull or face
• 2E83.1/D16.5 Benign osteogenic tumours of bone or articular cartilage of lower jaw
• 2E83.2/D16.6 Benign osteogenic tumours of bone or articular cartilage of vertebral column
• 2E83.3/D16.7 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle
• 2E83.4/D16.8 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx
• 2E83.5/D16 Benign osteogenic tumours of bone or articular cartilage of limbs
• 2E83/D16 Benign osteogenic tumours
• 2E83.Y/D16.8 Benign osteogenic tumour of other specified site
• 2E83.Z/D16 Benign osteogenic tumour of unspecified site
• 2E84.0/D10-D36 Benign fibrogenic or myofibrogenic tumour of skin
• 2E84/D10-D36 Benign fibrogenic or myofibrogenic tumour
• 2E84.Y/D10-D36 Benign fibrogenic or myofibrogenic tumour of other specified sites
• 2E84.Z/D10-D36 Benign fibrogenic or myofibrogenic tumour, site unknown
• 2E85.0/D21 Benign fibrohistiocytic tumour of soft tissues of limbs
• 2E85.1/D20 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum
• 2E85.2/D10-D36 Benign fibrohistiocytic tumour of skin
• 2E85/D10-D36 Benign fibrohistiocytic tumour
• 2E85.Y/D10-D36 Benign fibrohistiocytic tumour of other specified sites
• 2E85.Z/D10-D36 Benign fibrohistiocytic tumour, site unspecified
• 2E86.0/D25.9 Leiomyoma of uterus
• 2E86.1/D21.9 Leiomyoma of other or unspecified sites
• 2E86.2/D21.9 Rhabdomyoma
• 2E86/D10-D36 Benign smooth muscle or skeletal muscle tumour
• 2E86.Y/D10-D36 Other specified benign smooth muscle or skeletal muscle tumour
• 2E86.Z/D10-D36 Benign smooth muscle or skeletal muscle tumour, unspecified
• 2E87/D10-D36 Benign gastrointestinal stromal tumour
• 2E88/D10-D36 Benign endometrial stromal nodule
• 2E89.0/D16 Benign tumours of uncertain differentiation, bone or cartilage
• 2E89.1/D21.9 Benign tumours of uncertain differentiation, soft tissue
• 2E89/D10-D36 Benign mesenchymal tumours of uncertain differentiation
• 2E89.Y/D10-D36 Benign mesenchymal tumours of uncertain differentiation of other specified site
• 2E89.Z/D10-D36 Benign mesenchymal tumours of uncertain differentiation of unspecified site
• 2E8A/D10-D36 Other mixed or unspecified benign mesenchymal tumours
• 2E8Y/D10-D36 Other specified benign mesenchymal neoplasm
• 2E8Z/D10-D36 Benign mesenchymal neoplasms, unspecified
• 2E90.0/D10.0 Benign neoplasm of lip
• 2E90.1/D10.1 Benign neoplasm of tongue
• 2E90.2/D10.2 Benign neoplasm of floor of mouth
• 2E90.3/D10.3 Benign neoplasm of other or unspecified parts of mouth
• 2E90.4/D10.4 Benign neoplasm of tonsil
• 2E90.5/D10.5 Benign neoplasm of oropharynx
• 2E90.6/D10.6 Benign neoplasm of nasopharynx
• 2E90.7/D10.7 Benign neoplasm of hypopharynx
• 2E90.8/D10.9 Benign neoplasm of pharynx, unspecified
• 2E90/D10 Benign neoplasm of lip, oral cavity or pharynx
• 2E91.0/D11.0 Benign neoplasm of parotid gland
• 2E91.1/D11.7 Benign neoplasm of other specified major salivary glands
• 2E91/D11 Benign neoplasm of major salivary glands
• 2E91.Z/D11 Benign neoplasm of unspecified major salivary glands
• 2E92.0/D13 Benign neoplasm of oesophagus
• 2E92.1/D13.1 Benign neoplasm of stomach
• 2E92.2/D13.2 Benign neoplasm of duodenum
• 2E92.3/D13 Benign neoplasm of other or unspecified parts of small intestine
• 2E92.4/D12 Benign neoplasm of the large intestine
• 2E92.40/D12.6 Polyposis syndrome
• 2E92.4Y/D12.8 Other specified benign neoplasm of the large intestine
• 2E92.4Z/D12 Benign neoplasm of the large intestine, unspecified
• 2E92.5/D12.9 Benign neoplasm of anus or anal canal
• 2E92.6/D13.5 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater
• 2E92.7/D13.4 Benign neoplasm of liver or intrahepatic bile ducts
• 2E92.8/D13.6 Benign neoplasm of pancreas
• 2E92.9/D13.7 Benign neoplasm of endocrine pancreas
• 2E92.A/D13.9 Benign neoplasm of ill-defined site within the digestive system
• 2E92/D13 Benign neoplasm of digestive organs
• 2E92.Y/D13 Benign neoplasm of other specified digestive organs
• 2E92.Z/D13 Benign neoplasm of unspecified digestive organs
• 2F00.0/D14.0 Middle ear endocrine tumour
• 2F00.1/D14 Recurrent respiratory papillomatosis
• 2F00.2/D14.1 Laryngeal endocrine tumour
• 2F00/D14 Benign neoplasm of middle ear or respiratory system
• 2F00.Y/D14 Other specified benign neoplasm of middle ear or respiratory system
• 2F00.Z/D14 Benign neoplasm of middle ear or respiratory system, unspecified
• 2F01/D15 Benign neoplasm of intrathoracic organs
• 2F0Y/D15.7 Benign neoplasms of other specified respiratory and intrathoracic organs
• 2F0Z/D15.7 Benign neoplasms of unspecified respiratory and intrathoracic organs
• 2F10/D19 Benign neoplasm of mesothelial tissue
• 2F20.0/D22 Common acquired melanocytic naevus
• 2F20.00/D22 Multiple benign melanocytic naevi
• 2F20.0Y/D22 Other specified common acquired melanocytic naevus
• 2F20.1/D22 Atypical melanocytic naevus
• 2F20.2/D22 Congenital melanocytic naevus
• 2F20.20/D22 Giant congenital melanocytic naevus
• 2F20.2Y/D22 Other specified congenital melanocytic naevus
• 2F20.2Z/D22 Congenital melanocytic naevus, unspecified
• 2F20.3/D22 Generalised eruptive melanocytic naevi
• 2F20/D22 Benign cutaneous melanocytic neoplasms
• 2F20.Y/D22 Other specific types of melanocytic naevus
• 2F20.Z/D22 Melanocytic naevus, unspecified
• 2F21.0/L82 Seborrhoeic keratosis
• 2F21/D23 Benign keratinocytic acanthomas
• 2F21.Y/D23 Other specified benign keratinocytic acanthomas
• 2F22/D23 Benign neoplasms of epidermal appendages
• 2F23.0/D23 Dermatofibroma
• 2F23/D23 Benign dermal fibrous or fibrohistiocytic neoplasms
• 2F23.Y/D23 Other specified benign dermal fibrous or fibrohistiocytic neoplasms
• 2F24/D23 Benign cutaneous neoplasms of neural or nerve sheath origin
• 2F25/D18.0 Cherry angioma
• 2F26/L98.0 Lobular capillary haemangioma
• 2F2Y/D23 Other specified benign cutaneous neoplasms
• 2F2Z/D23 Benign cutaneous neoplasm of unspecified type
• 2F30.0/D24 Tubular adenoma of breast
• 2F30.1/D24 Lactating adenoma of breast
• 2F30.2/D24 Intraductal papilloma of breast
• 2F30.3/D24 Benign phyllodes tumour of breast
• 2F30.4/D24 Fibromatosis of breast
• 2F30.5/D24 Fibroadenoma of breast
• 2F30.6/D24 Extensive adenomatosis of nipple
• 2F30/D24 Benign neoplasm of breast
• 2F30.Y/D24 Other specified benign neoplasm of breast
• 2F30.Z/D24 Benign neoplasm of breast, unspecified
• 2F31.0/D26.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri
• 2F31.1/D26.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri
• 2F31.2/D26.7 Benign non-mesenchymal neoplasms of uterus, other parts
• 2F31/D26 Benign non-mesenchymal neoplasms of uterus
• 2F32.0/D27 Cystic teratoma
• 2F32.1/D27 Ovarian fibroma
• 2F32.2/D27 Meigs’ Syndrome
• 2F32.3/D27 Serous ovarian cystadenoma
• 2F32/D27 Benign neoplasm of ovary
• 2F32.Y/D27 Other specified benign neoplasm of ovary
• 2F32.Z/D27 Benign neoplasm of ovary, unspecified
• 2F33/D28.9 Benign neoplasm of other or unspecified female genital organs
• 2F34/D29.7 Benign neoplasm of male genital organs
• 2F35/D30.9 Benign neoplasm of urinary organs
• 2F36.0/D31.3 Benign neoplasm of choroid
• 2F36.1/D31 Benign neoplasm of iris
• 2F36.2/D31.4 Benign neoplasm of ciliary body
• 2F36.3/D31.6 Teratoma of orbit
• 2F36.4/D23.1 Cysts of eyelid
• 2F36/D31 Benign neoplasm of eye or ocular adnexa
• 2F36.Y/D31 Other specified benign neoplasm of eye or ocular adnexa
• 2F36.Z/D31 Benign neoplasm of eye or ocular adnexa, unspecified
• 2F37.0/D35.9 Non-secreting pituitary adenoma
• 2F37/D35.9 Benign neoplasm of endocrine glands
• 2F37.Y/D35.9 Other specified benign neoplasm of endocrine glands
• 2F37.Z/D35.9 Benign neoplasm of endocrine glands, unspecified
• 2F3Y/D10-D36 Benign non-mesenchymal neoplasms of other specified site
• 2F3Z/D10-D36 Benign non-mesenchymal neoplasms of unspecified site
• 2F5Y/D10-D36 Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
• 2F5Z/D10-D36 Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
• 2F70.0/D37.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx
• 2F70.1/D37.1 Neoplasms of uncertain behaviour of stomach
• 2F70.2/D37.2 Neoplasms of uncertain behaviour of small intestine
• 2F70.3/D37.4 Neoplasms of uncertain behaviour of colon
• 2F70.4/D37.5 Neoplasms of uncertain behaviour of rectum
• 2F70.5/D37.6 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts
• 2F70/D37 Neoplasms of uncertain behaviour of oral cavity or digestive organs
• 2F70.Y/D37 Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site
• 2F70.Z/D37 Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site
• 2F71.0/D38.4 Neoplasms of uncertain behaviour of thymus
• 2F71.1/D38.0 Neoplasms of uncertain behaviour of larynx
• 2F71.2/D38.2 Neoplasms of uncertain behaviour of pleura
• 2F71.3/D38.1 Neoplasms of uncertain behaviour of trachea, bronchus or lung
• 2F71.4/D38.3 Neoplasms of uncertain behaviour of mediastinum
• 2F71/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs
• 2F71.Y/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site
• 2F71.Z/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site
• 2F72.1/D48.5 Spitzoid tumour of uncertain malignant potential
• 2F72.2/D48.5 Melanocytic naevus with severe melanocytic dysplasia
• 2F72/D48.5 Neoplasms of uncertain behaviour of skin
• 2F72.Y/D48.5 Other specified neoplasms of uncertain behaviour of skin
• 2F73/D48.3 Neoplasms of uncertain behaviour of retroperitoneum
• 2F74/D48.4 Neoplasms of uncertain behaviour of peritoneum
• 2F75/D48.6 Neoplasms of uncertain behaviour of breast
• 2F76/D37-D48 Neoplasms of uncertain behaviour of female genital organs
• 2F77/D37-D48 Neoplasms of uncertain behaviour of male genital organs
• 2F78/D37-D48 Neoplasms of uncertain behaviour of urinary organs
• 2F79/D37-D48 Neoplasms of uncertain behaviour of eye or ocular adnexa
• 2F7A.0/D37-D48 Multiple polyglandular tumours
• 2F7A/D37-D48 Neoplasms of uncertain behaviour of endocrine glands
• 2F7A.Y/D37-D48 Other specified neoplasms of uncertain behaviour of endocrine glands
• 2F7A.Z/D37-D48 Neoplasms of uncertain behaviour of endocrine glands, unspecified
• 2F7B/D48.0 Neoplasms of uncertain behaviour of bone or articular cartilage
• 2F7C/D48.1 Neoplasms of uncertain behaviour of connective or other soft tissue
• 2F7Y/D37-D48 Neoplasms of uncertain behaviour of other specified site
• 2F7Z/D37-D48 Neoplasms of uncertain behaviour of unspecified site
• 2F90.0/D37.4 Neoplasms of unknown behaviour of colon
• 2F90.1/D37.5 Neoplasms of unknown behaviour of rectum
• 2F90/D37-D48 Neoplasms of unknown behaviour of oral cavity or digestive organs
• 2F90.Y/D37-D48 Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site
• 2F90.Z/D37-D48 Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site
• 2F91.0/D38.0 Neoplasms of unknown behaviour of larynx
• 2F91.1/D38.1 Neoplasms of unknown behaviour of trachea, bronchus or lung
• 2F91/D38 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs
• 2F91.Y/D38 Neoplasms of unknown behaviour of other specified middle ear, respiratory or intrathoracic organ
• 2F92/D48.5 Neoplasms of unknown behaviour of skin
• 2F93/D48.3 Neoplasms of unknown behaviour of retroperitoneum
• 2F94/D48.4 Neoplasms of unknown behaviour of peritoneum
• 2F95/D48.6 Neoplasms of unknown behaviour of breast
• 2F96/D39 Neoplasms of unknown behaviour of female genital organs
• 2F97/D40 Neoplasms of unknown behaviour of male genital organs
• 2F98/D41 Neoplasms of unknown behaviour of urinary organs
• 2F99/D37-D48 Neoplasms of unknown behaviour of eye or ocular adnexa
• 2F9A/D44 Neoplasms of unknown behaviour of endocrine glands
• 2F9B/D48.0 Neoplasms of unknown behaviour of bone or articular cartilage
• 2F9C/D48.1 Neoplasms of unknown behaviour of connective or other soft tissue
• 2F9Y/D37-D48 Neoplasms of unknown behaviour of other specified site
• 2F9Z/D37-D48 Neoplasms of unknown behaviour of unspecified site
• 3A00.0/D50.0 Acquired iron deficiency anaemia due to blood loss
• 3A00.01/D50.0 Chronic posthaemorrhagic anaemia
• 3A00.0Z/D50.0 Acquired iron deficiency anaemia due to blood loss, unspecified
• 3A00.1/D50 Acquired iron deficiency anaemia due to low intake
• 3A00.2/D50 Acquired iron deficiency anaemia due to decreased absorption
• 3A00.3/D50 Acquired iron deficiency anaemia due to increased requirement
• 3A00/D50.9 Iron deficiency anaemia
• 3A00.Y/D50.9 Other specified iron deficiency anaemia
• 3A00.Z/D50.9 Iron deficiency anaemia, unspecified
• 3A01.0/D51.8 Hereditary Vitamin B12 deficiency anaemia
• 3A01.1/D51.8 Neonatal vitamin B12 deficiency anaemia
• 3A01.2/D51.8 Vitamin B12 deficiency anaemia due to low intake
• 3A01.3/D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
• 3A01.30/D51.0 Pernicious anaemia
• 3A01.3Y/D51.0 Other specified vitamin B12 deficiency anaemia due to intrinsic factor deficiency
• 3A01.4/D51.8 Vitamin B12 deficiency anaemia due to intestinal disease
• 3A01.5/D51.8 Drug-induced vitamin B12 deficiency anaemia
• 3A01/D51 Megaloblastic anaemia due to vitamin B12 deficiency
• 3A01.Y/D51.8 Other specified megaloblastic anaemia due to vitamin B12 deficiency
• 3A01.Z/D51 Megaloblastic anaemia due to vitamin B12 deficiency, unspecified
• 3A02.0/D52.8 Hereditary folate deficiency anaemia
• 3A02.1/D52.0 Folate deficiency anaemia due to low intake
• 3A02.2/D52.8 Folate deficiency anaemia due to increased requirements
• 3A02.3/D52 Folate deficiency anaemia due to decreased intestinal absorption
• 3A02.4/D52.1 Drug-induced folate deficiency anaemia
• 3A02/D52.9 Folate deficiency anaemia
• 3A02.Y/D52.9 Other specified folate deficiency anaemia
• 3A02.Z/D52.9 Folate deficiency anaemia, unspecified
• 3A03.0/D53 Hereditary orotic aciduria
• 3A03.1/D53.0 Protein deficiency anaemia
• 3A03.2/D53.2 Scorbutic anaemia
• 3A03.3/D53.8 Copper deficiency anaemia
• 3A03.4/D53.8 Acquired other vitamin B deficiency anaemia
• 3A03.40/D53.8 Acquired pyridoxine deficiency anaemia
• 3A03.41/D53.8 Acquired riboflavin deficiency anaemia
• 3A03.42/D53.8 Acquired thiamine deficiency anaemia
• 3A03.4Y/D53.8 Other specified acquired other vitamin B deficiency anaemia
• 3A03.5/D53.8 Acquired vitamin A deficiency anaemia
• 3A03.6/D53.8 Acquired vitamin E deficiency anaemia
• 3A03/D50-D53 Other nutritional or metabolic anaemias
• 3A03.Y/D50-D53 Other and unspecified nutritional or metabolic anaemia
• 3A10.0/D55.1 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
• 3A10.00/D55.0 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency
• 3A10.0Y/D55.1 Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
• 3A10.0Z/D55.1 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified
• 3A10.1/D55.3 Haemolytic anaemia due to adenosine deaminase excess
• 3A10.2/D58.1 Hereditary elliptocytosis
• 3A10.3/D58.8 Familial pseudohyperkalaemia
• 3A10/D55-D59 Hereditary haemolytic anaemia
• 3A10.Y/D55-D59 Other specified hereditary haemolytic anaemia
• 3A10.Z/D55-D59 Hereditary haemolytic anaemia, unspecified
• 3A1Y/D55-D59 Other specified congenital haemolytic anaemia
• 3A20.0/D59.1 Autoimmune haemolytic anaemia, warm type
• 3A20.1/D59 Autoimmune haemolytic anaemia, cold type
• 3A20.2/D59 Autoimmune haemolytic anaemia, mixed type, cold and warm
• 3A20.3/D59 Paroxysmal cold haemoglobinuria
• 3A20.4/D59 Alloimmune haemolytic anaemia
• 3A20.5/D59 Evans syndrome
• 3A20/D59 Acquired haemolytic anaemia, immune
• 3A20.Y/D59 Other specified acquired haemolytic anaemia, immune
• 3A21.0/D59.5 Paroxysmal nocturnal haemoglobinuria
• 3A21.1/D59 Microangiopathic haemolytic anaemia
• 3A21.2/D59.3 Haemolytic uraemic syndrome
• 3A21/D59 Acquired haemolytic anaemia, non-immune
• 3A21.Y/D59 Other specified acquired haemolytic anaemia, non-immune
• 3A2Z/D59 Acquired haemolytic anaemia, unspecified
• 3A4Z/D55-D59 Haemolytic anaemias, unspecified
• 3A50.0/D56.0 Alpha thalassaemia
• 3A50.00/D56.3 Mild alpha thalassaemia diseases
• 3A50.01/D56.0 Thalassaemic alpha-chain variants
• 3A50.02/D56.0 Haemoglobin H disease (– α/– – included)
• 3A50.03/D56.0 Homozygous or compound heterozygous alpha0 thalassaemia
• 3A50.0Y/D56.0 Other specified alpha thalassaemia
• 3A50.0Z/D56.0 Alpha thalassaemia, unspecified
• 3A50.1/D56 Alpha thalassaemia related syndromes
• 3A50.2/D56.1 Beta thalassaemia
• 3A50.3/D56.2 Delta, delta-beta or gamma-delta-beta thalassaemia
• 3A50.4/D56.4 Hereditary persistence of fetal haemoglobin
• 3A50/D56 Thalassaemias
• 3A50.Y/D56.8 Other specified thalassaemias
• 3A50.Z/D56 Thalassaemias, unspecified
• 3A51.0/D57.3 Sickle cell trait
• 3A51.1/D57.1 Sickle cell disease without crisis
• 3A51.2/D57.0 Sickle cell disease with crisis
• 3A51.3/D57.2 Compound heterozygous sickling disorders without crisis
• 3A51.4/D57 Compound heterozygous sickling disorders with crisis
• 3A51.5/D57 Haemoglobin C disease
• 3A51.6/D57 Haemoglobin D disease
• 3A51.7/D57 High affinity haemoglobin
• 3A51.8/D57 Low affinity haemoglobin
• 3A51.9/D57 Haemoglobin O disease
• 3A51.A/D57 Haemoglobin E disease
• 3A51.B/D57 Haemoglobin C/beta thalassaemia compound heterozygosity
• 3A51/D57 Sickle cell disorders or other haemoglobinopathies
• 3A51.Y/D57.8 Other specified sickle cell disorders or other haemoglobinopathies
• 3A51.Z/D57 Sickle cell disorders or other haemoglobinopathies, unspecified
• 3A60.0/D61.0 Congenital non-inherited pure red cell aplasia
• 3A60.1/D61.0 Hereditary pure red cell aplasia
• 3A60/D61.0 Congenital pure red cell aplasia
• 3A60.Z/D61.0 Congenital pure red cell aplasia, unspecified
• 3A61.0/D60.1 Acute acquired pure red cell aplasia
• 3A61.1/D60.0 Chronic acquired pure red cell aplasia
• 3A61/D60 Acquired pure red cell aplasia
• 3A61.Y/D60.8 Other specified acquired pure red cell aplasia
• 3A61.Z/D60 Acquired pure red cell aplasia, unspecified
• 3A6Z/D64.9 Pure red cell aplasia, unspecified
• 3A70.0/D61.0 Congenital aplastic anaemia
• 3A70.1/D61 Acquired aplastic anaemias
• 3A70.10/D61.1 Drug-induced aplastic anaemia
• 3A70.11/D61.2 Aplastic anaemia due to other external agents
• 3A70.12/D61.3 Idiopathic aplastic anaemia
• 3A70.1Y/D61.8 Other specified acquired aplastic anaemias
• 3A70.1Z/D61 Acquired aplastic anaemias, unspecified
• 3A70/D64.9 Aplastic anaemia
• 3A70.Z/D64.9 Aplastic anaemia, unspecified
• 3A71.0/D63 Anaemia in neoplastic disease
• 3A71.1/D63 Anaemia in chronic infectious diseases
• 3A71.2/D63 Anaemia in chronic kidney disease
• 3A71/D63 Anaemia due to chronic disease
• 3A71.Y/D63.8 Anaemia due to other specified chronic disease
• 3A71.Z/D63 Anaemia due to chronic disease, unspecified
• 3A72.0/D64 Congenital sideroblastic anaemias
• 3A72.00/D64.0 Hereditary sideroblastic anaemias
• 3A72.01/D64.0 Hereditary syndromic sideroblastic anaemia
• 3A72.0Y/D64 Other specified congenital sideroblastic anaemias
• 3A72.0Z/D64 Congenital sideroblastic anaemias, unspecified
• 3A72.1/D64 Acquired sideroblastic anaemias
• 3A72/D64 Sideroblastic anaemia
• 3A72.Z/D64 Sideroblastic anaemia, unspecified
• 3A73/D64.4 Congenital dyserythropoietic anaemia
• 3A80.0/D75.0 Primary inherited erythrocytosis
• 3A80/D75.0 Congenital polycythaemia
• 3A80.Y/D75.0 Other specified congenital polycythaemia
• 3A80.Z/D75.0 Congenital polycythaemia, unspecified
• 3A81.0/D75.1 Polycythaemia due to hypoxia, including high altitude
• 3A81.1/D75.1 Polycythaemia due to over-transfusion or blood doping
• 3A81.2/D75.1 Relative polycythaemia
• 3A81/D75.1 Acquired polycythaemia
• 3A81.Y/D75.1 Other specified acquired polycythaemia
• 3A81.Z/D75.1 Acquired polycythaemia, unspecified
• 3A8Z/D64.9 Polycythaemia, unspecified
• 3A90/D64.8 Anaemia due to acute disease
• 3A91/D74.0 Congenital methaemoglobinaemia
• 3A92/D74.0 Hereditary methaemoglobinaemia
• 3A93/D74.8 Acquired methaemoglobinaemia
• 3A94/D62 Acute posthaemorrhagic anaemia
• 3A9Y/D64.9 Other specified anaemias or erythrocyte disorders
• 3A9Z/D64.9 Anaemias or other erythrocyte disorders, unspecified
• 3B10.0/D66 Haemophilia A
• 3B10.1/D66 Hereditary factor VIII deficiency with anti-factor VIII inhibitor
• 3B10/D66 Hereditary factor VIII deficiency
• 3B10.Y/D66 Other specified hereditary factor VIII deficiency
• 3B10.Z/D66 Hereditary factor VIII deficiency, unspecified
• 3B11.0/D67 Haemophilia B
• 3B11/D67 Hereditary factor IX deficiency
• 3B11.Y/D67 Other specified hereditary factor IX deficiency
• 3B11.Z/D67 Hereditary factor IX deficiency, unspecified
• 3B12/D68.0 Von Willebrand disease
• 3B13/D68.1 Haemophilia C
• 3B14.0/D68.2 Hereditary deficiency of factor I
• 3B14.1/D68.2 Hereditary factor X deficiency
• 3B14.2/D68.2 Combined deficiency of vitamin K-dependent clotting factors
• 3B14/D68.2 Other inherited coagulation factor deficiency with bleeding tendency
• 3B14.Z/D68.2 Other inherited coagulation factor deficiency with bleeding tendency, unspecified
• 3B15/D68.2 Inherited coagulation factor deficiency without bleeding tendency
• 3B1Z/D65-D69 Congenital or constitutional haemorrhagic condition, unspecified
• 3B20/D65 Disseminated intravascular coagulation
• 3B21.0/D68.3 Haemorrhage due to thrombin inhibitor other than heparin
• 3B21.1/D68.3 Haemorrhage due to factor Xa inhibitor
• 3B21/D68.3 Haemorrhagic disorder due to circulating anticoagulants and coagulation factors
• 3B21.Y/D68.3 Haemorrhagic disorder due to other specified circulating anticoagulants
• 3B21.Z/D68.3 Haemorrhagic disorder due to unspecified circulating anticoagulants
• 3B22/D68.4 Acquired haemophilia
• 3B2Y/D68.4 Other specified haemorrhagic diseases due to acquired coagulation factor defects
• 3B4Z/D65-D69 Coagulation defects, unspecified
• 3B50.0/D68.8 Congenital alpha-2 antiplasmin deficiency
• 3B50.1/D68.8 Congenital plasminogen activator inhibitor type 1 deficiency
• 3B50/D68.8 Inherited fibrinolytic defects
• 3B50.Y/D68.8 Other specified inherited fibrinolytic defects
• 3B50.Z/D68.8 Inherited fibrinolytic defects, unspecified
• 3B51/D77 Acquired fibrinolytic defects
• 3B60.0/D69.2 Hereditary vascular purpura
• 3B60.1/D69.2 Acquired vascular purpura
• 3B60/D69.2 Non-thrombocytopenic purpura
• 3B61.0/D68.5 Hereditary thrombophilia
• 3B61.00/D68.5 Hyperhomocysteinaemia
• 3B61.0Y/D68.5 Other specified hereditary thrombophilia
• 3B61.1/D68.6 Acquired thrombophilia
• 3B61/D68 Thrombophilia
• 3B61.Y/D68.8 Other specified thrombophilia
• 3B61.Z/D68 Thrombophilia, unspecified
• 3B62.0/D69.1 Inherited qualitative platelet defects
• 3B62.00/D69.1 Alpha-granule diseases
• 3B62.01/D69.1 Inherited giant platelet disorder
• 3B62.0Y/D69.1 Other specified inherited qualitative platelet defects
• 3B62.0Z/D69.1 Inherited qualitative platelet defects, unspecified
• 3B62.1/D69.1 Bleeding diathesis due to thromboxane synthesis deficiency
• 3B62.2/D69.1 Isolated thrombocytopenia
• 3B62.3/D69.1 Dense granule disease
• 3B62.4/D69.1 Alpha-delta dense granule deficiency
• 3B62.5/D76.2 Haemophagocytic syndrome associated with infection
• 3B62/D69.1 Qualitative platelet defects
• 3B62.Y/D69.1 Other specified qualitative platelet defects
• 3B62.Z/D69.1 Qualitative platelet defects, unspecified
• 3B63.0/D47.3 Congenital thrombocytosis
• 3B63.1/D47.3 Acquired thrombocytosis
• 3B63.10/D47.3 Secondary thrombocytosis
• 3B63.1Y/D47.3 Other specified acquired thrombocytosis
• 3B63.1Z/D47.3 Acquired thrombocytosis, unspecified
• 3B63/D47.3 Thrombocytosis
• 3B63.Y/D47.3 Other specified thrombocytosis
• 3B63.Z/D47.3 Thrombocytosis, unspecified
• 3B64.0/D69.6 Congenital thrombocytopenia
• 3B64.00/D69.6 Congenital non-inherited thrombocytopenia
• 3B64.01/D69.6 Hereditary thrombocytopenia
• 3B64.0Z/D69.6 Congenital thrombocytopenia, unspecified
• 3B64.1/D69.5 Acquired thrombocytopenia
• 3B64.10/D69.3 Immune thrombocytopenic purpura
• 3B64.11/D69.5 Secondary thrombocytopenic purpura
• 3B64.12/D69.5 Drug-induced thrombocytopenic purpura
• 3B64.13/D69.5 Alloimmune thrombocytopenia
• 3B64.14/M31.1 Thrombotic thrombocytopenic purpura
• 3B64.1Y/D69.5 Other specified acquired thrombocytopenia
• 3B64/D69.6 Thrombocytopenia
• 3B64.Z/D69.6 Thrombocytopenia, unspecified
• 3B65/M31.1 Thrombotic microangiopathy, not elsewhere classified
• 3B6Y/D65-D69 Other specified coagulation defects, purpura or other haemorrhagic or related conditions
• 3B6Z/D65-D69 Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
• 3B80.0/D73 Splenomegaly in storage diseases
• 3B80/D73 Congenital disorders of spleen
• 3B81.0/D73 Tumour-like conditions of spleen
• 3B81.1/D73 Postsurgical asplenia
• 3B81.2/D73.0 Atrophy of spleen
• 3B81.3/D73 Nontraumatic laceration or rupture of spleen
• 3B81.4/D73 Splenosis
• 3B81.5/D73 Splenic cyst or pseudocyst
• 3B81.50/D73.4 Pseudocyst of spleen
• 3B81.51/D73.4 Epithelial cyst of spleen
• 3B81.5Y/D73 Other specified splenic cyst
• 3B81.5Z/D73 Splenic cyst, unspecified
• 3B81.6/D73.5 Infarction of spleen
• 3B81.7/D73 Infection of spleen
• 3B81.70/D73 Acute septic splenitis
• 3B81.71/D73.3 Abscess of spleen
• 3B81.7Y/D73 Other specified infection of spleen
• 3B81.7Z/D73 Infection of spleen, unspecified
• 3B81.8/D73 Torsion of spleen
• 3B81.9/D73 Fibrosis of spleen
• 3B81.A/D73 Perisplenitis
• 3B81.B/D73.1 Hypersplenism
• 3B81.C/D73.2 Chronic congestive splenomegaly
• 3B81/D73 Acquired disorders of spleen
• 3B81.Y/D73 Other specified acquired disorders of spleen
• 3B8Z/D73 Diseases of spleen, unspecified
• 3C0Y/III Other specified diseases of the blood or blood-forming organs
• 3C0Z/III Diseases of the blood or blood-forming organs, unspecified
• 4A00.0/D71 Functional neutrophil defects
• 4A00.00/D71 Neutrophil immunodeficiency syndrome
• 4A00.0Y/D71 Other specified functional neutrophil defects
• 4A00.0Z/D71 Functional neutrophil defects, unspecified
• 4A00.1/D84.1 Defects in the complement system
• 4A00.10/D84.1 Immunodeficiency with an early component of complement deficiency
• 4A00.11/D84.1 Immunodeficiency with a late component of complement deficiency
• 4A00.12/D84.1 Immunodeficiency with factor B deficiency
• 4A00.13/D84.1 Immunodeficiency with factor D anomaly
• 4A00.14/D84.1 Hereditary angioedema
• 4A00.15/D84.1 Acquired angioedema
• 4A00.1Y/D84.1 Other specified defects in the complement system
• 4A00.1Z/D84.1 Defects in the complement system, unspecified
• 4A00.2/D84.8 Genetic susceptibility to particular pathogens
• 4A00.3/D84.8 Immunodeficiency with natural-killer cell deficiency
• 4A00/D84.9 Primary immunodeficiencies due to disorders of innate immunity
• 4A00.Y/D84.9 Other specified primary immunodeficiencies due to disorders of innate immunity
• 4A00.Z/D84.9 Primary immunodeficiencies due to disorders of innate immunity, unspecified
• 4A01.0/D80 Immunodeficiencies with predominantly antibody defects
• 4A01.00/D80.0 Hereditary agammaglobulinaemia with profoundly reduced or absent B cells
• 4A01.01/D80.1 Immunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells
• 4A01.02/D80.6 Specific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells
• 4A01.03/D80.7 Transient hypogammaglobulinaemia of infancy
• 4A01.04/D80 Immunodeficiencies with isotype or light chain deficiencies with normal number of B cells
• 4A01.05/D80.5 Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells
• 4A01.0Y/D80.8 Other specified immunodeficiencies with predominantly antibody defects
• 4A01.0Z/D80 Immunodeficiencies with predominantly antibody defects, unspecified
• 4A01.1/D81 Combined immunodeficiencies
• 4A01.10/D81 Severe combined immunodeficiencies
• 4A01.11/D81.6 Major histocompatibility complex class I deficiency
• 4A01.12/D81.7 Major histocompatibility complex class II deficiency
• 4A01.1Y/D81.8 Other specified combined immunodeficiencies
• 4A01.1Z/D81 Combined immunodeficiencies, unspecified
• 4A01.2/D76.3 Diseases of immune dysregulation
• 4A01.20/D89.8 Immune dysregulation syndromes with hypopigmentation
• 4A01.21/D89.8 Immune dysregulation syndromes presenting primarily with autoimmunity
• 4A01.22/D76.3 Immune dysregulation syndromes presenting primarily with lymphoproliferation
• 4A01.23/D76.1 Primary haemophagocytic lymphohistiocytosis
• 4A01.2Y/D76.3 Other specified diseases of immune dysregulation
• 4A01.2Z/D76.3 Diseases of immune dysregulation, unspecified
• 4A01.3/D84.9 Other well-defined immunodeficiency syndromes due to defects in adaptive immunity
• 4A01.30/D84.9 Immunodeficiency due to defects of the thymus
• 4A01.31/D84.9 DNA repair defects other than combined T-cell or B-cell immunodeficiencies
• 4A01.32/D84.9 Immuno-osseous dysplasia
• 4A01.33/D89.8 immunodeficiency syndrome
• 4A01.34/D82.4 Hyperimmunoglobulin E syndromes
• 4A01/D84.9 Primary immunodeficiencies due to disorders of adaptive immunity
• 4A01.Z/D84.9 Primary immunodeficiencies due to disorders of adaptive immunity, unspecified
• 4A0Y/D84.9 Other specified primary immunodeficiencies
• 4A0Z/D84.9 Primary immunodeficiencies, unspecified
• 4A20.0/D89.9 Adult-onset immunodeficiency
• 4A20.1/D89.9 Acquired immunodeficiency due to loss of immunoglobulin
• 4A20/D89.9 Acquired immunodeficiencies
• 4A20.Y/D89.9 Other specified acquired immunodeficiencies
• 4A20.Z/D89.9 Acquired immunodeficiencies, unspecified
• 4A40.0/M32 Systemic lupus erythematosus
• 4A40.00/M32.1 Systemic lupus erythematosus with skin involvement
• 4A40.0Y/M32.8 Other specified systemic lupus erythematosus
• 4A40.0Z/M32 Systemic lupus erythematosus, unspecified
• 4A40.1/M32.0 Drug-induced lupus erythematosus
• 4A40/L93 Lupus erythematosus
• 4A40.Y/L93 Other specified lupus erythematosus
• 4A40.Z/L93 Lupus erythematosus, unspecified
• 4A41.0/M33.1 Dermatomyositis
• 4A41.00/M33.1 Adult dermatomyositis
• 4A41.01/M33.0 Juvenile dermatomyositis
• 4A41.0Z/M33.1 Dermatomyositis, unspecified
• 4A41.1/M33.2 Polymyositis
• 4A41.10/M33.2 Juvenile polymyositis
• 4A41.11/M33.2 Paraneoplastic polymyositis
• 4A41.1Y/M33.2 Other specified polymyositis
• 4A41.1Z/M33.2 Polymyositis, unspecified
• 4A41.2/G72.8 Inclusion body myopathy
• 4A41.20/G72.4 Inflammatory inclusion body myositis
• 4A41.21/G72.8 Noninflammatory inclusion body myopathy
• 4A41.2Z/G72.8 Inclusion body myopathy, unspecified
• 4A41/M33.9 Idiopathic inflammatory myopathy
• 4A41.Y/M33.9 Other specified idiopathic inflammatory myopathy
• 4A41.Z/M33.9 Idiopathic inflammatory myopathy, unspecified
• 4A42.0/M34 Paediatric onset systemic sclerosis
• 4A42.1/M34.0 Diffuse systemic sclerosis
• 4A42.2/M34.1 Limited systemic sclerosis
• 4A42/M34 Systemic sclerosis
• 4A42.Z/M34 Systemic sclerosis, unspecified
• 4A43.0/M35.8 IgG4 related disease
• 4A43.1/K11.8 Mikulicz disease
• 4A43.2/M35.0 Sjögren syndrome
• 4A43.20/M35.0 Primary Sjögren syndrome
• 4A43.21/M35.0 Secondary Sjögren syndrome
• 4A43.22/M35.0 Paediatric onset Sjögren syndrome
• 4A43.2Y/M35.0 Other specified sjögren syndrome
• 4A43.3/M35.1 Mixed connective tissue disease
• 4A43.4/M35.4 Diffuse eosinophilic fasciitis
• 4A43/M35.1 Overlap or undifferentiated nonorgan specific systemic autoimmune disease
• 4A43.Y/M35.1 Other specified overlap non-organ specific systemic autoimmune disease
• 4A43.Z/M35.1 Undifferentiated non-organ specific systemic autoimmune disease
• 4A44.0/M35.3 Rhizomelic pseudopolyarthritis
• 4A44.1/M31.4 Aortic arch syndrome
• 4A44.2/M31.6 Giant cell arteritis
• 4A44.3/M30-M36 Single organ vasculitis
• 4A44.4/M30 Polyarteritis nodosa
• 4A44.5/M30.3 Mucocutaneous lymph node syndrome
• 4A44.6/I77.8 Sneddon syndrome
• 4A44.7/I67.7 Primary angiitis of the central nervous system
• 4A44.8/I73.1 Thromboangiitis obliterans
• 4A44.9/I77.6 Immune complex small vessel vasculitis
• 4A44.90/D89.1 Cryoglobulinaemic vasculitis
• 4A44.91/M31.8 Hypocomplementaemic urticarial vasculitis
• 4A44.92/D69.0 IgA vasculitis
• 4A44.9Y/I77.6 Other specified immune complex small vessel vasculitis
• 4A44.9Z/I77.6 Immune complex small vessel vasculitis, unspecified
• 4A44.A/I77.6 Antineutrophil cytoplasmic antibody-associated vasculitis
• 4A44.A0/M31.7 Microscopic polyangiitis
• 4A44.A1/M31.3 Granulomatosis with polyangiitis
• 4A44.A2/M30.1 Eosinophilic granulomatosis with polyangiitis
• 4A44.AY/I77.6 Other specified antineutrophil cytoplasmic antibody-associated vasculitis
• 4A44.AZ/I77.6 Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified
• 4A44.B/M31.0 Leukocytoclastic vasculitis
• 4A44.B0/M31.0 Cutaneous leukocytoclastic vasculitis
• 4A44.BY/M31.0 Other specified leukocytoclastic vasculitis
• 4A44.BZ/M31.0 Leukocytoclastic vasculitis, unspecified
• 4A44/M30-M36 Vasculitis
• 4A44.Y/M30-M36 Other specified vasculitis
• 4A44.Z/M30-M36 Vasculitis, unspecified
• 4A45.0/D68.6 Primary antiphospholipid syndrome
• 4A45.1/D68.6 Secondary antiphospholipid syndrome
• 4A45.2/D68.6 Antiphospholipid syndrome in pregnancy
• 4A45.3/D68.6 Lupus anticoagulant-hypoprothrombinaemia syndrome
• 4A45/D68.6 Antiphospholipid syndrome
• 4A45.Z/D68.6 Antiphospholipid syndrome, unspecified
• 4A4Y/M30-M36 Other specified nonorgan specific systemic autoimmune disorders
• 4A4Z/M30-M36 Nonorgan specific systemic autoimmune disorders, unspecified
• 4A60.0/D89.8 Familial Mediterranean fever
• 4A60.1/D89.8 Cryopyrin-associated periodic syndromes
• 4A60.2/D89.8 Tumour necrosis factor receptor 1 associated periodic syndrome
• 4A60/D89.9 Monogenic autoinflammatory syndromes
• 4A60.Y/D89.9 Other specified monogenic autoinflammatory syndromes
• 4A60.Z/D89.9 Autoimflammatory syndrome, unspecified
• 4A61/M86.3 SAPHO syndrome
• 4A62/M35.2 Behçet disease
• 4A6Y/D89.9 Other specified autoinflammatory disorders
• 4A6Z/D89.9 Autoinflammatory disorders, unspecified
• 4A80.0/J39.3 Drug-induced bronchospasm
• 4A80.1/J39.3 Bronchospasm provoked by allergy to food substance
• 4A80/J39.3 Allergic or hypersensitivity disorders involving the respiratory tract
• 4A80.Y/J39.3 Other specified allergic or hypersensitivity disorders involving the respiratory tract
• 4A80.Z/J39.3 Allergic or hypersensitivity disorders involving the respiratory tract, unspecified
• 4A81/T78.4 Allergic or hypersensitivity disorders involving the eye
• 4A82/T78.4 Allergic or hypersensitivity disorders involving skin or mucous membranes
• 4A83.0/T78.4 Food-induced eosinophilic gastroenteritis
• 4A83.1/T78.4 Food-induced eosinophilic oesophagitis
• 4A83/T78.4 Allergic or hypersensitivity disorders involving the gastrointestinal tract
• 4A83.Y/T78.4 Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract
• 4A83.Z/T78.4 Allergic or hypersensitivity disorders involving the gastrointestinal tract, unspecified
• 4A84.0/T78.0 Anaphylaxis due to allergic reaction to food
• 4A84.1/T88.6 Drug-induced anaphylaxis
• 4A84.2/T63.4 Anaphylaxis due to insect venom
• 4A84.3/T78.2 Anaphylaxis provoked by physical factors
• 4A84.30/T78.2 Exercise-induced anaphylaxis
• 4A84.31/T78.2 Cold-induced anaphylaxis
• 4A84.3Y/T78.2 Anaphylaxis provoked by other specified physical factors
• 4A84.3Z/T78.2 Anaphylaxis provoked by unspecified physical factors
• 4A84.4/T78.2 Anaphylaxis due to inhaled allergens
• 4A84.5/T78.2 Anaphylaxis due to contact with allergens
• 4A84.6/T78.2 Anaphylaxis secondary to mast cell disorder
• 4A84/T78.2 Anaphylaxis
• 4A84.Y/T78.2 Other specified anaphylaxis
• 4A84.Z/T78.2 Anaphylaxis, unspecified
• 4A85.0/T78.4 Drug or pharmacological agents hypersensitivity
• 4A85.00/K71 Drug-induced liver hypersensitivity disease
• 4A85.01/T78.4 Drug-induced kidney hypersensitivity
• 4A85.02/D69.5 Drug-induced cytopenia
• 4A85.03/D69.0 Drug-induced vasculitis
• 4A85.04/T78.4 Multiple drug hypersensitivity syndrome
• 4A85.0Y/T78.4 Drug hypersensitivity of other specified type
• 4A85.0Z/T78.4 Drug hypersensitivity of unspecified type
• 4A85.1/T78.4 Hypersensitivity to herbal and alternative medical therapies
• 4A85.2/T78.1 Food hypersensitivity
• 4A85.20/K52.2 Food-induced gastrointestinal hypersensitivity
• 4A85.21/T78.1 Food-induced urticaria or angioedema
• 4A85.22/L23.6 Allergic contact dermatitis due to food allergen
• 4A85.2Y/T78.1 Other specified food hypersensitivity
• 4A85.2Z/T78.1 Food hypersensitivity, unspecified
• 4A85.3/T78.4 Allergic or hypersensitivity reactions to arthropods
• 4A85.30/T63.4 Systemic allergic reaction due to Hymenoptera venom
• 4A85.31/T63.4 Cutaneous allergic or hypersensitivity reactions to Hymenoptera venom
• 4A85.32/T63.4 Cutaneous allergic or hypersensitivity reactions to arthropods
• 4A85/T78.4 Complex allergic or hypersensitivity conditions
• 4A85.Y/T78.4 Other specified complex allergic or hypersensitivity conditions
• 4A85.Z/T78.4 Complex allergic or hypersensitivity conditions, unspecified
• 4A8Y/T78.4 Allergic or hypersensitivity conditions of other specified type
• 4A8Z/T78.4 Allergic or hypersensitivity conditions of unspecified type
• 4B00.0/D89.9 Neutropaenia
• 4B00.00/D89.9 Constitutional neutropaenia
• 4B00.01/D89.9 Acquired neutropaenia
• 4B00.0Z/D89.9 Neutropenia, unspecified
• 4B00.1/D89.9 Neutrophilia
• 4B00.10/D72.0 Constitutional neutrophilia
• 4B00.11/D72.8 Acquired neutrophilia
• 4B00.1Z/D89.9 Neutrophilia, unspecified
• 4B00/D89.9 Disorders of neutrophil number
• 4B00.Y/D89.9 Other specified disorders of neutrophil number
• 4B01.0/D72.0 Constitutional disorders of neutrophil function
• 4B01.00/D72.0 Disorders of neutrophil adhesion
• 4B01.01/D72.0 Disorders of neutrophil chemotaxis
• 4B01.02/D72.0 Disorders of neutrophil granule formation or release
• 4B01.03/D72.0 Disorders of neutrophil oxidative metabolism
• 4B01.0Y/D72.0 Other specified constitutional disorders of neutrophil function
• 4B01.0Z/D72.0 Constitutional disorders of neutrophil function, unspecified
• 4B01.1/D72.8 Acquired disorders of neutrophil function
• 4B01/D89.9 Disorders of neutrophil function
• 4B01.Z/D89.9 Disorders of neutrophil function, unspecified
• 4B02.0/D72.0 Constitutional decrease in eosinophil number
• 4B02.1/D72.8 Acquired decrease in eosinophil number
• 4B02/D89.9 Eosinopenia
• 4B02.Z/D89.9 Eosinopenia, unspecified
• 4B03.0/D72.1 Constitutional eosinophilia
• 4B03.1/D72.1 Acquired eosinophilia
• 4B03/D72.1 Eosinophilia
• 4B03.Z/D72.1 Eosinophilia, unspecified
• 4B04/D72.8 Disorders with decreased monocyte counts
• 4B05/D72.8 Disorders with increased monocyte counts
• 4B06/D72.8 Acquired lymphopenia
• 4B07/D72.8 Acquired lymphocytosis
• 4B0Y/D89.9 Other specified immune system disorders involving white cell lineages
• 4B0Z/D89.9 Immune system disorders involving white cell lineages, unspecified
• 4B20.0/D86.0 Sarcoidosis of lung
• 4B20.1/D86.1 Sarcoidosis of lymph nodes
• 4B20.2/D86 Sarcoidosis of the digestive system
• 4B20.3/D86 Neurosarcoidosis
• 4B20.4/D86 Ocular sarcoidosis
• 4B20.5/D86.3 Cutaneous sarcoidosis
• 4B20/D86 Sarcoidosis
• 4B20.Y/D86.8 Other specified sarcoidosis
• 4B20.Z/D86 Sarcoidosis, unspecified
• 4B21/D89.0 Polyclonal hypergammaglobulinaemia
• 4B22/D89.1 Cryoglobulinaemia
• 4B23/D89.3 Immune reconstitution inflammatory syndrome
• 4B24.0/T86.0 Acute graft-versus-host disease
• 4B24.1/T86.0 Chronic graft-versus-host disease
• 4B24/D89.9 Graft-versus-host disease
• 4B24.Y/D89.9 Other specified graft-versus-host disease
• 4B24.Z/D89.9 Graft-versus-host disease, unspecified
• 4B2Y/D89.9 Other specified disorders involving the immune system
• 4B40.0/E32.0 Persistent hyperplasia of thymus
• 4B40.1/E32.1 Abscess of thymus
• 4B40.2/E32 Good syndrome
• 4B40/E32.9 Diseases of thymus
• 4B40.Y/E32.9 Other specified diseases of thymus
• 4B40.Z/E32.9 Diseases of thymus, unspecified
• 4B4Y/IV Other specified diseases of the immune system
• 4B4Z/IV Diseases of the immune system, unspecified
• 5A00.0/E03.9 Congenital hypothyroidism
• 5A00.00/E03.0 Permanent congenital hypothyroidism with diffuse goitre
• 5A00.01/E03.1 Permanent congenital hypothyroidism without goitre
• 5A00.02/E03.9 Pendred syndrome
• 5A00.03/E03.9 Transient congenital hypothyroidism
• 5A00.04/E00 Congenital hypothyroidism due to iodine deficiency
• 5A00.0Y/E03.9 Other specified congenital hypothyroidism
• 5A00.0Z/E03.9 Congenital hypothyroidism, unspecified
• 5A00.1/E01 Iodine-deficiency-related thyroid disorders or allied conditions
• 5A00.10/E01.0 Iodine-deficiency-related diffuse goitre
• 5A00.11/E01.1 Iodine-deficiency-related multinodular goitre
• 5A00.1Z/E01 Iodine-deficiency-related thyroid disorders or allied conditions, unspecified
• 5A00.2/E03.9 Acquired hypothyroidism
• 5A00.20/E03.2 Hypothyroidism due to medicaments or other exogenous substances
• 5A00.21/E03.5 Myxoedema coma
• 5A00.22/E02 Subclinical iodine-deficiency hypothyroidism
• 5A00.2Y/E03.9 Other specified acquired hypothyroidism
• 5A00.2Z/E03.9 Acquired hypothyroidism, unspecified
• 5A00/E03.9 Hypothyroidism
• 5A00.Z/E03.9 Hypothyroidism, unspecified
• 5A01.0/E04.0 Nontoxic diffuse goitre
• 5A01.1/E04.1 Nontoxic single thyroid nodule
• 5A01.2/E04.2 Nontoxic multinodular goitre
• 5A01/E04 Nontoxic goitre
• 5A01.Z/E04 Nontoxic goitre, unspecified
• 5A02.0/E05.0 Thyrotoxicosis with diffuse goitre
• 5A02.1/E05.1 Thyrotoxicosis with toxic single thyroid nodule
• 5A02.2/E05.2 Thyrotoxicosis with toxic multinodular goitre
• 5A02.3/E05.3 Thyrotoxicosis from ectopic thyroid tissue
• 5A02.4/E05.4 Thyrotoxicosis factitia
• 5A02.5/E05.5 Thyroid crisis
• 5A02.6/E05 Secondary hyperthyroidism
• 5A02/E05 Thyrotoxicosis
• 5A02.Y/E05.8 Other specified thyrotoxicosis
• 5A02.Z/E05 Thyrotoxicosis, unspecified
• 5A03.0/E06.0 Acute thyroiditis
• 5A03.1/E06.1 Subacute thyroiditis
• 5A03.2/E06.3 Autoimmune thyroiditis
• 5A03.20/E06.3 Hashimoto thyroiditis
• 5A03.21/E06.3 Painless thyroiditis
• 5A03.2Y/E06.3 Other specified autoimmune thyroiditis
• 5A03/E06 Thyroiditis
• 5A03.Y/E06 Other specified thyroiditis
• 5A03.Z/E06 Thyroiditis, unspecified
• 5A04/E07.0 Hypersecretion of calcitonin
• 5A05/E07 Generalised resistance to thyroid hormone
• 5A06/E07 Sick-euthyroid syndrome
• 5A0Y/E00-E07 Other specified disorders of the thyroid gland or thyroid hormones system
• 5A0Z/E00-E07 Disorders of the thyroid gland or thyroid hormones system, unspecified
• 5A10/E10-E14 Type 1 diabetes mellitus
• 5A11/E11 Type 2 diabetes mellitus
• 5A12/E12 Malnutrition-related diabetes mellitus
• 5A13.0/E13 Diabetes mellitus due to genetic defects of beta cell function
• 5A13.1/E13 Diabetes mellitus due to genetic defects in insulin action
• 5A13.2/E13 Diabetes mellitus due to diseases of the exocrine pancreas
• 5A13.3/E13 Diabetes mellitus due to endocrinopathies
• 5A13.4/E13 Diabetes mellitus due to drug or chemical
• 5A13.5/E13 Diabetes mellitus due to uncommon forms of immune-mediated diabetes
• 5A13.6/E13 Diabetes mellitus due to other genetic syndromes
• 5A13.7/E13 Diabetes mellitus due to clinically defined subtypes or syndromes
• 5A13/E13 Diabetes mellitus, other specified type
• 5A13.Y/E13.8 Diabetes mellitus due to other specified cause
• 5A14/E14 Diabetes mellitus, type unspecified
• 5A20.0/E10-E14 Hyperosmolar hyperglycaemic state without coma
• 5A20.1/E10-E14 Hyperosmolar hyperglycaemic state with coma
• 5A20/E10-E14 Diabetic hyperosmolar hyperglycaemic state
• 5A20.Z/E10-E14 Diabetic hyperosmolar hyperglycaemic state, unspecified
• 5A21.0/E10-E14 Hypoglycaemia in the context of diabetes mellitus without coma
• 5A21.1/E10-E14 Hypoglycaemia in the context of diabetes mellitus with coma
• 5A21/E10-E14 Hypoglycaemia in the context of diabetes mellitus
• 5A21.Z/E10-E14 Hypoglycaemia in the context of diabetes, unspecified
• 5A22.0/E14.1 Diabetic ketoacidosis without coma
• 5A22.1/E14.1 Diabetic lactic acidosis
• 5A22.2/E14.1 Diabetic metabolic acidosis
• 5A22.3/E10-E14 Diabetic ketoacidosis with coma
• 5A22/E14.1 Diabetic acidosis
• 5A22.Y/E14.1 Other specified diabetic acidosis
• 5A22.Z/E14.1 Diabetic acidosis, unspecified
• 5A23/E10-E14 Diabetic coma
• 5A24/E10-E14 Uncontrolled or unstable diabetes mellitus
• 5A2Y/E10-E14 Other specified acute complications of diabetes mellitus
• 5A40.0/E15-E16 Impaired fasting glucose
• 5A40.1/E15-E16 Impaired glucose tolerance
• 5A40/E15-E16 Intermediate hyperglycaemia
• 5A40.Y/E15-E16 Other specified intermediate hyperglycaemia
• 5A40.Z/E15-E16 Intermediate hyperglycaemia, unspecified
• 5A41/E16.2 Hypoglycaemia without associated diabetes
• 5A42/E16.3 Increased secretion of glucagon
• 5A43.0/E16.4 Drug-induced hypergastrinaemia
• 5A43.1/E16.4 Zollinger-Ellison syndrome
• 5A43/E16.4 Abnormal secretion of gastrin
• 5A43.Y/E16.4 Other specified abnormal secretion of gastrin
• 5A43.Z/E16.4 Abnormal secretion of gastrin, unspecified
• 5A44/E10-E14 Insulin-resistance syndromes
• 5A45/E16.1 Persistent hyperinsulinaemic hypoglycaemia of infancy
• 5A4Y/E15-E16 Other specified disorders of glucose regulation or pancreatic internal secretion
• 5A4Z/E15-E16 Disorders of glucose regulation or pancreatic internal secretion, unspecified
• 5A50.0/E20 Hypoparathyroidism due to impaired parathyroid hormone secretion
• 5A50.00/E20.0 Idiopathic hypoparathyroidism
• 5A50.01/E20 Secondary hypoparathyroidism
• 5A50.02/E20 Hypoparathyroidism due to destruction of the parathyroid glands
• 5A50.03/E20 Autoimmune hypoparathyroidism
• 5A50.0Y/E20 Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
• 5A50.0Z/E20 Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
• 5A50.1/E20.1 Pseudohypoparathyroidism
• 5A50/E20 Hypoparathyroidism
• 5A50.Y/E20.8 Other specified hypoparathyroidism
• 5A50.Z/E20 Hypoparathyroidism, unspecified
• 5A51.0/E21.0 Primary hyperparathyroidism
• 5A51.1/E21.1 Secondary hyperparathyroidism
• 5A51.2/E21.2 Familial hypocalciuric hypercalcaemia
• 5A51/IV Hyperparathyroidism
• 5A51.Y/IV Other specified hyperparathyroidism
• 5A51.Z/IV Hyperparathyroidism, unspecified
• 5A5Y/IV Other specified disorders of the parathyroids or parathyroid hormone system
• 5A5Z/IV Disorders of the parathyroids or parathyroid hormone system, unspecified
• 5A60.0/E22.0 Acromegaly or pituitary gigantism
• 5A60.1/E22.1 Hyperprolactinaemia
• 5A60.2/E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
• 5A60.20/E22.2 Nephrogenic syndrome of inappropriate antidiuresis
• 5A60.2Y/E22.2 Other specified syndrome of inappropriate secretion of antidiuretic hormone
• 5A60.2Z/E22.2 Syndrome of inappropriate secretion of antidiuretic hormone, unspecified
• 5A60.3/E22.8 Central precocious puberty
• 5A60/E22 Hyperfunction of pituitary gland
• 5A60.Y/E22.8 Other specified hyperfunction of pituitary gland
• 5A60.Z/E22 Hyperfunction of pituitary gland, unspecified
• 5A61.0/E23.0 Hypopituitarism
• 5A61.1/E23 Adrenocorticotropic hormone deficiency
• 5A61.2/E23 Gonadotropin deficiency
• 5A61.3/E23 Growth hormone deficiency
• 5A61.4/E23 Thyroid stimulating hormone deficiency
• 5A61.40/E23 Acquired central hypothyroidism
• 5A61.41/E23 Congenital central hypothyroidism
• 5A61.4Y/E23 Other specified thyroid stimulating hormone deficiency
• 5A61.4Z/E23 Thyroid stimulating hormone deficiency, unspecified
• 5A61.5/E23.2 Central diabetes insipidus
• 5A61.6/E23 Oxytocin deficiency
• 5A61/E23 Hypofunction or certain other specified disorders of pituitary gland
• 5A61.Y/E23 Other specified hypofunction or disorders of pituitary gland
• 5A6Z/IV Disorders of the pituitary hormone system, unspecified
• 5A70.0/E24.0 Pituitary-dependent Cushing disease
• 5A70.1/E24.3 Ectopic ACTH syndrome
• 5A70.2/E24 Pseudo-Cushing syndrome
• 5A70.3/E24.1 Nelson syndrome
• 5A70/E24 Cushing syndrome
• 5A70.Y/E24.8 Other specified Cushing syndrome
• 5A70.Z/E24 Cushing syndrome, unspecified
• 5A71.0/E25 46,XX disorders of sex development induced by androgens of fetal origin
• 5A71.00/E25 Glucocorticoid resistance
• 5A71.01/E25.0 Congenital adrenal hyperplasia
• 5A71.0Y/E25 Other specified 46,XX disorders of sex development induced by androgens of fetal origin
• 5A71.0Z/E25 46,XX disorders of sex development induced by androgens of fetal origin, unspecified
• 5A71.1/E25 46,XX disorders of sex development induced by androgens of maternal origin
• 5A71/E25 Adrenogenital disorders
• 5A71.Y/E25.8 Other specified adrenogenital disorders
• 5A71.Z/E25 Adrenogenital disorders, unspecified
• 5A72.0/E26.0 Primary hyperaldosteronism
• 5A72.1/E26.1 Secondary hyperaldosteronism
• 5A72/E26 Hyperaldosteronism
• 5A72.Z/E26 Hyperaldosteronism, unspecified
• 5A73/E27.4 Hypoaldosteronism
• 5A74.0/E27.1 Acquired adrenocortical insufficiency
• 5A74.1/E27.2 Adrenal crisis
• 5A74/E27.4 Adrenocortical insufficiency
• 5A74.Y/E27.4 Other specified adrenocortical insufficiency
• 5A74.Z/E27.4 Adrenocortical insufficiency, unspecified
• 5A75/E27.5 Adrenomedullary hyperfunction
• 5A76.0/E27.0 Premature adrenarche
• 5A76/E27.8 Certain specified disorders of adrenal gland
• 5A76.Y/E27.8 Other specified disorders of adrenal gland
• 5A7Z/IV Disorders of the adrenal glands or adrenal hormone system, unspecified
• 5A80.0/E28.1 Clinical hyperandrogenism
• 5A80.1/E28.2 Polycystic ovary syndrome
• 5A80.2/E28 Polycystic ovary
• 5A80.3/E28 Anovulation
• 5A80.4/E28 Oligo-ovulation
• 5A80.5/E28 Diminished ovarian reserve
• 5A80/E28 Ovarian dysfunction
• 5A80.Y/E28.8 Other specified ovarian dysfunction
• 5A80.Z/E28 Ovarian dysfunction, unspecified
• 5A81.0/E29.0 Testicular hyperfunction
• 5A81.1/E29.1 Testicular hypofunction
• 5A81/E29 Testicular dysfunction or testosterone-related disorders
• 5A81.Y/E29.8 Other specified testicular dysfunction or testosterone-related disorders
• 5A81.Z/E29 Testicular dysfunction or testosterone-related disorders, unspecified
• 5A8Z/IV Disorders of the gonadal hormone system, unspecified
• 5A90/E30 Disorder of puberty due to oestrogen resistance
• 5A91/E30.0 Delayed puberty
• 5A92/E30.1 Peripheral precocious puberty
• 5A9Y/E30.8 Other disorders of puberty
• 5A9Z/E30 Disorders of puberty, unspecified
• 5B00/E31.0 Autoimmune polyendocrinopathy
• 5B01/E31.1 Polyglandular hyperfunction
• 5B0Y/E31.8 Other specified polyglandular dysfunction
• 5B0Z/E31 Polyglandular dysfunction, unspecified
• 5B10/E34.0 Carcinoid syndrome
• 5B11/E34.3 Short stature, not elsewhere classified
• 5B12/E34.4 Constitutional tall stature
• 5B1Y/IV Other specified endocrine disorders, not elsewhere classified
• 5B3Y/IV Other specified endocrine diseases
• 5B3Z/IV Endocrine diseases, unspecified
• 5B50/E46 Underweight in infants, children or adolescents
• 5B51/E46 Wasting in infants, children or adolescents
• 5B52/E46 Acute malnutrition in infants, children or adolescents
• 5B53/E46 Stunting in infants, children or adolescents
• 5B54/E46 Underweight in adults
• 5B55.0/E50.5 Vitamin A deficiency with night blindness
• 5B55.1/E50.0 Vitamin A deficiency with conjunctival xerosis
• 5B55.2/E50.1 Vitamin A deficiency with conjunctival xerosis and Bitot’s spots
• 5B55.3/E50.2 Vitamin A deficiency with corneal xerosis
• 5B55.4/E50.3 Vitamin A deficiency with corneal ulceration or keratomalacia
• 5B55.5/E50.6 Vitamin A deficiency with xerophthalmic scars of cornea or blindness
• 5B55/E50 Vitamin A deficiency
• 5B55.Y/E50.8 Vitamin A deficiency with other specified manifestations
• 5B55.Z/E50 Vitamin A deficiency, unspecified
• 5B56.0/E54 Scurvy
• 5B56/E54 Vitamin C deficiency
• 5B56.Y/E54 Other specified vitamin C deficiency
• 5B56.Z/E54 Vitamin C deficiency, unspecified
• 5B57.0/E55.0 Vitamin D deficiency rickets
• 5B57.1/E55 Vitamin D deficiency osteomalacia
• 5B57/E55 Vitamin D deficiency
• 5B57.Y/E55 Other specified vitamin D deficiency
• 5B57.Z/E55 Vitamin D deficiency, unspecified
• 5B58/E56.0 Vitamin E deficiency
• 5B59/E56.1 Vitamin K deficiency
• 5B5A.0/E51.1 Beriberi
• 5B5A.00/E51.1 Dry beriberi
• 5B5A.01/E51.1 Wet beriberi
• 5B5A.0Z/E51.1 Beriberi, unspecified
• 5B5A.1/E51 Wernicke-Korsakoff Syndrome
• 5B5A.10/E51.2 Wernicke encephalopathy
• 5B5A.11/E51 Korsakoff syndrome
• 5B5A.1Y/E51 Other specified Wernicke-Korsakoff Syndrome
• 5B5A.1Z/E51 Wernicke-Korsakoff Syndrome, unspecified
• 5B5A/E51 Vitamin B1 deficiency
• 5B5A.Y/E51.8 Other specified vitamin B1 deficiency
• 5B5A.Z/E51 Vitamin B1 deficiency, unspecified
• 5B5B/E53.0 Vitamin B2 deficiency
• 5B5C.0/E52 Pellagra
• 5B5C/E52 Vitamin B3 deficiency
• 5B5C.Y/E52 Other specified vitamin B3 deficiency
• 5B5D/E53.1 Vitamin B6 deficiency
• 5B5E/E53.8 Folate deficiency
• 5B5F/E53.8 Vitamin B12 deficiency
• 5B5G/E53.8 Biotin deficiency
• 5B5H/E53.8 Pantothenic acid deficiency
• 5B5J/E53.8 Choline deficiency
• 5B5K.0/E61.1 Iron deficiency
• 5B5K.1/E58 Calcium deficiency
• 5B5K.10/E58 Tetany due to acute calcium deficiency
• 5B5K.1Y/E58 Other specified calcium deficiency
• 5B5K.1Z/E58 Calcium deficiency, unspecified
• 5B5K.2/E60 Zinc deficiency
• 5B5K.3/E61.8 Iodine deficiency
• 5B5K.4/E61.8 Fluorine deficiency
• 5B5K.5/E61.8 Sodium chloride deficiency
• 5B5K.6/E61.0 Copper deficiency
• 5B5K.7/E59 Selenium deficiency
• 5B5K.8/E61.4 Chromium deficiency
• 5B5K.9/E61.3 Manganese deficiency
• 5B5K.A/E61.5 Molybdenum deficiency
• 5B5K.B/E61.6 Vanadium deficiency
• 5B5K/E61.9 Mineral deficiencies
• 5B5K.Y/E61.9 Other specified mineral deficiency
• 5B5K.Z/E61.9 Mineral deficiency, unspecified
• 5B60/E64.0 Sequelae of protein-energy malnutrition
• 5B61/E64 Sequelae of vitamin A deficiency
• 5B62/E64.2 Sequelae of vitamin C deficiency
• 5B63/E64 Sequelae of rickets
• 5B6Y/E64.8 Other specified sequelae of malnutrition or certain specified nutritional deficiencies
• 5B6Z/E64 Sequelae of malnutrition or certain specified nutritional deficiencies, unspecified
• 5B70/E63.0 Essential fatty acid deficiency
• 5B71/E63 Protein deficiency
• 5B7Y/E90 Other specified undernutrition
• 5B7Z/E90 Unspecified undernutrition
• 5B80.0/E66.9 Overweight
• 5B80.00/E66.9 Overweight in infants, children or adolescents
• 5B80.01/E66.9 Overweight in adults
• 5B80.0Z/E66.9 Overweight, unspecified
• 5B80.1/E65 Localised adiposity
• 5B80/E65-E68 Overweight or localised adiposity
• 5B81.0/E66.0 Obesity due to energy imbalance
• 5B81.00/E66.0 Obesity in children or adolescents
• 5B81.01/E66.0 Obesity in adults
• 5B81.1/E66.1 Drug-induced obesity
• 5B81/E66 Obesity
• 5B81.Y/E66.8 Other specified obesity
• 5B81.Z/E66 Obesity, unspecified
• 5B90.0/E67.0 Hypervitaminosis A
• 5B90.1/E67.1 Hypercarotenaemia
• 5B90.2/E67.3 Hypervitaminosis D
• 5B90.3/E67.2 Megavitamin-B6 syndrome
• 5B90/E67 Vitamin excesses
• 5B90.Y/E67 Other specified vitamin excess
• 5B90.Z/E67 Unspecified vitamin excesses
• 5B91.0/E67 Hypercalcaemia
• 5B91.1/E67.8 Zinc excess
• 5B91.2/E67.8 Sodium chloride excess
• 5B91.3/E67.8 Fluorine excess
• 5B91.4/E67.8 Aluminium excess
• 5B91.5/E67.8 Manganese excess
• 5B91/E67 Mineral excesses
• 5B91.Y/E67 Other specified mineral excess
• 5B91.Z/E67 Unspecified mineral excess
• 5B9Y/E67.8 Other specified nutrient excesses
• 5B9Z/E67 Certain specified nutrient excesses, unspecified
• 5C1Y/E65-E68 Other specified overweight, obesity or specific nutrient excesses
• 5C1Z/E65-E68 Overweight, obesity or specific nutrient excesses, unspecified
• 5C3Y/E90 Other specified nutritional disorders
• 5C3Z/E90 Nutritional disorders, unspecified
• 5C50.0/E70 Phenylketonuria
• 5C50.00/E70.0 Classical phenylketonuria
• 5C50.01/E70.1 Nonclassical phenylketonuria
• 5C50.02/E70.1 Embryofetopathy due to maternal phenylketonuria
• 5C50.0Y/E70.8 Other specified phenylketonuria
• 5C50.0Z/E70 Phenylketonuria, unspecified
• 5C50.1/E70.2 Disorders of tyrosine metabolism
• 5C50.10/E70.2 Alkaptonuria
• 5C50.11/E70.2 Tyrosinaemia type 1
• 5C50.12/E70.2 Tyrosinaemia type 2
• 5C50.1Y/E70.2 Other specified disorders of tyrosine metabolism
• 5C50.1Z/E70.2 Disorders of tyrosine metabolism, unspecified
• 5C50.2/E70.8 Disorders of histidine metabolism
• 5C50.20/E70.8 Histidinaemia
• 5C50.21/E70.8 Urocanic aciduria
• 5C50.2Y/E70.8 Other specified disorders of histidine metabolism
• 5C50.2Z/E70.8 Disorders of histidine metabolism, unspecified
• 5C50.3/E70.8 Disorders of tryptophan metabolism
• 5C50.4/E72.3 Disorders of lysine or hydroxylysine metabolism
• 5C50.5/E72.8 Disorders of the gamma-glutamyl cycle
• 5C50.6/E72.8 Disorders of serine metabolism
• 5C50.7/E72.5 Disorders of glycine metabolism
• 5C50.70/E72.5 Glycine encephalopathy
• 5C50.71/E72.5 Sarcosinaemia
• 5C50.7Y/E72.5 Other specified disorders of glycine metabolism
• 5C50.7Z/E72.5 Disorders of glycine metabolism, unspecified
• 5C50.8/E72.8 Disorders of proline or hydroxyproline metabolism
• 5C50.9/E72.4 Disorders of ornithine metabolism
• 5C50.A/E72.2 Disorders of urea cycle metabolism
• 5C50.A0/E72.2 Argininosuccinic aciduria
• 5C50.A1/E72.2 Carbamoylphosphate synthetase deficiency
• 5C50.A2/E72.2 Argininaemia
• 5C50.A3/E72.2 Citrullinaemia
• 5C50.AY/E72.2 Other specified disorders of urea cycle metabolism
• 5C50.AZ/E72.2 Disorders of urea cycle metabolism, unspecified
• 5C50.B/E72.1 Disorders of methionine cycle or sulphur amino acid metabolism
• 5C50.C/E72.8 Disorders of beta or omega amino acid metabolism
• 5C50.D/E71.2 Disorders of branched-chain amino acid metabolism
• 5C50.D0/E71.0 Maple-syrup-urine disease
• 5C50.DY/E71.2 Other specified disorders of branched-chain amino acid metabolism
• 5C50.DZ/E71.2 Disorders of branched-chain amino acid metabolism, unspecified
• 5C50.E/E71.1 Organic aciduria
• 5C50.E0/E71.1 Classical organic aciduria
• 5C50.E1/E71.1 Cerebral organic aciduria
• 5C50/E70-E90 Inborn errors of amino acid or other organic acid metabolism
• 5C50.EY/E71.1 Other specified organic aciduria
• 5C50.EZ/E71.1 Organic aciduria, unspecified
• 5C50.F/E70-E90 Disorders of peptide metabolism
• 5C50.F0/E72.8 Prolidase deficiency
• 5C50.F1/E70.8 Carnosinaemia
• 5C50.F2/E72.8 Homocarnosinosis
• 5C50.FY/E70-E90 Other specified disorders of peptide metabolism
• 5C50.FZ/E70-E90 Disorders of peptide metabolism, unspecified
• 5C50.G/E88.8 Trimethylaminuria
• 5C50.Y/E70-E90 Other specified inborn errors of amino acid or other organic acid metabolism
• 5C50.Z/E70-E90 Inborn errors of amino acid or other organic acid metabolism, unspecified
• 5C51.0/E74 Disorders of the pentose phosphate pathway
• 5C51.1/E74 Disorders of glycerol metabolism
• 5C51.2/E74 Disorders of glyoxylate metabolism
• 5C51.20/E74 Primary hyperoxaluria type 1
• 5C51.2Y/E74 Other specified disorders of glyoxylate metabolism
• 5C51.2Z/E74 Disorders of glyoxylate metabolism, unspecified
• 5C51.3/E74.0 Glycogen storage disease
• 5C51.4/E74.2 Disorders of galactose metabolism
• 5C51.40/E74.2 Galactose-1-phosphate uridyltransferase deficiency
• 5C51.41/E74.2 Galactokinase deficiency
• 5C51.42/E74.2 Glucose or galactose intolerance of newborn
• 5C51.4Y/E74.2 Other specified disorders of galactose metabolism
• 5C51.4Z/E74.2 Disorders of galactose metabolism, unspecified
• 5C51.5/E74.1 Disorders of fructose metabolism
• 5C51.50/E74.1 Hereditary fructose intolerance
• 5C51.5Y/E74.1 Other specified disorders of fructose metabolism
• 5C51.5Z/E74.1 Disorders of fructose metabolism, unspecified
• 5C51/E74 Inborn errors of carbohydrate metabolism
• 5C51.Y/E74.8 Other specified inborn errors of carbohydrate metabolism
• 5C51.Z/E74 Inborn errors of carbohydrate metabolism, unspecified
• 5C52.0/E71.3 Inborn errors of fatty acid oxidation or ketone body metabolism
• 5C52.00/E71.3 Disorders of carnitine transport or the carnitine cycle
• 5C52.01/E71.3 Disorders of mitochondrial fatty acid oxidation
• 5C52.02/E71.3 Disorders of ketone body metabolism
• 5C52.03/E71.3 Sjögren-Larsson syndrome
• 5C52.0Y/E71.3 Other specified inborn errors of fatty acid oxidation or ketone body metabolism
• 5C52.0Z/E71.3 Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified
• 5C52.1/E75 Inborn errors of sterol metabolism
• 5C52.10/E75 Disorders of cholesterol synthesis
• 5C52.11/E75 Bile acid synthesis defect with cholestasis
• 5C52.1Y/E75 Other specified inborn errors of sterol metabolism
• 5C52.1Z/E75 Inborn errors of sterol metabolism, unspecified
• 5C52.2/E75 Neutral lipid storage disease
• 5C52/E75 Inborn errors of lipid metabolism
• 5C52.Y/E75 Other specified inborn errors of lipid metabolism
• 5C52.Z/E75 Inborn errors of lipid metabolism, unspecified
• 5C53.0/E74.4 Disorders of pyruvate metabolism
• 5C53.00/E74.4 Pyruvate kinase deficiency
• 5C53.01/E74.4 Lactate dehydrogenase deficiency
• 5C53.02/E74.4 Pyruvate dehydrogenase complex deficiency
• 5C53.03/E74.4 Pyruvate carboxylase deficiency
• 5C53.0Y/E74.4 Other specified disorders of pyruvate metabolism
• 5C53.0Z/E74.4 Disorders of pyruvate metabolism, unspecified
• 5C53.1/E88.8 Disorders of the citric acid cycle
• 5C53.2/E88.8 Disorders of mitochondrial oxidative phosphorylation
• 5C53.20/E88.8 Mitochondrial DNA depletion syndromes
• 5C53.21/E88.8 Multiple mitochondrial DNA deletion syndromes
• 5C53.22/E88.8 Coenzyme Q10 deficiency
• 5C53.23/E88.8 Mitochondrial protein translation defects
• 5C53.24/G31.8 Leigh syndrome
• 5C53.25/E88.8 Isolated ATP synthase deficiency
• 5C53.2Y/E88.8 Other specified disorders of mitochondrial oxidative phosphorylation
• 5C53.2Z/E88.8 Disorders of mitochondrial oxidative phosphorylation, unspecified
• 5C53.3/E88.8 Disorders of mitochondrial membrane transport
• 5C53.30/E88.8 Mitochondrial substrate carrier disorders
• 5C53.31/E88.8 Mitochondrial protein import disorders
• 5C53.3Y/E88.8 Other specified disorders of mitochondrial membrane transport
• 5C53.3Z/E88.8 Disorders of mitochondrial membrane transport, unspecified
• 5C53.4/E72.8 Disorders of creatine metabolism
• 5C53/E70-E90 Inborn errors of energy metabolism
• 5C53.Y/E70-E90 Other specified inborn errors of energy metabolism
• 5C53.Z/E70-E90 Inborn errors of energy metabolism, unspecified
• 5C54.0/E77.8 Disorders of protein N-glycosylation
• 5C54.1/E77.8 Disorders of protein O-glycosylation
• 5C54.2/E77.8 Disorders of multiple glycosylation or other pathways
• 5C54/E70-E90 Inborn errors of glycosylation or other specified protein modification
• 5C54.Y/E70-E90 Other specified congenital disorders of glycosylation and protein modification
• 5C54.Z/E70-E90 Congenital disorders of glycosylation and protein modification, unspecified
• 5C55.0/E79 Disorders of purine metabolism
• 5C55.00/E79.8 Xanthinuria
• 5C55.01/E79.1 Lesch-Nyhan syndrome
• 5C55.0Y/E79 Other specified disorders of purine metabolism
• 5C55.0Z/E79 Disorders of purine metabolism, unspecified
• 5C55.1/E79 Disorders of pyrimidine metabolism
• 5C55.2/E79 Disorders of nucleotide metabolism
• 5C55/E79 Inborn errors of purine, pyrimidine or nucleotide metabolism
• 5C55.Y/E79.8 Other specified inborn errors of purine, pyrimidine or nucleotide metabolism
• 5C55.Z/E79 Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified
• 5C56.0/E75.3 Sphingolipidosis
• 5C56.00/E75.3 Gangliosidosis
• 5C56.01/E75.3 Fabry disease
• 5C56.02/E75.2 Metachromatic leukodystrophy
• 5C56.0Y/E75.3 Other specified sphingolipidosis
• 5C56.0Z/E75.3 Sphingolipidosis, unspecified
• 5C56.1/E75.4 Neuronal ceroid lipofuscinosis
• 5C56.2/E77 Glycoproteinosis
• 5C56.20/E77 Mucolipidosis
• 5C56.21/E77 Oligosaccharidosis
• 5C56.2Y/E77.8 Other specified glycoproteinosis
• 5C56.2Z/E77 Glycoproteinosis, unspecified
• 5C56.3/E76.3 Mucopolysaccharidosis
• 5C56.30/E76.0 Mucopolysaccharidosis type 1
• 5C56.31/E76.1 Mucopolysaccharidosis type 2
• 5C56.32/E76.2 Mucopolysaccharidosis type 4
• 5C56.33/E76.2 Mucopolysaccharidosis type 6
• 5C56.3Y/E76.3 Other specified mucopolysaccharidosis
• 5C56.3Z/E76.3 Mucopolysaccharidosis, unspecified
• 5C56.4/E77.1 Disorders of sialic acid metabolism
• 5C56/E70-E90 Lysosomal diseases
• 5C56.Y/E70-E90 Other specified lysosomal diseases
• 5C56.Z/E70-E90 Lysosomal diseases, unspecified
• 5C57.0/Q87.8 Disorders of peroxisome biogenesis
• 5C57.1/Q87.8 or omega-oxidation
• 5C57/E70-E90 Peroxisomal diseases
• 5C57.Y/E70-E90 Other specified peroxisomal diseases
• 5C57.Z/E70-E90 Peroxisomal diseases, unspecified
• 5C58.0/E80.7 Disorders of bilirubin metabolism or excretion
• 5C58.00/E80.5 Crigler-Najjar syndrome
• 5C58.01/E80.4 Gilbert syndrome
• 5C58.02/E80.6 Dubin-Johnson syndrome
• 5C58.03/K76.8 Progressive familial intrahepatic cholestasis
• 5C58.04/K83.1 Benign recurrent intrahepatic cholestasis
• 5C58.0Y/E80.7 Other specified disorders of bilirubin metabolism or excretion
• 5C58.0Z/E80.7 Disorders of bilirubin metabolism or excretion, unspecified
• 5C58.1/E80 Porphyrias
• 5C58.10/E80.1 Porphyria cutanea tarda
• 5C58.12/E80.0 Erythropoietic porphyrias
• 5C58.13/E80.2 Variegate porphyria
• 5C58.1Y/E80 Other specified porphyrias
• 5C58.1Z/E80 Porphyrias, unspecified
• 5C58/E80 Inborn errors of porphyrin or heme metabolism
• 5C58.Y/E80 Other specified inborn errors of porphyrin or heme metabolism
• 5C58.Z/E80 Inborn errors of porphyrin or heme metabolism, unspecified
• 5C59.0/E88.8 Disorders of biogenic amine metabolism
• 5C59.00/E88.8 Disorders of catecholamine synthesis
• 5C59.01/E88.8 Disorders of pterin metabolism
• 5C59.0Y/E88.8 Other specified disorders of biogenic amine metabolism
• 5C59.0Z/E88.8 Disorders of biogenic amine metabolism, unspecified
• 5C59.1/E88.8 Disorders of gamma aminobutyric acid metabolism
• 5C59.2/E88.8 Disorders of pyridoxine metabolism
• 5C59/E88.8 Inborn errors of neurotransmitter metabolism
• 5C59.Y/E88.8 Other specified inborn errors of neurotransmitter metabolism
• 5C59.Z/E88.8 Inborn errors of neurotransmitter metabolism, unspecified
• 5C5A/E88.0 Alpha-1-antitrypsin deficiency
• 5C5Y/E70-E90 Other specified inborn errors of metabolism
• 5C5Z/E70-E90 Inborn errors of metabolism, unspecified
• 5C60.0/E72.0 Oculocerebrorenal syndrome
• 5C60.1/E72.0 Cystinosis
• 5C60.2/E72.0 Cystinuria
• 5C60/E72.0 Disorders of amino acid absorption or transport
• 5C60.Y/E72.0 Other specified disorders of amino acid absorption or transport
• 5C60.Z/E72.0 Disorders of amino acid absorption or transport, unspecified
• 5C61.0/E74.3 Glucose-galactose malabsorption
• 5C61.1/E74.3 Maltase-glucoamylase deficiency
• 5C61.2/E74.3 Congenital sucrase-isomaltase deficiency
• 5C61.3/E74.8 Alpha, alpha trehalase deficiency
• 5C61.4/E74.3 Acquired monosaccharide malabsorption
• 5C61.40/E74.1 Fructose malabsorption
• 5C61.4Y/E74.3 Other specified acquired monosaccharide malabsorption
• 5C61.4Z/E74.3 Acquired monosaccharide malabsorption, unspecified
• 5C61.5/E74.8 Disorders of facilitated glucose transport
• 5C61.6/E73 Lactose intolerance
• 5C61.60/E73 Primary lactase deficiency
• 5C61.61/E73.0 Congenital lactase deficiency
• 5C61.62/E73.1 Secondary lactase deficiency
• 5C61.6Z/E73 Lactose intolerance, unspecified
• 5C61/E70-E90 Disorders of carbohydrate absorption or transport
• 5C61.Y/E70-E90 Other specified disorders of carbohydrate absorption or transport
• 5C61.Z/E70-E90 Disorders of carbohydrate absorption or transport, unspecified
• 5C62/E78.8 Disorders of lipid absorption or transport
• 5C63.0/E88.8 Disorders of cobalamin metabolism or transport
• 5C63.1/E88.8 Disorders of folate metabolism or transport
• 5C63.2/E88.8 Disorders of vitamin D metabolism or transport
• 5C63.20/E88.8 Hypocalcaemic vitamin D dependent rickets
• 5C63.21/E88.8 Hypocalcaemic vitamin D resistant rickets
• 5C63.22/E88.8 Hypophosphataemic rickets
• 5C63.2Y/E88.8 Other specified disorders of vitamin D metabolism or transport
• 5C63.2Z/E88.8 Disorders of vitamin D metabolism or transport, unspecified
• 5C63/E88.8 Disorders of vitamin or non-protein cofactor absorption or transport
• 5C63.Y/E88.8 Other specified disorders of vitamin or non-protein cofactor absorption or transport
• 5C63.Z/E88.8 Disorders of vitamin or non-protein cofactor absorption or transport, unspecified
• 5C64.0/E83.0 Disorders of copper metabolism
• 5C64.00/E83.0 Wilson disease
• 5C64.0Y/E83.0 Other specified disorders of copper metabolism
• 5C64.0Z/E83.0 Disorders of copper metabolism, unspecified
• 5C64.1/E83.1 Disorders of iron metabolism
• 5C64.10/E83.1 Iron overload diseases
• 5C64.1Y/E83.1 Other specified disorders of iron metabolism
• 5C64.1Z/E83.1 Disorders of iron metabolism, unspecified
• 5C64.2/E83.2 Disorders of zinc metabolism
• 5C64.20/E83.2 Acrodermatitis enteropathica
• 5C64.21/E83.2 Zinc deficiency syndromes
• 5C64.2Y/E83.2 Other specified disorders of zinc metabolism
• 5C64.2Z/E83.2 Disorders of zinc metabolism, unspecified
• 5C64.3/E83.3 Disorders of phosphorus metabolism or phosphatases
• 5C64.4/E83.4 Disorders of magnesium metabolism
• 5C64.40/E83.4 Hypermagnesaemia
• 5C64.41/E61.2 Hypomagnesaemia
• 5C64.4Z/E83.4 Disorders of magnesium metabolism, unspecified
• 5C64.5/E83.5 Disorders of calcium metabolism
• 5C64.6/E83 Disorders of sodium metabolism
• 5C64.7/E83 Disorders of chloride metabolism
• 5C64/E83 Disorders of mineral absorption or transport
• 5C64.Y/E83.8 Disorders of other specified mineral absorption and transport
• 5C64.Z/E83 Disorders of mineral absorption or transport, unspecified
• 5C6Y/E70-E90 Other specified disorders of metabolite absorption or transport
• 5C6Z/E70-E90 Disorders of metabolite absorption or transport, unspecified
• 5C70.0/E86 Dehydration
• 5C70.1/E86 Hypovolaemia
• 5C70/E86 Volume depletion
• 5C70.Y/E86 Other specified volume depletion
• 5C70.Z/E86 Volume depletion, unspecified
• 5C71/E87.0 Hyperosmolality or hypernatraemia
• 5C72/E87.1 Hypo-osmolality or hyponatraemia
• 5C73.0/E87.2 Acute respiratory acidosis
• 5C73.1/E87.2 Chronic respiratory acidosis
• 5C73.2/E87.2 Anion gap metabolic acidosis
• 5C73/E87.2 Acidosis
• 5C73.Y/E87.2 Other specified acidosis
• 5C73.Z/E87.2 Acidosis, unspecified
• 5C74/E87.3 Alkalosis
• 5C75/E87.4 Mixed disorder of acid-base balance
• 5C76/E87.5 Hyperkalaemia
• 5C77/E87.6 Hypokalaemia
• 5C78/E87.7 Fluid overload
• 5C7Y/E70-E90 Other specified disorders of fluid, electrolyte or acid-base balance
• 5C7Z/E70-E90 Disorders of fluid, electrolyte or acid-base balance, unspecified
• 5C80.0/E78.5 Hypercholesterolaemia
• 5C80.00/E78.0 Primary hypercholesterolaemia
• 5C80.01/E78.5 Secondary hypercholesterolaemia
• 5C80.0Z/E78.5 Hypercholesterolaemia, unspecified
• 5C80.1/E78.1 Hypertriglyceridaemia
• 5C80.2/E78.2 Mixed hyperlipidaemia
• 5C80.3/E78.5 Hyperalphalipoproteinaemia
• 5C80/E78.5 Hyperlipoproteinaemia
• 5C80.Y/E78.5 Other specified hyperlipoproteinaemia
• 5C80.Z/E78.5 Hyperlipoproteinaemia, unspecified
• 5C81.0/E78.6 Hypoalphalipoproteinaemia
• 5C81.1/E78.6 Hypobetalipoproteinaemia
• 5C81/E78.6 Hypolipoproteinaemia
• 5C81.Y/E78.6 Other specified hypolipoproteinaemia
• 5C81.Z/E78.6 Hypolipoproteinaemia, unspecified
• 5C8Y/E78.9 Other specified disorders of lipoprotein metabolism or lipidaemias
• 5C8Z/E78.9 Unspecified disorders of lipoprotein metabolism or lipidaemias
• 5C90.0/E70-E90 Liver diseases due to urea cycle defects
• 5C90.1/E70-E90 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport
• 5C90.2/E70-E90 Liver diseases due to disorders of amino acid metabolism
• 5C90.3/E75 Liver disease due to disorders of lysosomal storage
• 5C90.4/E70-E90 Liver diseases due to mitochondrial disorders
• 5C90.5/E83 Liver diseases due to disorders of mineral metabolism
• 5C90/E70-E90 Metabolic or transporter liver disease
• 5C90.Y/E70-E90 Other specified metabolic or transporter liver disease
• 5C90.Z/E70-E90 Metabolic or transporter liver disease, unspecified
• 5D00.0/E85.8 AL amyloidosis
• 5D00.1/E85.3 AA amyloidosis
• 5D00.2/E85.2 Hereditary amyloidosis
• 5D00.20/E85.1 Hereditary ATTR amyloidosis
• 5D00.21/E85.0 Non-neuropathic heredofamilial amyloidosis
• 5D00.2Y/E85.2 Other specified hereditary amyloidosis
• 5D00.2Z/E85.2 Hereditary amyloidosis, unspecified
• 5D00.3/E85 Dialysis-associated amyloidosis
• 5D00/E85 Amyloidosis
• 5D00.Y/E85.8 Other specified amyloidosis
• 5D00.Z/E85 Amyloidosis, unspecified
• 5D01/E88.3 Tumour lysis syndrome
• 5D0Y/E88.8 Other specified metabolic disorders
• 5D2Z/E70-E90 Metabolic disorders, unspecified
• 5D40.0/E89.0 Postirridation hypothyroidism
• 5D40.00/E89.0 Hypothyroidism postradioactive iodine ablation
• 5D40.0Y/E89.0 Other specified postirridation hypothyroidism
• 5D40.0Z/E89.0 Postirridation hypothyroidism, unspecified
• 5D40/E89.0 Postprocedural hypothyroidism
• 5D40.Y/E89.0 Other specified postprocedural hypothyroidism
• 5D40.Z/E89.0 Postprocedural hypothyroidism, unspecified
• 5D41/E89.1 Postprocedural hypoinsulinaemia
• 5D42/E89.2 Postprocedural hypoparathyroidism
• 5D43/E89.3 Postprocedural hypopituitarism
• 5D44/E89.4 Postprocedural ovarian failure
• 5D45/E89.5 Postprocedural testicular hypofunction
• 5D46/E89.6 Postprocedural adrenocortical hypofunction
• 6A00.0/F70 Disorder of intellectual development, mild
• 6A00.1/F71 Disorder of intellectual development, moderate
• 6A00.2/F72 Disorder of intellectual development, severe
• 6A00.3/F73 Disorder of intellectual development, profound
• 6A00.4/F70-F79 Disorder of intellectual development, provisional
• 6A00/F70-F79 Disorders of intellectual development
• 6A00.Z/F70-F79 Disorders of intellectual development, unspecified
• 6A01.0/F80.0 Developmental speech sound disorder
• 6A01.1/F80.8 Developmental speech fluency disorder
• 6A01.2/F80.9 Developmental language disorder
• 6A01.20/F80.2 Developmental language disorder with impairment of receptive and expressive language
• 6A01.21/F80.1 Developmental language disorder with impairment of mainly expressive language
• 6A01.22/F80.8 Developmental language disorder with impairment of mainly pragmatic language
• 6A01.23/F80.8 Developmental language disorder, with other specified language impairment
• 6A01/F80-F89 Developmental speech or language disorders
• 6A01.Y/F80-F89 Other specified developmental speech or language disorders
• 6A01.Z/F80-F89 Developmental speech or language disorders, unspecified
• 6A02.0/F80-F89 Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language
• 6A02.1/F80-F89 Autism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language
• 6A02.2/F80-F89 Autism spectrum disorder without disorder of intellectual development and with impaired functional language
• 6A02.3/F80-F89 Autism spectrum disorder with disorder of intellectual development and with impaired functional language
• 6A02.5/F80-F89 Autism spectrum disorder with disorder of intellectual development and with absence of functional language
• 6A02/F80-F89 Autism spectrum disorder
• 6A02.Y/F80-F89 Other specified autism spectrum disorder
• 6A02.Z/F80-F89 Autism spectrum disorder, unspecified
• 6A03.0/F81.0 Developmental learning disorder with impairment in reading
• 6A03.1/F81.1 Developmental learning disorder with impairment in written expression
• 6A03.2/F81.2 Developmental learning disorder with impairment in mathematics
• 6A03.3/F81 Developmental learning disorder with other specified impairment of learning
• 6A03/F81 Developmental learning disorder
• 6A03.Z/F81 Developmental learning disorder, unspecified
• 6A04/F82 Developmental motor coordination disorder
• 6A05.0/F80-F89 Attention deficit hyperactivity disorder, predominantly inattentive presentation
• 6A05.1/F80-F89 Attention deficit hyperactivity disorder, predominantly hyperactive-impulsive presentation
• 6A05.2/F80-F89 Attention deficit hyperactivity disorder, combined presentation
• 6A05/F80-F89 Attention deficit hyperactivity disorder
• 6A05.Y/F80-F89 Attention deficit hyperactivity disorder, other specified presentation
• 6A05.Z/F80-F89 Attention deficit hyperactivity disorder, presentation unspecified
• 6A06.0/F98.4 Stereotyped movement disorder without self-injury
• 6A06.1/F98.4 Stereotyped movement disorder with self-injury
• 6A06/F98.4 Stereotyped movement disorder
• 6A06.Z/F98.4 Stereotyped movement disorder, unspecified
• 6A0Y/F80-F89 Other specified neurodevelopmental disorders
• 6A0Z/F80-F89 Neurodevelopmental disorders, unspecified
• 6A20.0/F20 Schizophrenia, first episode
• 6A20.00/F20 Schizophrenia, first episode, currently symptomatic
• 6A20.01/F20 Schizophrenia, first episode, in partial remission
• 6A20.02/F20 Schizophrenia, first episode, in full remission
• 6A20.0Z/F20 Schizophrenia, first episode, unspecified
• 6A20.1/F20 Schizophrenia, multiple episodes
• 6A20.10/F20 Schizophrenia, multiple episodes, currently symptomatic
• 6A20.11/F20 Schizophrenia, multiple episodes, in partial remission
• 6A20.12/F20 Schizophrenia, multiple episodes, in full remission
• 6A20.1Z/F20 Schizophrenia, multiple episodes, unspecified
• 6A20.2/F20 Schizophrenia, continuous
• 6A20.20/F20 Schizophrenia, continuous, currently symptomatic
• 6A20.21/F20 Schizophrenia, continuous, in partial remission
• 6A20.22/F20 Schizophrenia, continuous, in full remission
• 6A20.2Z/F20 Schizophrenia, continuous, unspecified
• 6A20/F20 Schizophrenia
• 6A20.Y/F20.8 Other specified episode of schizophrenia
• 6A20.Z/F20 Schizophrenia, episode unspecified
• 6A21.0/F25 Schizoaffective disorder, first episode
• 6A21.00/F25 Schizoaffective disorder, first episode, currently symptomatic
• 6A21.01/F25 Schizoaffective disorder, first episode, in partial remission
• 6A21.02/F25 Schizoaffective disorder, first episode, in full remission
• 6A21.0Z/F25 Schizoaffective disorder, first episode, unspecified
• 6A21.1/F25 Schizoaffective disorder, multiple episodes
• 6A21.10/F25 Schizoaffective disorder, multiple episodes, currently symptomatic
• 6A21.11/F25 Schizoaffective disorder, multiple episodes, in partial remission
• 6A21.12/F25 Schizoaffective disorder, multiple episodes, in full remission
• 6A21.1Z/F25 Schizoaffective disorder, multiple episodes, unspecified
• 6A21.2/F25 Schizoaffective disorder, continuous
• 6A21.20/F25 Schizoaffective disorder, continuous, currently symptomatic
• 6A21.21/F25 Schizoaffective disorder, continuous, in partial remission
• 6A21.22/F25 Schizoaffective disorder, continuous, in full remission
• 6A21.2Z/F25 Schizoaffective disorder, continuous, unspecified
• 6A21/F25 Schizoaffective disorder
• 6A21.Y/F25.8 Other specified schizoaffective disorder
• 6A21.Z/F25 Schizoaffective disorder, unspecified
• 6A22/F21 Schizotypal disorder
• 6A23.0/F23 Acute and transient psychotic disorder, first episode
• 6A23.00/F23 Acute and transient psychotic disorder, first episode, currently symptomatic
• 6A23.01/F23 Acute and transient psychotic disorder, first episode, in partial remission
• 6A23.02/F23 Acute and transient psychotic disorder, first episode, in full remission
• 6A23.0Z/F23 Acute and transient psychotic disorder, first episode, unspecified
• 6A23.1/F23 Acute and transient psychotic disorder, multiple episodes
• 6A23.10/F23 Acute and transient psychotic disorder, multiple episodes, currently symptomatic
• 6A23.11/F23 Acute and transient psychotic disorder, multiple episodes, in partial remission
• 6A23.12/F23 Acute and transient psychotic disorder, multiple episodes, in full remission
• 6A23.1Z/F23 Acute and transient psychotic disorder, multiple episodes, unspecified
• 6A23/F23 Acute and transient psychotic disorder
• 6A23.Y/F23.8 Other specified acute and transient psychotic disorder
• 6A23.Z/F23 Acute and transient psychotic disorder, unspecified
• 6A24.0/F22.9 Delusional disorder, currently symptomatic
• 6A24.1/F22.9 Delusional disorder, in partial remission
• 6A24.2/F22.9 Delusional disorder, in full remission
• 6A24/F22.9 Delusional disorder
• 6A24.Z/F22.9 Delusional disorder, unspecified
• 6A25.0/F20-F29 Positive symptoms in primary psychotic disorders
• 6A25.1/F20-F29 Negative symptoms in primary psychotic disorders
• 6A25.2/F20-F29 Depressive mood symptoms in primary psychotic disorders
• 6A25.3/F20-F29 Manic mood symptoms in primary psychotic disorders
• 6A25.4/F20-F29 Psychomotor symptoms in primary psychotic disorders
• 6A25.5/F20-F29 Cognitive symptoms in primary psychotic disorders
• 6A25/F20-F29 Symptomatic manifestations of primary psychotic disorders
• 6A2Y/F20-F29 Other specified primary psychotic disorder
• 6A2Z/F20-F29 Schizophrenia or other primary psychotic disorders, unspecified
• 6A40/F06.1 Catatonia associated with another mental disorder
• 6A41/F06.1 Catatonia induced by substances or medications
• 6A4Z/F06.1 Catatonia, unspecified
• 6A60.0/F31.1 Bipolar type I disorder, current episode manic, without psychotic symptoms
• 6A60.1/F31.2 Bipolar type I disorder, current episode manic, with psychotic symptoms
• 6A60.2/F31.0 Bipolar type I disorder, current episode hypomanic
• 6A60.3/F31.3 Bipolar type I disorder, current episode depressive, mild
• 6A60.4/F31 Bipolar type I disorder, current episode depressive, moderate without psychotic symptoms
• 6A60.5/F31 Bipolar type I disorder, current episode depressive, moderate with psychotic symptoms
• 6A60.6/F31.4 Bipolar type I disorder, current episode depressive, severe without psychotic symptoms
• 6A60.7/F31.5 Bipolar type I disorder, current episode depressive, severe with psychotic symptoms
• 6A60.8/F31 Bipolar type I disorder, current episode depressive, unspecified severity
• 6A60.9/F31.6 Bipolar type I disorder, current episode mixed, without psychotic symptoms
• 6A60.A/F31 Bipolar type I disorder, current episode mixed, with psychotic symptoms
• 6A60.B/F31 Bipolar type I disorder, currently in partial remission, most recent episode manic or hypomanic
• 6A60.C/F31 Bipolar type I disorder, currently in partial remission, most recent episode depressive
• 6A60.D/F31 Bipolar type I disorder, currently in partial remission, most recent episode mixed
• 6A60.E/F31 Bipolar type I disorder, currently in partial remission, most recent episode unspecified
• 6A60.F/F31.7 Bipolar type I disorder, currently in full remission
• 6A60/F31 Bipolar type I disorder
• 6A60.Y/F31.8 Other specified bipolar type I disorder
• 6A60.Z/F31 Bipolar type I disorder, unspecified
• 6A61.0/F31 Bipolar type II disorder, current episode hypomanic
• 6A61.1/F31 Bipolar type II disorder, current episode depressive, mild
• 6A61.2/F31 Bipolar type II disorder, current episode depressive, moderate without psychotic symptoms
• 6A61.3/F31 Bipolar type II disorder, current episode depressive, moderate with psychotic symptoms
• 6A61.4/F31 Bipolar type II disorder, current episode depressive, severe without psychotic symptoms
• 6A61.5/F31 Bipolar type II disorder, current episode depressive, severe with psychotic symptoms
• 6A61.6/F31 Bipolar type II disorder, current episode depressive, unspecified severity
• 6A61.7/F31 Bipolar type II disorder, currently in partial remission, most recent episode hypomanic
• 6A61.8/F31 Bipolar type II disorder, currently in partial remission, most recent episode depressive
• 6A61.9/F31 Bipolar type II disorder, currently in partial remission, most recent episode unspecified
• 6A61.A/F31 Bipolar type II disorder, currently in full remission
• 6A61/F31 Bipolar type II disorder
• 6A61.Y/F31.8 Other specified bipolar type II disorder
• 6A61.Z/F31 Bipolar type II disorder, unspecified
• 6A62/F34.0 Cyclothymic disorder
• 6A6Y/F31.9 Other specified bipolar or related disorders
• 6A6Z/F31.9 Bipolar or related disorders, unspecified
• 6A70.0/F32.0 Single episode depressive disorder, mild
• 6A70.1/F32.1 Single episode depressive disorder, moderate, without psychotic symptoms
• 6A70.2/F32 Single episode depressive disorder, moderate, with psychotic symptoms
• 6A70.3/F32.2 Single episode depressive disorder, severe, without psychotic symptoms
• 6A70.4/F32.3 Single episode depressive disorder, severe, with psychotic symptoms
• 6A70.5/F32 Single episode depressive disorder, unspecified severity
• 6A70.6/F32 Single episode depressive disorder, currently in partial remission
• 6A70.7/F32 Single episode depressive disorder, currently in full remission
• 6A70/F32 Single episode depressive disorder
• 6A70.Y/F32.8 Other specified single episode depressive disorder
• 6A70.Z/F32 Single episode depressive disorder, unspecified
• 6A71.0/F33.0 Recurrent depressive disorder, current episode mild
• 6A71.1/F33.1 Recurrent depressive disorder, current episode moderate, without psychotic symptoms
• 6A71.2/F33 Recurrent depressive disorder, current episode moderate, with psychotic symptoms
• 6A71.3/F33.2 Recurrent depressive disorder, current episode severe, without psychotic symptoms
• 6A71.4/F33.3 Recurrent depressive disorder, current episode severe, with psychotic symptoms
• 6A71.5/F33 Recurrent depressive disorder, current episode, unspecified severity
• 6A71.6/F33 Recurrent depressive disorder, currently in partial remission
• 6A71.7/F33.4 Recurrent depressive disorder, currently in full remission
• 6A71/F33 Recurrent depressive disorder
• 6A71.Y/F33.8 Other specified recurrent depressive disorder
• 6A71.Z/F33 Recurrent depressive disorder, unspecified
• 6A72/F34.1 Dysthymic disorder
• 6A73/F41.2 Mixed depressive and anxiety disorder
• 6A7Y/F32.9 Other specified depressive disorders
• 6A7Z/F32.9 Depressive disorders, unspecified
• 6A80.0/F30.9 Prominent anxiety symptoms in mood episodes
• 6A80.1/F30.9 Panic attacks in mood episodes
• 6A80.2/F30.9 Current depressive episode persistent
• 6A80.3/F30.9 Current depressive episode with melancholia
• 6A80.4/F30.9 Seasonal pattern of mood episode onset
• 6A80.5/F30.9 Rapid cycling
• 6A80/F30.9 Symptomatic and course presentations for mood episodes in mood disorders
• 6A8Y/F30.9 Other specified mood disorders
• 6A8Z/F30.9 Mood disorders, unspecified
• 6B00/F41.1 Generalised anxiety disorder
• 6B01/F41.0 Panic disorder
• 6B02/F40.0 Agoraphobia
• 6B03/F40.2 Specific phobia
• 6B04/F40.1 Social anxiety disorder
• 6B05/F93.0 Separation anxiety disorder
• 6B06/F94.0 Selective mutism
• 6B0Y/F41.8 Other specified anxiety or fear-related disorders
• 6B0Z/F41 Anxiety or fear-related disorders, unspecified
• 6B20.0/F42 Obsessive-compulsive disorder with fair to good insight
• 6B20.1/F42 Obsessive-compulsive disorder with poor to absent insight
• 6B20/F42 Obsessive-compulsive disorder
• 6B20.Z/F42 Obsessive-compulsive disorder, unspecified
• 6B21.0/F45.2 Body dysmorphic disorder with fair to good insight
• 6B21.1/F45.2 Body dysmorphic disorder with poor to absent insight
• 6B21/F45.2 Body dysmorphic disorder
• 6B21.Z/F45.2 Body dysmorphic disorder, unspecified
• 6B22.0/F42.8 Olfactory reference disorder with fair to good insight
• 6B22.1/F42.8 Olfactory reference disorder with poor to absent insight
• 6B22/F42.8 Olfactory reference disorder
• 6B22.Z/F42.8 Olfactory reference disorder, unspecified
• 6B23.0/F45.2 Hypochondriasis with fair to good insight
• 6B23.1/F45.2 Hypochondriasis with poor to absent insight
• 6B23/F45.2 Hypochondriasis
• 6B23.Z/F45.2 Hypochondriasis, unspecified
• 6B24.0/F63.8 Hoarding disorder with fair to good insight
• 6B24.1/F63.8 Hoarding disorder with poor to absent insight
• 6B24/F63.8 Hoarding disorder
• 6B24.Z/F63.8 Hoarding disorder, unspecified
• 6B25.0/F63.3 Trichotillomania
• 6B25.1/L98.1 Excoriation disorder
• 6B25/F42.8 Body-focused repetitive behaviour disorders
• 6B25.Y/F42.8 Other specified body-focused repetitive behaviour disorders
• 6B25.Z/F42.8 Body-focused repetitive behaviour disorders, unspecified
• 6B2Y/F99-F99 Other specified obsessive-compulsive or related disorders
• 6B2Z/F99-F99 Obsessive-compulsive or related disorders, unspecified
• 6B40/F43.1 Post traumatic stress disorder
• 6B41/F62.0 Complex post traumatic stress disorder
• 6B42/F43 Prolonged grief disorder
• 6B43/F43.2 Adjustment disorder
• 6B44/F94.1 Reactive attachment disorder
• 6B45/F94.2 Disinhibited social engagement disorder
• 6B4Y/F43.8 Other specified disorders specifically associated with stress
• 6B4Z/F43 Disorders specifically associated with stress, unspecified
• 6B60.0/F48.9 Dissociative neurological symptom disorder, with visual disturbance
• 6B60.1/F48.9 Dissociative neurological symptom disorder, with auditory disturbance
• 6B60.2/F48.9 Dissociative neurological symptom disorder, with vertigo or dizziness
• 6B60.3/F44.6 Dissociative neurological symptom disorder, with other sensory disturbance
• 6B60.4/F44.5 Dissociative neurological symptom disorder, with non-epileptic seizures
• 6B60.5/F48.9 Dissociative neurological symptom disorder, with speech disturbance
• 6B60.6/F48.9 Dissociative neurological symptom disorder, with paresis or weakness
• 6B60.7/F48.9 Dissociative neurological symptom disorder, with gait disturbance
• 6B60.8/F44.4 Dissociative neurological symptom disorder, with movement disturbance
• 6B60.80/F44.4 Dissociative neurological symptom disorder, with chorea
• 6B60.81/F44.4 Dissociative neurological symptom disorder, with myoclonus
• 6B60.82/F44.4 Dissociative neurological symptom disorder, with tremor
• 6B60.83/F44.4 Dissociative neurological symptom disorder, with dystonia
• 6B60.84/F44.4 Dissociative neurological symptom disorder, with facial spasm
• 6B60.85/F44.4 Dissociative neurological symptom disorder, with Parkinsonism
• 6B60.8Y/F44.4 Dissociative neurological symptom disorder, with other specified movement disturbance
• 6B60.8Z/F44.4 Dissociative neurological symptom disorder, with unspecified movement disturbance
• 6B60.9/F48.9 Dissociative neurological symptom disorder, with cognitive symptoms
• 6B60/F48.9 Dissociative neurological symptom disorder
• 6B60.Y/F48.9 Dissociative neurological symptom disorder, with other specified symptoms
• 6B60.Z/F48.9 Dissociative neurological symptom disorder, with unspecified symptoms
• 6B61.0/F44.1 Dissociative amnesia with dissociative fugue
• 6B61.1/F44.0 Dissociative amnesia without dissociative fugue
• 6B61/F44.0 Dissociative amnesia
• 6B61.Z/F44.0 Dissociative amnesia, unspecified
• 6B62/F48.9 Trance disorder
• 6B63/F44.3 Possession trance disorder
• 6B64/F48.9 Dissociative identity disorder
• 6B65/F48.9 Partial dissociative identity disorder
• 6B66/F48.1 Depersonalization-derealization disorder
• 6B6Y/F48.9 Other specified dissociative disorders
• 6B6Z/F48.9 Dissociative disorders, unspecified
• 6B80.0/F50 Anorexia Nervosa with significantly low body weight
• 6B80.00/F50 Anorexia Nervosa with significantly low body weight, restricting pattern
• 6B80.01/F50 Anorexia Nervosa with significantly low body weight, binge-purge pattern
• 6B80.0Z/F50 Anorexia Nervosa with significantly low body weight, unspecified
• 6B80.1/F50 Anorexia Nervosa with dangerously low body weight
• 6B80.10/F50 Anorexia Nervosa with dangerously low body weight, restricting pattern
• 6B80.11/F50 Anorexia Nervosa with dangerously low body weight, binge-purge pattern
• 6B80.1Z/F50 Anorexia Nervosa with dangerously low body weight, unspecified
• 6B80.2/F50 Anorexia Nervosa in recovery with normal body weight
• 6B80/F50 Anorexia Nervosa
• 6B80.Y/F50.8 Other specified anorexia Nervosa
• 6B80.Z/F50 Anorexia Nervosa, unspecified
• 6B81/F50 Bulimia Nervosa
• 6B82/F50 Binge eating disorder
• 6B83/F50 Avoidant-restrictive food intake disorder
• 6B84/F98.3 Pica
• 6B85/F50 Rumination-regurgitation disorder
• 6B8Y/F50.8 Other specified feeding or eating disorders
• 6B8Z/F50 Feeding or eating disorders, unspecified
• 6C00.0/F98.0 Nocturnal enuresis
• 6C00.1/F98.0 Diurnal enuresis
• 6C00.2/F98.0 Nocturnal and diurnal enuresis
• 6C00/F98.0 Enuresis
• 6C00.Z/F98.0 Enuresis, unspecified
• 6C01.0/F99-F99 Encopresis with constipation or overflow incontinence
• 6C01.1/F99-F99 Encopresis without constipation or overflow incontinence
• 6C01/F99-F99 Encopresis
• 6C01.Z/F99-F99 Encopresis, unspecified
• 6C0Z/F99-F99 Elimination disorders, unspecified
• 6C20.0/F45 Mild bodily distress disorder
• 6C20.1/F45 Moderate bodily distress disorder
• 6C20.2/F45 Severe bodily distress disorder
• 6C20/F45 Bodily distress disorder
• 6C20.Z/F45 Bodily distress disorder, unspecified
• 6C21/F99-F99 Body integrity dysphoria
• 6C2Y/F99-F99 Other specified disorders of bodily distress or bodily experience
• 6C2Z/F99-F99 Disorders of bodily distress or bodily experience, unspecified
• 6C40.0/F10 Episode of harmful use of alcohol
• 6C40.1/F10.1 Harmful pattern of use of alcohol
• 6C40.10/F10.1 Harmful pattern of use of alcohol, episodic
• 6C40.11/F10.1 Harmful pattern of use of alcohol, continuous
• 6C40.1Z/F10.1 Harmful pattern of use of alcohol, unspecified
• 6C40.2/F10.2 Alcohol dependence
• 6C40.20/F10.2 Alcohol dependence, current use, continuous
• 6C40.21/F10.2 Alcohol dependence, current use, episodic
• 6C40.22/F10.2 Alcohol dependence, early full remission
• 6C40.23/F10.2 Alcohol dependence, sustained partial remission
• 6C40.24/F10.2 Alcohol dependence, sustained full remission
• 6C40.2Z/F10.2 Alcohol dependence, unspecified
• 6C40.3/F10.0 Alcohol intoxication
• 6C40.4/F10.3 Alcohol withdrawal
• 6C40.40/F10.3 Alcohol withdrawal, uncomplicated
• 6C40.41/F10.3 Alcohol withdrawal with perceptual disturbances
• 6C40.42/F10.3 Alcohol withdrawal with seizures
• 6C40.43/F10.3 Alcohol withdrawal with perceptual disturbances and seizures
• 6C40.4Z/F10.3 Alcohol withdrawal, unspecified
• 6C40.5/F10.4 Alcohol-induced delirium
• 6C40.6/F10.5 Alcohol-induced psychotic disorder
• 6C40.60/F10.5 Alcohol-induced psychotic disorder with hallucinations
• 6C40.61/F10.5 Alcohol-induced psychotic disorder with delusions
• 6C40.62/F10.5 Alcohol-induced psychotic disorder with mixed psychotic symptoms
• 6C40.6Z/F10.5 Alcohol-induced psychotic disorder, unspecified
• 6C40.7/F10 Certain specified alcohol-induced mental or behavioural disorders
• 6C40.70/F10 Alcohol-induced mood disorder
• 6C40.71/F10 Alcohol-induced anxiety disorder
• 6C40/F10 Disorders due to use of alcohol
• 6C40.Y/F10.8 Other specified disorders due to use of alcohol
• 6C40.Z/F10 Disorders due to use of alcohol, unspecified
• 6C41.0/F12 Episode of harmful use of cannabis
• 6C41.1/F12.1 Harmful pattern of use of cannabis
• 6C41.10/F12.1 Harmful pattern of use of cannabis, episodic
• 6C41.11/F12.1 Harmful pattern of use of cannabis, continuous
• 6C41.1Z/F12.1 Harmful pattern of use of cannabis, unspecified
• 6C41.2/F12.2 Cannabis dependence
• 6C41.20/F12.2 Cannabis dependence, current use
• 6C41.21/F12.2 Cannabis dependence, early full remission
• 6C41.22/F12.2 Cannabis dependence, sustained partial remission
• 6C41.23/F12.2 Cannabis dependence, sustained full remission
• 6C41.2Z/F12.2 Cannabis dependence, unspecified
• 6C41.3/F12.0 Cannabis intoxication
• 6C41.4/F12.3 Cannabis withdrawal
• 6C41.5/F12.4 Cannabis-induced delirium
• 6C41.6/F12 Cannabis-induced psychotic disorder
• 6C41.7/F12 Certain specified cannabis-induced mental or behavioural disorders
• 6C41.70/F12 Cannabis-induced mood disorder
• 6C41.71/F12 Cannabis-induced anxiety disorder
• 6C41/F12 Disorders due to use of cannabis
• 6C41.Y/F12.8 Other specified disorders due to use of cannabis
• 6C41.Z/F12 Disorders due to use of cannabis, unspecified
• 6C42.0/F12.1 Episode of harmful use of synthetic cannabinoids
• 6C42.1/F12.1 Harmful pattern of use of synthetic cannabinoids
• 6C42.10/F12.1 Harmful pattern of use of synthetic cannabinoids, episodic
• 6C42.11/F12.1 Harmful pattern of use of synthetic cannabinoids, continuous
• 6C42.1Y/F12.1 Other specified harmful pattern of use of synthetic cannabinoids
• 6C42.1Z/F12.1 Harmful pattern of use of synthetic cannabinoids, unspecified
• 6C42.2/F12.2 Synthetic cannabinoid dependence
• 6C42.20/F12.2 Synthetic cannabinoid dependence, current use
• 6C42.21/F12.2 Synthetic cannabinoid dependence, early full remission
• 6C42.22/F12.2 Synthetic cannabinoid dependence, sustained partial remission
• 6C42.23/F12.2 Synthetic cannabinoid dependence, sustained full remission
• 6C42.2Y/F12.2 Other specified synthetic cannabinoid dependence
• 6C42.2Z/F12.2 Synthetic cannabinoid dependence, unspecified
• 6C42.3/F12.0 Synthetic cannabinoid intoxication
• 6C42.4/F12.3 Synthetic cannabinoid withdrawal
• 6C42.5/F12.4 Synthetic cannabinoid-induced delirium
• 6C42.6/F12 Synthetic cannabinoid-induced psychotic disorder
• 6C42.7/F12.9 Certain specified synthetic cannabinoids-induced mental or behavioural disorders
• 6C42.70/F12.9 Synthetic cannabinoid-induced mood disorder
• 6C42.71/F12.8 Synthetic cannabinoid-induced anxiety disorder
• 6C42/F12.9 Disorders due to use of synthetic cannabinoids
• 6C42.Y/F12.9 Other specified disorders due to use of synthetic cannabinoids
• 6C42.Z/F12.9 Disorders due to use of synthetic cannabinoids, unspecified
• 6C43.0/F11 Episode of harmful use of opioids
• 6C43.1/F11.1 Harmful pattern of use of opioids
• 6C43.10/F11.1 Harmful pattern of use of opioids, episodic
• 6C43.11/F11.1 Harmful pattern of use of opioids, continuous
• 6C43.1Z/F11.1 Harmful pattern of use of opioids, unspecified
• 6C43.2/F11.2 Opioid dependence
• 6C43.20/F11.2 Opioid dependence, current use
• 6C43.21/F11.2 Opioid dependence, early full remission
• 6C43.22/F11.2 Opioid dependence, sustained partial remission
• 6C43.23/F11.2 Opioid dependence, sustained full remission
• 6C43.2Z/F11.2 Opioid dependence, unspecified
• 6C43.3/F11.0 Opioid intoxication
• 6C43.4/F11.3 Opioid withdrawal
• 6C43.5/F11.4 Opioid-induced delirium
• 6C43.6/F11 Opioid-induced psychotic disorder
• 6C43.7/F11 Certain specified opioid-induced mental or behavioural disorders
• 6C43.70/F11 Opioid-induced mood disorder
• 6C43.71/F11 Opioid-induced anxiety disorder
• 6C43/F11 Disorders due to use of opioids
• 6C43.Y/F11.8 Other specified disorders due to use of opioids
• 6C43.Z/F11 Disorders due to use of opioids, unspecified
• 6C44.0/F13 Episode of harmful use of sedatives, hypnotics or anxiolytics
• 6C44.1/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics
• 6C44.10/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic
• 6C44.11/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous
• 6C44.1Z/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified
• 6C44.2/F13.2 Sedative, hypnotic or anxiolytic dependence
• 6C44.20/F13.2 Sedative, hypnotic or anxiolytic dependence, current use
• 6C44.21/F13.2 Sedative, hypnotic or anxiolytic dependence, early full remission
• 6C44.22/F13.2 Sedative, hypnotic or anxiolytic dependence, sustained partial remission
• 6C44.23/F13.2 Sedative, hypnotic or anxiolytic dependence, sustained full remission
• 6C44.2Z/F13.2 Sedative, hypnotic or anxiolytic dependence, unspecified
• 6C44.3/F13.0 Sedative, hypnotic or anxiolytic intoxication
• 6C44.4/F13.3 Sedative, hypnotic or anxiolytic withdrawal
• 6C44.40/F13.3 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated
• 6C44.41/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances
• 6C44.42/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with seizures
• 6C44.43/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures
• 6C44.4Z/F13.3 Sedative, hypnotic or anxiolytic withdrawal, unspecified
• 6C44.5/F13.4 Sedative, hypnotic or anxiolytic-induced delirium
• 6C44.6/F13 Sedative, hypnotic or anxiolytic-induced psychotic disorder
• 6C44.7/F13 Certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders
• 6C44.70/F13.8 Sedative, hypnotic or anxiolytic-induced mood disorder
• 6C44.71/F13.8 Sedative, hypnotic or anxiolytic-induced anxiety disorder
• 6C44/F13 Disorders due to use of sedatives, hypnotics or anxiolytics
• 6C44.Y/F13.8 Other specified disorders due to use of sedatives, hypnotics or anxiolytics
• 6C44.Z/F13 Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified
• 6C45.0/F14 Episode of harmful use of cocaine
• 6C45.1/F14.1 Harmful pattern of use of cocaine
• 6C45.10/F14.1 Harmful pattern of use of cocaine, episodic
• 6C45.11/F14.1 Harmful pattern of use of cocaine, continuous
• 6C45.1Z/F14.1 Harmful pattern of use of cocaine, unspecified
• 6C45.2/F14.2 Cocaine dependence
• 6C45.20/F14.2 Cocaine dependence, current use
• 6C45.21/F14.2 Cocaine dependence, early full remission
• 6C45.22/F14.2 Cocaine dependence, sustained partial remission
• 6C45.23/F14.2 Cocaine dependence, sustained full remission
• 6C45.2Z/F14.2 Cocaine dependence, unspecified
• 6C45.3/F14.0 Cocaine intoxication
• 6C45.4/F14.3 Cocaine withdrawal
• 6C45.5/F14.4 Cocaine-induced delirium
• 6C45.6/F14 Cocaine-induced psychotic disorder
• 6C45.60/F14 Cocaine-induced psychotic disorder with hallucinations
• 6C45.61/F14 Cocaine-induced psychotic disorder with delusions
• 6C45.62/F14 Cocaine-induced psychotic disorder with mixed psychotic symptoms
• 6C45.6Z/F14 Cocaine-induced psychotic disorder, unspecified
• 6C45.7/F14 Certain specified cocaine-induced mental or behavioural disorders
• 6C45.70/F14 Cocaine-induced mood disorder
• 6C45.71/F14 Cocaine-induced anxiety disorder
• 6C45.72/F14 Cocaine-induced obsessive-compulsive or related disorder
• 6C45.73/F14 Cocaine-induced impulse control disorder
• 6C45/F14 Disorders due to use of cocaine
• 6C45.Y/F14.8 Other specified disorders due to use of cocaine
• 6C45.Z/F14 Disorders due to use of cocaine, unspecified
• 6C46.0/F15.9 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
• 6C46.1/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
• 6C46.10/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic
• 6C46.11/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous
• 6C46.1Z/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified
• 6C46.2/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone
• 6C46.20/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use
• 6C46.21/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission
• 6C46.22/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
• 6C46.23/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission
• 6C46.2Z/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified
• 6C46.3/F15.0 Stimulant intoxication including amphetamines, methamphetamine or methcathinone
• 6C46.4/F15.3 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
• 6C46.5/F15.4 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
• 6C46.6/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
• 6C46.60/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations
• 6C46.61/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions
• 6C46.62/F15 Stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms
• 6C46.6Z/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified
• 6C46.7/F15.9 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
• 6C46.70/F15.8 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone
• 6C46.71/F15.8 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone
• 6C46.72/F15.8 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone
• 6C46.73/F15.9 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone
• 6C46/F15.9 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
• 6C46.Y/F15.9 Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
• 6C46.Z/F15.9 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified
• 6C47.0/F19.1 Episode of harmful use of synthetic cathinones
• 6C47.1/F19.1 Harmful pattern of use of synthetic cathinones
• 6C47.10/F19.1 Harmful pattern of use of synthetic cathinones, episodic
• 6C47.11/F19.1 Harmful use of synthetic cathinones, continuous
• 6C47.1Y/F19.1 Other specified harmful pattern of use of synthetic cathinones
• 6C47.1Z/F19.1 Harmful pattern of use of synthetic cathinones, unspecified
• 6C47.2/F19.2 Synthetic cathinone dependence
• 6C47.20/F19.2 Synthetic cathinone dependence, current use
• 6C47.21/F19.2 Synthetic cathinone dependence, early full remission
• 6C47.22/F19.2 Synthetic cathinone dependence, sustained partial remission
• 6C47.23/F19.2 Synthetic cathinone dependence, sustained full remission
• 6C47.2Y/F19.2 Other specified synthetic cathinone dependence
• 6C47.2Z/F19.2 Synthetic cathinone dependence, unspecified
• 6C47.3/F19.0 Synthetic cathinone intoxication
• 6C47.4/F19 Synthetic cathinone withdrawal
• 6C47.5/F19 Synthetic cathinone-induced delirium
• 6C47.6/F19.5 Synthetic cathinone-induced psychotic disorder
• 6C47.60/F19.5 Synthetic cathinone-induced psychotic disorder with hallucinations
• 6C47.61/F19.5 Synthetic cathinone-induced psychotic disorder with delusions
• 6C47.62/F19.5 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms
• 6C47.6Z/F19.5 Synthetic cathinone-induced psychotic disorder, unspecified
• 6C47.7/F12.9 Certain specified synthetic cathinone-induced mental or behavioural disorders
• 6C47.70/F19 Synthetic cathinone-induced mood disorder
• 6C47.71/F19.8 Synthetic cathinone-induced anxiety disorder
• 6C47.72/F19 Synthetic cathinone-induced obsessive-compulsive or related syndrome
• 6C47.73/F12.9 Synthetic cathinone-induced impulse control disorder
• 6C47/F12.9 Disorders due to use of synthetic cathinones
• 6C47.Y/F12.9 Other specified disorders due to use of synthetic cathinones
• 6C47.Z/F12.9 Disorders due to use of synthetic cathinones, unspecified
• 6C48.0/F15 Episode of harmful use of caffeine
• 6C48.1/F15.1 Harmful pattern of use of caffeine
• 6C48.10/F15.1 Harmful pattern of use of caffeine, episodic
• 6C48.11/F15.1 Harmful pattern of use of caffeine, continuous
• 6C48.1Z/F15.1 Harmful pattern of use of caffeine, unspecified
• 6C48.2/F15.0 Caffeine intoxication
• 6C48.3/F15.3 Caffeine withdrawal
• 6C48.4/F15 Certain specified caffeine-induced mental or behavioural disorders
• 6C48.40/F15 Caffeine-induced anxiety disorder
• 6C48/F15 Disorders due to use of caffeine
• 6C48.Y/F15.8 Other specified disorders due to use of caffeine
• 6C48.Z/F15 Disorders due to use of caffeine, unspecified
• 6C49.0/F16 Episode of harmful use of hallucinogens
• 6C49.1/F16.1 Harmful pattern of use of hallucinogens
• 6C49.10/F16.1 Harmful pattern of use of hallucinogens, episodic
• 6C49.11/F16.1 Harmful pattern of use of hallucinogens, continuous
• 6C49.1Z/F16.1 Harmful pattern of use of hallucinogens, unspecified
• 6C49.2/F16.2 Hallucinogen dependence
• 6C49.20/F16.2 Hallucinogen dependence, current use
• 6C49.21/F16.2 Hallucinogen dependence, early full remission
• 6C49.22/F16.2 Hallucinogen dependence, sustained partial remission
• 6C49.23/F16.2 Hallucinogen dependence, sustained full remission
• 6C49.2Z/F16.2 Hallucinogen dependence, unspecified
• 6C49.3/F16.0 Hallucinogen intoxication
• 6C49.4/F16 Hallucinogen-induced delirium
• 6C49.5/F16 Hallucinogen-induced psychotic disorder
• 6C49.6/F16 Certain specified hallucinogen-induced mental or behavioural disorders
• 6C49.60/F16 Hallucinogen-induced mood disorder
• 6C49.61/F16 Hallucinogen-induced anxiety disorder
• 6C49/F16 Disorders due to use of hallucinogens
• 6C49.Y/F16.8 Other specified disorders due to use of hallucinogens
• 6C49.Z/F16 Disorders due to use of hallucinogens, unspecified
• 6C4A.0/F17 Episode of harmful use of nicotine
• 6C4A.1/F17.1 Harmful pattern of use of nicotine
• 6C4A.10/F17.1 Harmful pattern of use of nicotine, episodic
• 6C4A.11/F17.1 Harmful pattern of use of nicotine, continuous
• 6C4A.1Z/F17.1 Harmful pattern of use of nicotine, unspecified
• 6C4A.2/F17.2 Nicotine dependence
• 6C4A.20/F17.2 Nicotine dependence, current use
• 6C4A.21/F17.2 Nicotine dependence, early full remission
• 6C4A.22/F17.2 Nicotine dependence, sustained partial remission
• 6C4A.23/F17.2 Nicotine dependence, sustained full remission
• 6C4A.2Z/F17.2 Nicotine dependence, unspecified
• 6C4A.3/F17.0 Nicotine intoxication
• 6C4A.4/F17 Nicotine withdrawal
• 6C4A/F17 Disorders due to use of nicotine
• 6C4A.Y/F17.8 Other specified disorders due to use of nicotine
• 6C4A.Z/F17 Disorders due to use of nicotine, unspecified
• 6C4B.0/F18 Episode of harmful use of volatile inhalants
• 6C4B.1/F18.1 Harmful pattern of use of volatile inhalants
• 6C4B.10/F18.1 Harmful pattern of use of volatile inhalants, episodic
• 6C4B.11/F18.1 Harmful pattern of use of volatile inhalants, continuous
• 6C4B.1Z/F18.1 Harmful pattern of use of volatile inhalants, unspecified
• 6C4B.2/F18.2 Volatile inhalant dependence
• 6C4B.20/F18.2 Volatile inhalant dependence, current use
• 6C4B.21/F18.2 Volatile inhalant dependence, early full remission
• 6C4B.22/F18.2 Volatile inhalant dependence, sustained partial remission
• 6C4B.23/F18.2 Volatile inhalant dependence, sustained full remission
• 6C4B.2Z/F18.2 Volatile inhalant dependence, unspecified
• 6C4B.3/F18.0 Volatile inhalant intoxication
• 6C4B.4/F18.3 Volatile inhalant withdrawal
• 6C4B.5/F18.4 Volatile inhalant-induced delirium
• 6C4B.6/F18 Volatile inhalant-induced psychotic disorder
• 6C4B.7/F18 Certain specified volatile inhalants-induced mental or behavioural disorders
• 6C4B.70/F18 Volatile inhalant-induced mood disorder
• 6C4B.71/F18 Volatile inhalant-induced anxiety disorder
• 6C4B/F18 Disorders due to use of volatile inhalants
• 6C4B.Y/F18.8 Other specified disorders due to use of volatile inhalants
• 6C4B.Z/F18 Disorders due to use of volatile inhalants, unspecified
• 6C4C.0/F15.8 Episode of harmful use of MDMA or related drugs, including MDA
• 6C4C.1/F15.1 Harmful pattern of use of MDMA or related drugs, including MDA
• 6C4C.10/F15.1 Harmful use of MDMA or related drugs, including MDA, episodic
• 6C4C.11/F15.1 Harmful use of MDMA or related drugs, including MDA, continuous
• 6C4C.1Z/F15.1 Harmful pattern of use of MDMA or related drugs, including MDA, unspecified
• 6C4C.2/F15.2 MDMA or related drug dependence, including MDA
• 6C4C.20/F15.2 MDMA or related drug dependence, including MDA, current use
• 6C4C.21/F15.2 MDMA or related drug dependence, including MDA, early full remission
• 6C4C.22/F15.2 MDMA or related drug dependence, including MDA, sustained partial remission
• 6C4C.23/F15.2 MDMA or related drug dependence, including MDA, sustained full remission
• 6C4C.2Z/F15.2 MDMA or related drug dependence, including MDA, unspecified
• 6C4C.3/F15.0 MDMA or related drug intoxication, including MDA
• 6C4C.4/F15.3 MDMA or related drug withdrawal, including MDA
• 6C4C.5/F15.4 MDMA or related drug-induced delirium, including MDA
• 6C4C.6/F15.5 MDMA or related drug-induced psychotic disorder, including MDA
• 6C4C.7/F15 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
• 6C4C.70/F15.8 MDMA or related drug-induced mood disorder, including MDA
• 6C4C.71/F15.8 MDMA or related drug-induced anxiety disorder
• 6C4C/F15 Disorders due to use of MDMA or related drugs, including MDA
• 6C4C.Y/F15.8 Other specified disorders due to use of MDMA or related drugs, including MDA
• 6C4C.Z/F15 Disorders due to use of MDMA or related drugs, including MDA, unspecified
• 6C4D.0/F19 Episode of harmful use of dissociative drugs including ketamine or PCP
• 6C4D.1/F19.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP
• 6C4D.10/F19.1 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic
• 6C4D.11/F19.1 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous
• 6C4D.1Z/F19.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified
• 6C4D.2/F19.2 Dissociative drug dependence including ketamine or PCP
• 6C4D.20/F19.2 Dissociative drug dependence including Ketamine or PCP, current use
• 6C4D.21/F19.2 Dissociative drug dependence including Ketamine or PCP, early full remission
• 6C4D.22/F19.2 Dissociative drug dependence including Ketamine or PCP, sustained partial remission
• 6C4D.23/F19.2 Dissociative drug dependence including Ketamine or PCP, sustained full remission
• 6C4D.2Z/F19.2 Dissociative drug dependence including ketamine or PCP, unspecified
• 6C4D.3/F19.0 Dissociative drug intoxication including Ketamine or PCP
• 6C4D.4/F19 Dissociative drug-induced delirium including ketamine or PCP
• 6C4D.5/F19 Dissociative drug-induced psychotic disorder including Ketamine or PCP
• 6C4D.6/F19 Certain specified dissociative drugs -induced mental or behavioural disorders, including ketamine and phencyclidine [PCP]
• 6C4D.60/F19 Dissociative drug-induced mood disorder including Ketamine or PCP
• 6C4D.61/F19 Dissociative drug-induced anxiety disorder including Ketamine or PCP
• 6C4D/F19 Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP]
• 6C4D.Y/F19.8 Other specified disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP]
• 6C4D.Z/F19 Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP], unspecified
• 6C4E.0/F19.9 Episode of harmful use of other specified psychoactive substance
• 6C4E.1/F19.1 Harmful pattern of use of other specified psychoactive substance
• 6C4E.10/F19.1 Harmful pattern of use of other specified psychoactive substance, episodic
• 6C4E.11/F19.1 Harmful pattern of use of other specified psychoactive substance, continuous
• 6C4E.1Z/F19.1 Harmful pattern of use of other specified psychoactive substance, unspecified
• 6C4E.2/F19.2 Other specified psychoactive substance dependence
• 6C4E.20/F19.2 Other specified psychoactive substance dependence, current use
• 6C4E.21/F19.2 Other specified psychoactive substance dependence, early full remission
• 6C4E.22/F19.2 Other specified psychoactive substance dependence, sustained partial remission
• 6C4E.23/F19.2 Other specified psychoactive substance dependence, sustained full remission
• 6C4E.2Z/F19.2 Other specified psychoactive substance dependence, unspecified
• 6C4E.3/F19.0 Other specified psychoactive substance intoxication
• 6C4E.4/F19 Other specified psychoactive substance withdrawal
• 6C4E.40/F19 Other specified psychoactive substance withdrawal, uncomplicated
• 6C4E.41/F19 Other specified psychoactive substance withdrawal, with perceptual disturbances
• 6C4E.42/F19 Other specified psychoactive substance withdrawal, with seizures
• 6C4E.43/F19 Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures
• 6C4E.4Z/F19 Other specified psychoactive substance withdrawal, unspecified
• 6C4E.5/F19 Delirium induced by other specified psychoactive substance including medications
• 6C4E.6/F19 Psychotic disorder induced by other specified psychoactive substance
• 6C4E.7/F19.9 Certain other specified psychoactive substance-induced mental or behavioural disorders
• 6C4E.70/F19.9 Mood disorder induced by other specified psychoactive substance
• 6C4E.71/F19.9 Anxiety disorder induced by other specified psychoactive substance
• 6C4E.72/F19.9 Obsessive-compulsive or related disorder induced by other specified psychoactive substance
• 6C4E.73/F19.9 Impulse control disorder induced by other specified psychoactive substance
• 6C4E/F19.9 Disorders due to use of other specified psychoactive substances, including medications
• 6C4E.Y/F19.9 Other specified disorders due to use of other specified psychoactive substances, including medications
• 6C4E.Z/F19.9 Disorders due to use of other specified psychoactive substances, including medications, unspecified
• 6C4F.0/F99-F99 Episode of harmful use of multiple specified psychoactive substances
• 6C4F.1/F99-F99 Harmful pattern of use of multiple specified psychoactive substances
• 6C4F.10/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, episodic
• 6C4F.11/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, continuous
• 6C4F.1Z/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, unspecified
• 6C4F.2/F99-F99 Multiple specified psychoactive substances dependence
• 6C4F.20/F99-F99 Multiple specified psychoactive substances dependence, current use
• 6C4F.21/F99-F99 Multiple specified psychoactive substances dependence, early full remission
• 6C4F.22/F99-F99 Multiple specified psychoactive substances dependence, sustained partial remission
• 6C4F.23/F99-F99 Multiple specified psychoactive substances dependence, sustained full remission
• 6C4F.2Z/F99-F99 Multiple specified psychoactive substances dependence, unspecified
• 6C4F.3/F99-F99 Intoxication due to multiple specified psychoactive substances
• 6C4F.4/F99-F99 Multiple specified psychoactive substances withdrawal
• 6C4F.40/F99-F99 Multiple specified psychoactive substances withdrawal, uncomplicated
• 6C4F.41/F99-F99 Multiple specified psychoactive substances withdrawal, with perceptual disturbances
• 6C4F.42/F99-F99 Multiple specified psychoactive substances withdrawal, with seizures
• 6C4F.43/F99-F99 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures
• 6C4F.4Y/F99-F99 Other specified multiple specified psychoactive substances withdrawal
• 6C4F.4Z/F99-F99 Multiple specified psychoactive substances withdrawal, unspecified
• 6C4F.5/F99-F99 Delirium induced by multiple specified psychoactive substances including medications
• 6C4F.6/F99-F99 Psychotic disorder induced by multiple specified psychoactive substances
• 6C4F.7/F99-F99 Certain multiple specified psychoactive substances-induced mental or behavioural disorders
• 6C4F.70/F99-F99 Mood disorder induced by multiple specified psychoactive substances
• 6C4F.71/F99-F99 Anxiety disorder induced by multiple specified psychoactive substances
• 6C4F.72/F99-F99 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances
• 6C4F.73/F99-F99 Impulse control syndrome induced by multiple specified psychoactive substances
• 6C4F/F99-F99 Disorders due to use of multiple specified psychoactive substances, including medications
• 6C4F.Y/F99-F99 Other specified disorders due to use of multiple specified psychoactive substances, including medications
• 6C4F.Z/F99-F99 Disorders due to use of multiple specified psychoactive substances, including medications, unspecified
• 6C4G.0/F19 Episode of harmful use of unknown or unspecified psychoactive substances
• 6C4G.1/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance
• 6C4G.10/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic
• 6C4G.11/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, continuous
• 6C4G.1Z/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, unspecified
• 6C4G.2/F19.2 Unknown or unspecified psychoactive substance dependence
• 6C4G.20/F19.2 Unknown or unspecified psychoactive substance dependence, current use
• 6C4G.21/F19.2 Unknown or unspecified psychoactive substance dependence, early full remission
• 6C4G.22/F19.2 Unknown or unspecified psychoactive substance dependence, sustained partial remission
• 6C4G.23/F19.2 Unknown or unspecified psychoactive substance dependence, sustained full remission
• 6C4G.2Z/F19.2 Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified
• 6C4G.3/F19.0 Intoxication due to unknown or unspecified psychoactive substance
• 6C4G.4/F19 Withdrawal due to unknown or unspecified psychoactive substance
• 6C4G.40/F19 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated
• 6C4G.41/F19 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances
• 6C4G.42/F19 Withdrawal due to unknown or unspecified psychoactive substance, with seizures
• 6C4G.43/F19 Withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures
• 6C4G.4Z/F19 Withdrawal due to unknown or unspecified psychoactive substance, unspecified
• 6C4G.5/F19 Delirium induced by unknown or unspecified psychoactive substance
• 6C4G.6/F19 Psychotic disorder induced by unknown or unspecified psychoactive substance
• 6C4G.7/F19 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders
• 6C4G.70/F19 Mood disorder induced by unknown or unspecified psychoactive substance
• 6C4G.71/F19 Anxiety disorder induced by unknown or unspecified psychoactive substance
• 6C4G.72/F19 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance
• 6C4G.73/F19 Impulse control disorder induced by unknown or unspecified psychoactive substance
• 6C4G/F19 Disorders due to use of unknown or unspecified psychoactive substances
• 6C4G.Y/F19.8 Other specified disorders due to use of unknown or unspecified psychoactive substances
• 6C4G.Z/F19 Disorders due to use of unknown or unspecified psychoactive substances, unspecified
• 6C4H.0/F19 Episode of harmful use of non-psychoactive substances
• 6C4H.1/F55 Harmful pattern of use of non-psychoactive substances
• 6C4H.10/F55 Harmful pattern of use of non-psychoactive substances, episodic
• 6C4H.11/F55 Harmful pattern of use of non-psychoactive substances, continuous
• 6C4H.1Z/F55 Harmful pattern of use of non-psychoactive substances, unspecified
• 6C4H/F19 Disorders due to use of non-psychoactive substances
• 6C4H.Y/F19.8 Other specified disorders due to use of non-psychoactive substances
• 6C4H.Z/F19 Disorders due to use of non-psychoactive substances, unspecified
• 6C4Y/F99-F99 Other specified disorders due to substance use
• 6C4Z/F99-F99 Disorders due to substance use, unspecified
• 6C50.0/F63.0 Gambling disorder, predominantly offline
• 6C50.1/F63.0 Gambling disorder, predominantly online
• 6C50/F63.0 Gambling disorder
• 6C50.Z/F63.0 Gambling disorder, unspecified
• 6C51.0/F63.8 Gaming disorder, predominantly online
• 6C51.1/F63.8 Gaming disorder, predominantly offline
• 6C51/F63.8 Gaming disorder
• 6C51.Z/F63.8 Gaming disorder, unspecified
• 6C5Y/F63.8 Other specified disorders due to addictive behaviours
• 6C5Z/F63.8 Disorders due to addictive behaviours, unspecified
• 6C70/F63.1 Pyromania
• 6C71/F63.2 Kleptomania
• 6C72/F52.7 Compulsive sexual behaviour disorder
• 6C73/F63.8 Intermittent explosive disorder
• 6C7Y/F63.8 Other specified impulse control disorders
• 6C7Z/F63 Impulse control disorders, unspecified
• 6C90.0/F91.3 Oppositional defiant disorder with chronic irritability-anger
• 6C90.00/F91.3 Oppositional defiant disorder with chronic irritability-anger with limited prosocial emotions
• 6C90.01/F91.3 Oppositional defiant disorder with chronic irritability-anger with typical prosocial emotions
• 6C90.0Z/F91.3 Oppositional defiant disorder with chronic irritability-anger, unspecified
• 6C90.1/F91.3 Oppositional defiant disorder without chronic irritability-anger
• 6C90.10/F91.3 Oppositional defiant disorder without chronic irritability-anger with limited prosocial emotions
• 6C90.11/F91.3 Oppositional defiant disorder without chronic irritability-anger with typical prosocial emotions
• 6C90.1Z/F91.3 Oppositional defiant disorder without chronic irritability-anger, unspecified
• 6C90/F91.3 Oppositional defiant disorder
• 6C90.Z/F91.3 Oppositional defiant disorder, unspecified
• 6C91.0/F91 Conduct-dissocial disorder, childhood onset
• 6C91.00/F91 Conduct-dissocial disorder, childhood onset with limited prosocial emotions
• 6C91.01/F91 Conduct-dissocial disorder, childhood onset with typical prosocial emotions
• 6C91.0Z/F91 Conduct-dissocial disorder, childhood onset, unspecified
• 6C91.1/F91 Conduct-dissocial disorder, adolescent onset
• 6C91.10/F91 Conduct-dissocial disorder, adolescent onset with limited prosocial emotions
• 6C91.11/F91 Conduct-dissocial disorder, adolescent onset with typical prosocial emotions
• 6C91.1Y/F91 Other specified conduct-dissocial disorder, adolescent onset
• 6C91/F91 Conduct-dissocial disorder
• 6C91.Z/F91 Conduct-dissocial disorder, unspecified
• 6C9Y/F92.9 Other specified disruptive behaviour or dissocial disorders
• 6C9Z/F92.9 Disruptive behaviour or dissocial disorders, unspecified
• 6D10.0/F60.9 Mild personality disorder
• 6D10.1/F60.9 Moderate personality disorder
• 6D10.2/F60.9 Severe personality disorder
• 6D10/F60.9 Personality disorder
• 6D10.Z/F60.9 Personality disorder, severity unspecified
• 6D11.0/F60.8 Negative affectivity in personality disorder or personality difficulty
• 6D11.1/F60.8 Detachment in personality disorder or personality difficulty
• 6D11.2/F60.2 Dissociality in personality disorder or personality difficulty
• 6D11.3/F60.8 Disinhibition in personality disorder or personality difficulty
• 6D11.4/F60.5 Anankastia in personality disorder or personality difficulty
• 6D11.5/F99-F99 Borderline pattern
• 6D11/F99-F99 Prominent personality traits or patterns
• 6D30/F65.2 Exhibitionistic disorder
• 6D31/F65.3 Voyeuristic disorder
• 6D32/F65.4 Pedophilic disorder
• 6D33/F65.9 Coercive sexual sadism disorder
• 6D34/F65.9 Frotteuristic disorder
• 6D35/F65.8 Other paraphilic disorder involving non-consenting individuals
• 6D36/F65.5 Paraphilic disorder involving solitary behaviour or consenting individuals
• 6D3Z/F65.9 Paraphilic disorders, unspecified
• 6D50/F68.1 Factitious disorder imposed on self
• 6D51/F68 Factitious disorder imposed on another
• 6D5Z/F68 Factitious disorders, unspecified
• 6D70.0/F05.8 Delirium due to disease classified elsewhere
• 6D70.1/F19.8 Delirium due to psychoactive substances including medications
• 6D70.2/F05.8 Delirium due to multiple etiological factors
• 6D70/F09 Delirium
• 6D70.Y/F09 Delirium, other specified cause
• 6D70.Z/F09 Delirium, unspecified or unknown cause
• 6D71/F06.7 Mild neurocognitive disorder
• 6D72.0/F04 Amnestic disorder due to diseases classified elsewhere
• 6D72.1/F10-F19 Amnestic disorder due to psychoactive substances including medications
• 6D72.10/F10.6 Amnestic disorder due to use of alcohol
• 6D72.11/F13.6 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics
• 6D72.12/F10-F19 Amnestic disorder due to other specified psychoactive substance including medications
• 6D72.13/F10-F19 Amnestic disorder due to use of volatile inhalants
• 6D72.2/R41.3 Amnestic disorder due to unknown or unspecified aetiological factors
• 6D72/R41.8 Amnestic disorder
• 6D72.Y/R41.8 Amnestic disorder, other specified cause
• 6D72.Z/R41.8 Amnestic disorder, unknown or unspecified cause
• 6D80.0/F00.0 Dementia due to Alzheimer disease with early onset
• 6D80.1/F00.1 Dementia due to Alzheimer disease with late onset
• 6D80.2/F00.2 Alzheimer disease dementia, mixed type, with cerebrovascular disease
• 6D80.3/F00.2 Alzheimer disease dementia, mixed type, with other nonvascular aetiologies
• 6D80/F00 Dementia due to Alzheimer disease
• 6D80.Z/F00 Dementia due to Alzheimer disease, onset unknown or unspecified
• 6D81/F01 Dementia due to cerebrovascular disease
• 6D82/F02 Dementia due to Lewy body disease
• 6D83/F02 Frontotemporal dementia
• 6D84.0/F10.7 Dementia due to use of alcohol
• 6D84.1/F02.8 Dementia due to use of sedatives, hypnotics or anxiolytics
• 6D84.2/F02.8 Dementia due to use of volatile inhalants
• 6D84/F02.8 Dementia due to psychoactive substances including medications
• 6D84.Y/F02.8 Dementia due to other specified psychoactive substance
• 6D85.0/F02.3 Dementia due to Parkinson disease
• 6D85.1/F02.2 Dementia due to Huntington disease
• 6D85.2/F02.8 Dementia due to exposure to heavy metals and other toxins
• 6D85.3/F02.4 Dementia due to human immunodeficiency virus
• 6D85.4/F02.8 Dementia due to multiple sclerosis
• 6D85.5/F02.8 Dementia due to prion disease
• 6D85.6/F02.8 Dementia due to normal pressure hydrocephalus
• 6D85.7/F02.8 Dementia due to injury to the head
• 6D85.8/F02 Dementia due to pellagra
• 6D85.9/F02.8 Dementia due to Down syndrome
• 6D85/F02 Dementia due to diseases classified elsewhere
• 6D85.Y/F02.8 Dementia due to other specified diseases classified elsewhere
• 6D86.0/F00-F09 Psychotic symptoms in dementia
• 6D86.1/F00-F09 Mood symptoms in dementia
• 6D86.2/F00-F09 Anxiety symptoms in dementia
• 6D86.3/F00-F09 Apathy in dementia
• 6D86.4/F00-F09 Agitation or aggression in dementia
• 6D86.5/F00-F09 Disinhibition in dementia
• 6D86.6/F00-F09 Wandering in dementia
• 6D86/F00-F09 Behavioural or psychological disturbances in dementia
• 6D86.Y/F00-F09 Other specified behavioural or psychological disturbances in dementia
• 6D86.Z/F00-F09 Behavioural or psychological disturbances in dementia, unspecified
• 6D8Y/F00-F09 Dementia, other specified cause
• 6D8Z/F00-F09 Dementia, unknown or unspecified cause
• 6E0Y/F09 Other specified neurocognitive disorders
• 6E0Z/F09 Neurocognitive disorders, unspecified
• 6E20/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms
• 6E21/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, with psychotic symptoms
• 6E2Z/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, unspecified
• 6E40.0/F54 Mental disorder affecting disorders or diseases classified elsewhere
• 6E40.1/F54 Psychological symptoms affecting disorders or diseases classified elsewhere
• 6E40.2/F54 Personality traits or coping style affecting disorders or diseases classified elsewhere
• 6E40.3/F54 Maladaptive health behaviours affecting disorders or diseases classified elsewhere
• 6E40.4/F54 Stress-related physiological response affecting disorders or diseases classified elsewhere
• 6E40/F54 Psychological or behavioural factors affecting disorders or diseases classified elsewhere
• 6E40.Y/F54 Other specified psychological or behavioural factors affecting disorders or diseases classified elsewhere
• 6E40.Z/F54 Psychological or behavioural factors affecting disorders or diseases classified elsewhere, unspecified
• 6E60.0/F06 Secondary speech or language syndrome
• 6E60/F06 Secondary neurodevelopmental syndrome
• 6E60.Y/F06 Other specified secondary neurodevelopmental syndrome
• 6E60.Z/F06 Secondary neurodevelopmental syndrome, unspecified
• 6E61.0/F06.0 Secondary psychotic syndrome, with hallucinations
• 6E61.1/F06.2 Secondary psychotic syndrome, with delusions
• 6E61.2/F06 Secondary psychotic syndrome, with hallucinations and delusions
• 6E61.3/F06 Secondary psychotic syndrome, with unspecified symptoms
• 6E61/F06 Secondary psychotic syndrome
• 6E62.0/F06.3 Secondary mood syndrome, with depressive symptoms
• 6E62.1/F06.3 Secondary mood syndrome, with manic symptoms
• 6E62.2/F06.3 Secondary mood syndrome, with mixed symptoms
• 6E62.3/F06.3 Secondary mood syndrome, with unspecified symptoms
• 6E62/F06.3 Secondary mood syndrome
• 6E63/F06.4 Secondary anxiety syndrome
• 6E64/F06 Secondary obsessive-compulsive or related syndrome
• 6E65/F06.5 Secondary dissociative syndrome
• 6E66/F06 Secondary impulse control syndrome
• 6E67/F06 Secondary neurocognitive syndrome
• 6E68/F06.6 Secondary personality change
• 6E69/F06 Secondary catatonia syndrome
• 6E6Y/F06.8 Other specified secondary mental or behavioural syndrome
• 6E6Z/F06 Secondary mental or behavioural syndrome, unspecified
• 6E8Y/F99-F99 Other specified mental, behavioural or neurodevelopmental disorders
• 6E8Z/F99-F99 Mental, behavioural or neurodevelopmental disorders, unspecified
• 7A00/F51.0 Chronic insomnia
• 7A01/F51.0 Short-term insomnia
• 7A0Z/G47.0 Insomnia disorders, unspecified
• 7A20.0/G47.4 Narcolepsy, Type 1
• 7A20.1/G47.4 Narcolepsy, Type 2
• 7A20/G47.4 Narcolepsy
• 7A20.Z/G47.4 Narcolepsy, unspecified
• 7A21/G47.1 Idiopathic hypersomnia
• 7A22/G47.8 Kleine-Levin syndrome
• 7A23/F51.9 Hypersomnia due to a medical condition
• 7A24/G47.1 Hypersomnia due to a medication or substance
• 7A25/F51.9 Hypersomnia associated with a mental disorder
• 7A26/F51.1 Insufficient sleep syndrome
• 7A2Y/F51.9 Other specified hypersomnolence disorders
• 7A2Z/F51.9 Hypersomnolence disorders, unspecified
• 7A40.0/G47.3 Primary central sleep apnoea
• 7A40.1/P28.3 Primary central sleep apnoea of infancy
• 7A40.2/G47.3 Primary central sleep apnoea of prematurity
• 7A40.3/G47.3 Central sleep apnoea due to a medical condition with Cheyne-Stokes breathing
• 7A40.4/G47.3 Central sleep apnoea due to a medical condition without Cheyne-Stokes breathing
• 7A40.5/G47.3 Central sleep apnoea due to high-altitude periodic breathing
• 7A40.6/G47.3 Central sleep apnoea due to a medication or substance
• 7A40.7/G47.3 Treatment-emergent central sleep apnoea
• 7A40/G47.3 Central sleep apnoeas
• 7A40.Y/G47.3 Other specified central sleep apnoeas
• 7A40.Z/G47.3 Central sleep apnoeas, unspecified
• 7A41/G47.3 Obstructive sleep apnoea
• 7A42.0/E66.2 Obesity hypoventilation syndrome
• 7A42.1/G47.3 Congenital central alveolar sleep-related hypoventilation
• 7A42.2/G47.3 Non-congenital central hypoventilation with hypothalamic abnormalities
• 7A42.3/G47.3 Idiopathic central alveolar hypoventilation
• 7A42.4/G47.3 Sleep-related hypoventilation due to a medication or substance
• 7A42.5/G47.3 Sleep-related hypoventilation due to medical condition
• 7A42.6/G47.3 Sleep-related hypoxemia due to a medical condition
• 7A42/G47.3 Sleep-related hypoventilation or hypoxemia disorders
• 7A42.Y/G47.3 Other specified sleep-related hypoventilation or hypoxemia disorders
• 7A42.Z/G47.3 Sleep-related hypoventilation or hypoxemia disorders, unspecified
• 7A4Y/G47.3 Other specified sleep-related breathing disorders
• 7A4Z/G47.3 Sleep-related breathing disorders, unspecified
• 7A60/G47.2 Delayed sleep-wake phase disorder
• 7A61/G47.2 Advanced sleep-wake phase disorder
• 7A62/G47.2 Irregular sleep-wake rhythm disorder
• 7A63/G47.2 Non-24 hour sleep-wake rhythm disorder
• 7A64/G47.2 Circadian rhythm sleep-wake disorder, shift work type
• 7A65/G47.2 Circadian rhythm sleep-wake disorder, jet lag type
• 7A6Z/G47.2 Circadian rhythm sleep-wake disorders, unspecified
• 7A80/G25.8 Restless legs syndrome
• 7A81/G25.8 Periodic limb movement disorder
• 7A82/R25.2 Sleep-related leg cramps
• 7A83/F45.8 Sleep-related bruxism
• 7A84/G25.8 Sleep-related rhythmic movement disorder
• 7A85/F51.9 Benign sleep myoclonus of infancy
• 7A86/F51.9 Propriospinal myoclonus at sleep onset
• 7A87/G25.8 Sleep-related movement disorder due to a medical condition
• 7A88/F51.9 Sleep-related movement disorder due to a medication or substance
• 7A8Y/F51.9 Other specified sleep-related movement disorders
• 7A8Z/F51.9 Sleep-related movement disorders, unspecified
• 7B00.0/G47.8 Confusional arousals
• 7B00.1/F51.3 Sleepwalking disorder
• 7B00.2/F51.4 Sleep terrors
• 7B00.3/G47.8 Sleep-related eating disorder
• 7B00/G47.8 Disorders of arousal from non-REM sleep
• 7B00.Y/G47.8 Other specified disorders of arousal from non-REM sleep
• 7B00.Z/G47.8 Disorders of arousal from non-REM sleep, unspecified
• 7B01.0/G47.8 REM sleep behaviour disorder
• 7B01.1/G47.8 Recurrent isolated sleep paralysis
• 7B01.2/F51.5 Nightmare disorder
• 7B01/F51.9 Parasomnias related to REM sleep
• 7B01.Y/F51.9 Other specified parasomnias related to REM sleep
• 7B01.Z/F51.9 Parasomnias related to REM sleep, unspecified
• 7B02.0/G47.8 Hypnagogic exploding head syndrome
• 7B02.1/G47.8 Sleep-related hallucinations
• 7B02.2/F51.9 Parasomnia disorder due to a medical condition
• 7B02.3/G47.8 Parasomnia disorder due to a medication or substance
• 7B02/F51.9 Other parasomnias
• 7B0Y/F51.9 Other specified parasomnia disorders
• 7B0Z/VI Parasomnia disorders, unspecified
• 7B2Y/VI Other specified sleep-wake disorders
• 7B2Z/VI Sleep-wake disorders, unspecified
• 8A00.0/G20 Parkinson disease
• 8A00.00/G20 Sporadic Parkinson disease
• 8A00.01/G20 Familial Parkinson disease
• 8A00.0Y/G20 Other specified Parkinson disease
• 8A00.0Z/G20 Parkinson disease, unspecified
• 8A00.1/VI Atypical parkinsonism
• 8A00.10/VI Progressive supranuclear palsy
• 8A00.1Y/VI Other specified atypical parkinsonism
• 8A00.1Z/VI Atypical parkinsonism, unspecified
• 8A00.2/G21.9 Secondary parkinsonism
• 8A00.20/G21.9 Parkinsonism due to heredodegenerative disorders
• 8A00.21/G21.9 Hemiparkinsonism hemiatrophy syndrome
• 8A00.22/G21.9 Infectious or postinfectious parkinsonism
• 8A00.23/G21.4 Vascular parkinsonism
• 8A00.24/G21.1 Drug-induced parkinsonism
• 8A00.25/G21.9 Post traumatic Parkinsonism
• 8A00.26/G21.9 Parkinsonism due to structural lesions
• 8A00.2Y/G21.9 Other specified secondary parkinsonism
• 8A00.2Z/G21.9 Secondary parkinsonism, unspecified
• 8A00.3/VI Functional parkinsonism
• 8A00/VI Parkinsonism
• 8A00.Y/VI Other specified parkinsonism
• 8A00.Z/VI Parkinsonism, unspecified
• 8A01.0/G25.5 Benign hereditary chorea
• 8A01.1/G25.4 Secondary Chorea
• 8A01.10/G10 Huntington disease
• 8A01.11/G25.4 Chorea due to Huntington disease-like conditions
• 8A01.12/G25.4 Chorea due to Dentatorubral pallidoluysian atrophy
• 8A01.13/G25.4 Chorea due to Wilson disease
• 8A01.14/G25.4 Chorea due to infectious or para-infectious causes
• 8A01.15/G25.4 Chorea due to systemic lupus erythematosus
• 8A01.16/G25.4 Drug-induced chorea
• 8A01.1Y/G25.4 Other specified secondary chorea
• 8A01.1Z/G25.4 Secondary chorea, unspecified
• 8A01.2/G25.5 Hemichorea or hemiballismus
• 8A01.20/G25.5 Hemichorea
• 8A01.21/G25.5 Ballism
• 8A01.22/G25.5 Hemiballism
• 8A01.2Y/G25.5 Other specified hemichorea or hemiballismus
• 8A01.2Z/G25.5 Hemichorea or hemiballismus, unspecified
• 8A01/G25.4 Choreiform disorders
• 8A01.Y/G25.4 Other specified choreiform disorders
• 8A01.Z/G25.4 Choreiform disorders, unspecified
• 8A02.0/G24.9 Primary dystonia
• 8A02.00/G24.5 Benign essential blepharospasm
• 8A02.0Y/G24.9 Other specified primary dystonia
• 8A02.0Z/G24.9 Primary dystonia, unspecified
• 8A02.1/G24 Secondary dystonia
• 8A02.10/G24.0 Drug-induced dystonia
• 8A02.11/G24 Dystonia-plus
• 8A02.12/G24 Dystonia associated with heredodegenerative disorders
• 8A02.1Y/G24 Other specified secondary dystonia
• 8A02.1Z/G24 Secondary dystonia, unspecified
• 8A02.2/G24 Paroxysmal dystonia
• 8A02.3/G24 Functional dystonia or spasms
• 8A02/G24 Dystonic disorders
• 8A02.Y/G24.8 Other specified dystonic disorders
• 8A02.Z/G24 Dystonic disorders, unspecified
• 8A03.0/G11.0 Congenital ataxia
• 8A03.1/G11 Hereditary ataxia
• 8A03.10/G11 Friedreich ataxia
• 8A03.11/G11 Ataxia due to Cerebrotendinous xanthomatosis
• 8A03.12/G11 Ataxia due to Refsum disease
• 8A03.13/G11 Ataxia due to abetalipoproteinemia
• 8A03.14/G11 Hereditary episodic ataxia
• 8A03.15/G11 Ataxia due to mitochondrial mutations
• 8A03.16/G11 Spinocerebellar ataxia
• 8A03.1Y/G11.8 Other specified hereditary ataxia
• 8A03.1Z/G11 Hereditary ataxia, unspecified
• 8A03.2/G11 Non-hereditary degenerative ataxia
• 8A03.20/G11 Late onset cerebellar cortical atrophy
• 8A03.2Y/G11 Other specified non-hereditary degenerative ataxia
• 8A03.2Z/G11 Non-hereditary degenerative ataxia, unspecified
• 8A03.3/G11 Acquired ataxia
• 8A03.30/G11 Ataxia due to alcoholic cerebellar degeneration
• 8A03.3Y/G11 Other specified acquired ataxia
• 8A03.3Z/G11 Acquired ataxia, unspecified
• 8A03/G11 Ataxic disorders
• 8A03.Y/G11.8 Other specified ataxic disorders
• 8A03.Z/G11 Ataxic disorders, unspecified
• 8A04.0/G25.2 Enhanced physiological tremor
• 8A04.1/G25.0 Essential tremor or related tremors
• 8A04.2/G25.2 Rest tremor
• 8A04.3/G25.2 Secondary tremor
• 8A04.30/G25.2 Tremor due to metabolic disorders
• 8A04.31/G25.1 Tremor due to chronic or acute substance use
• 8A04.32/G25.2 Tremor due to drug withdrawal
• 8A04.33/G25.2 Tremor due to certain specified central nervous system diseases
• 8A04.3Y/G25.2 Other specified secondary tremor
• 8A04.3Z/G25.2 Secondary tremor, unspecified
• 8A04.4/G25.2 Functional tremor
• 8A04/G25.2 Disorders associated with tremor
• 8A04.Y/G25.2 Other specified disorders associated with tremor
• 8A04.Z/G25.2 Disorders associated with tremor, unspecified
• 8A05.0/F95.1 Primary tics or tic disorders
• 8A05.00/F95.2 Tourette syndrome
• 8A05.01/F95.1 Chronic motor tic disorder
• 8A05.02/F95.1 Chronic phonic tic disorder
• 8A05.03/F95.0 Transient motor tics
• 8A05.0Y/F95.1 Other specified primary tics or tic disorders
• 8A05.0Z/F95.1 Primary tics or tic disorders, unspecified
• 8A05.1/F95.8 Secondary tics
• 8A05.10/F95.8 Infectious or postinfectious tics
• 8A05.11/G25.6 Tics associated with developmental disorders
• 8A05.1Y/F95.8 Other specified secondary tics
• 8A05.1Z/F95.8 Secondary tics, unspecified
• 8A05/F95 Tic disorders
• 8A05.Y/F95.8 Other specified tic disorders
• 8A05.Z/F95 Tic disorders, unspecified
• 8A06.0/G25.3 Essential myoclonus
• 8A06.1/G25.3 Segmental myoclonus
• 8A06.2/G25.3 Focal myoclonus
• 8A06.20/G25.3 Palatal myoclonus
• 8A06.21/G25.3 Chronic hiccups
• 8A06.2Y/G25.3 Other specified focal myoclonus
• 8A06.2Z/G25.3 Focal myoclonus, unspecified
• 8A06/G25.3 Myoclonic disorders
• 8A06.Y/G25.3 Other specified myoclonic disorders
• 8A06.Z/G25.3 Myoclonic disorders, unspecified
• 8A07.0/F98.4 Stereotypies
• 8A07.00/F98.4 Primary stereotypy
• 8A07.01/F98.4 Secondary stereotypy
• 8A07.0Y/F98.4 Other specified stereotypies
• 8A07.0Z/F98.4 Stereotypies, unspecified
• 8A07.1/G25.8 Akathisia
• 8A07.2/G25.8 Excessive startle reflex
• 8A07/VI Certain specified movement disorder
• 8A0Y/VI Other specified movement disorders
• 8A0Z/VI Movement disorders, unspecified
• 8A20/G30 Alzheimer disease
• 8A21.0/G31.8 Posterior cortical atrophy
• 8A21/G30-G32 Progressive focal atrophies
• 8A21.Y/G30-G32 Other specified progressive focal atrophies
• 8A21.Z/G30-G32 Progressive focal atrophies, unspecified
• 8A22/G30-G32 Lewy body disease
• 8A23/G30-G32 Frontotemporal lobar degeneration
• 8A2Y/G30-G32 Other specified disorders with neurocognitive impairment as a major feature
• 8A2Z/G30-G32 Disorders with neurocognitive impairment as a major feature, unspecified
• 8A40.0/G35 Relapsing-remitting multiple sclerosis
• 8A40.1/G35 Primary progressive multiple sclerosis
• 8A40.2/G35 Secondary progressive multiple sclerosis
• 8A40/G35 Multiple sclerosis
• 8A40.Y/G35 Other specified multiple sclerosis
• 8A40.Z/G35 Multiple sclerosis, unspecified
• 8A41.0/G35-G37 Transverse myelitis
• 8A41.1/G35-G37 Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
• 8A41/G35-G37 Isolated demyelinating syndromes of the central nervous system
• 8A41.Y/G35-G37 Other specified isolated demyelinating syndromes of the central nervous system
• 8A41.Z/G35-G37 Isolated demyelinating syndromes of the central nervous system, unspecified
• 8A42.0/G36.1 Acute haemorrhagic leukoencephalitis
• 8A42/T88.0 Acute disseminated encephalomyelitis
• 8A42.Y/T88.0 Other specified acute disseminated encephalomyelitis
• 8A42.Z/T88.0 Acute disseminated encephalomyelitis, unspecified
• 8A43.0/G36.0 Neuromyelitis optica aquaporin-4 antibody positive
• 8A43.1/G36.0 Neuromyelitis optica aquaporin-4 antibody negative
• 8A43.2/G36.0 Single transverse myelitis aquaporin-4 antibody positive
• 8A43.3/G36.0 Recurrent transverse myelitis aquaporin-4 antibody positive
• 8A43.4/G36.0 Single optic neuritis aquaporin-4 antibody positive
• 8A43.5/G36.0 Recurrent optic neuritis aquaporin-4 antibody positive
• 8A43/G36.0 Neuromyelitis optica
• 8A43.Y/G36.0 Other specified neuromyelitis optica
• 8A43.Z/G36.0 Neuromyelitis optica, unspecified
• 8A44.0/E75.2 Pelizaeus-Merzbacher disease
• 8A44.1/G35-G37 Adrenoleukodystrophy
• 8A44.2/G35-G37 Alexander disease
• 8A44.3/G35-G37 Certain specified leukodystrophies
• 8A44.4/G35-G37 Krabbe disease
• 8A44/G35-G37 Leukodystrophies
• 8A44.Z/G35-G37 Leukodystrophies, unspecified
• 8A45.0/G35-G37 White matter disorders due to infections
• 8A45.00/G04.1 Human T-cell lymphotropic virus-associated myelopathy
• 8A45.01/A81.1 Subacute sclerosing panencephalitis
• 8A45.02/A81.2 Progressive multifocal leukoencephalopathy
• 8A45.0Y/G35-G37 Other specified white matter disorders due to infections
• 8A45.0Z/G35-G37 White matter disorders due to infections, unspecified
• 8A45.1/G35-G37 White matter disorders due to toxicity
• 8A45.2/G35-G37 White matter disorders due to vascular abnormality or ischemia
• 8A45.20/G35-G37 White matter disorder due to CADASIL
• 8A45.21/G37.4 Subacute necrotising myelitis
• 8A45.2Y/G35-G37 Other specified white matter disorders due to vascular abnormality or ischemia
• 8A45.2Z/G35-G37 White matter disorders due to vascular abnormality or ischemia, unspecified
• 8A45.3/G35-G37 White matter disorders due to nutritional deficiency
• 8A45.30/G35-G37 White matter disorder due to vitamin B12 deficiency
• 8A45.31/G37.2 Central pontine myelinolysis
• 8A45.3Y/G35-G37 Other specified white matter disorders due to nutritional deficiency
• 8A45.3Z/G35-G37 White matter disorders due to nutritional deficiency, unspecified
• 8A45.4/G35-G37 White matter disorders due to certain specified systemic disease
• 8A45.40/G35-G37 Demyelination due to sarcoidosis
• 8A45.41/G35-G37 Demyelination due to systemic lupus erythematosus
• 8A45.42/G35-G37 Demyelination due to Sjögren disease
• 8A45.43/G35-G37 Demyelination due to Behcet disease
• 8A45.44/G35-G37 Demyelination due to systemic vasculitis
• 8A45.45/G35-G37 Demyelination due to mitochondrial disease
• 8A45.4Z/G35-G37 White matter disorders due to certain specified systemic disease, unspecified
• 8A45/G35-G37 Secondary white matter disorders
• 8A45.Y/G35-G37 Other specified secondary white matter disorders
• 8A45.Z/G35-G37 Secondary white matter disorders, unspecified
• 8A46/G37.1 Central demyelination of corpus callosum
• 8A4Y/G35-G37 Other specified multiple sclerosis or other white matter disorders
• 8A4Z/G35-G37 Multiple sclerosis or other white matter disorders, unspecified
• 8A60.0/G40 Epilepsy due to prenatal or perinatal brain insults
• 8A60.00/G40 Epilepsy due to prenatal or perinatal vascular insults
• 8A60.01/G40 Epilepsy due to neonatal hypoxic ischemic encephalopathy
• 8A60.0Y/G40 Epilepsy due to other prenatal or perinatal brain insults
• 8A60.0Z/G40 Epilepsy due to unspecified prenatal or perinatal brain insults
• 8A60.1/G40 Epilepsy due to cerebrovascular disorders
• 8A60.2/G40 Epilepsy due to degenerative brain disorders
• 8A60.3/G40 Epilepsy due to dementias
• 8A60.4/G40 Epilepsy due to central nervous system infections or infestations
• 8A60.5/G40 Epilepsy due to injuries to the head
• 8A60.6/G40 Epilepsy due to tumours of the nervous system
• 8A60.7/G40 Epilepsy with mesial temporal sclerosis
• 8A60.8/G40 Epilepsy due to immune disorders
• 8A60.9/G40 Epilepsy due to abnormalities of brain development
• 8A60.A/G40 Epilepsy due to genetic syndromes with widespread or progressive effects
• 8A60.B/G40 Epilepsy due to multiple sclerosis or other demyelinating disorders
• 8A60/G40 Epilepsy due to structural or metabolic conditions or diseases
• 8A60.Y/G40 Epilepsy due to other structural or metabolic condition or disease
• 8A60.Z/G40 Epilepsy due to unspecified structural or metabolic condition or disease
• 8A61.0/G40.0 Genetic epileptic syndromes with neonatal onset
• 8A61.00/G40.0 Pyridoxal dependent epilepsy
• 8A61.0Y/G40.0 Other specified genetic epileptic syndromes with neonatal onset
• 8A61.0Z/G40.0 Genetic epileptic syndromes with neonatal onset, unspecified
• 8A61.1/G40.0 Genetic epileptic syndromes with onset in infancy
• 8A61.10/G40.0 Benign familial infantile epilepsy
• 8A61.11/G40.0 Dravet syndrome
• 8A61.12/G40.0 Epilepsy of infancy with migrating focal seizures
• 8A61.1Y/G40.0 Other specified genetic epileptic syndromes with onset in infancy
• 8A61.1Z/G40.0 Genetic epileptic syndromes with onset in infancy, unspecified
• 8A61.2/G40.0 Genetic epileptic syndromes with childhood onset
• 8A61.20/G40.0 Benign childhood epilepsy with centro-temporal spikes
• 8A61.21/G40.7 Childhood absence epilepsy
• 8A61.22/G40.0 Epilepsy with myoclonic-astatic seizures
• 8A61.23/G40.0 Myoclonic absences or absences with myoclonias
• 8A61.2Y/G40.0 Other specified genetic epileptic syndromes with childhood onset
• 8A61.2Z/G40.0 Genetic epileptic syndromes with childhood onset, unspecified
• 8A61.3/G40.0 Genetic epileptic syndrome with adolescent or adult onset
• 8A61.30/G40.0 Juvenile myoclonic epilepsy
• 8A61.31/G40.0 Juvenile absence epilepsy
• 8A61.32/G40.0 Benign adult familial myoclonus epilepsy
• 8A61.3Y/G40.0 Other specified genetic epileptic syndrome with adolescent or adult onset
• 8A61.3Z/G40.0 Genetic epileptic syndrome with adolescent or adult onset, unspecified
• 8A61.4/G40.0 Genetic epileptic syndromes with variable age of onset
• 8A61.40/G40.0 Reflex epilepsies
• 8A61.41/G40.0 Progressive myoclonic epilepsy
• 8A61.4Y/G40.0 Other specified genetic epileptic syndromes with variable age of onset
• 8A61.4Z/G40.0 Genetic epileptic syndromes with variable age of onset, unspecified
• 8A61/G40.0 Genetic or presumed genetic syndromes primarily expressed as epilepsy
• 8A61.Y/G40.0 Other specified genetic or presumed genetic syndromes primarily expressed as epilepsy
• 8A61.Z/G40.0 Genetic or presumed genetic syndromes primarily expressed as epilepsy, unspecified
• 8A62.0/G40.4 Infantile spasms
• 8A62.1/G40.4 Lennox-Gastaut syndrome
• 8A62.2/F80.3 Acquired epileptic aphasia
• 8A62/G40.4 Epileptic encephalopathies
• 8A62.Y/G40.4 Other specified epileptic encephalopathies
• 8A62.Z/G40.4 Epileptic encephalopathies, unspecified
• 8A63.0/R56.0 Febrile seizures
• 8A63.00/R56.0 Simple febrile seizures
• 8A63.01/R56.0 Complex febrile seizures
• 8A63.0Y/R56.0 Other specified febrile seizures
• 8A63/R56.8 Seizure due to acute causes
• 8A63.Y/R56.8 Seizure due to other acute cause
• 8A63.Z/R56.8 Seizure due to unspecified acute cause
• 8A64/R56.8 Single seizure due to remote causes
• 8A65/G40.6 Single unprovoked seizure
• 8A66.0/G41 Convulsive status epilepticus
• 8A66.1/G41.1 Non-convulsive status epilepticus
• 8A66.10/G41.1 Absence status epilepticus
• 8A66.1Y/G41.1 Other specified non-convulsive status epilepticus
• 8A66.1Z/G41.1 Non-convulsive status epilepticus, unspecified
• 8A66/G41 Status epilepticus
• 8A66.Y/G41.8 Other specified status epilepticus
• 8A66.Z/G41 Status epilepticus, unspecified
• 8A67/G41.2 Acute repetitive seizures
• 8A68.0/R56 Focal unaware seizure
• 8A68.1/R56 Absence seizures, atypical
• 8A68.2/R56 Absence seizures, typical
• 8A68.3/R56 Focal aware seizure
• 8A68.4/G40.6 Generalised tonic-clonic seizure
• 8A68.5/R56 Generalised myoclonic seizure
• 8A68.6/R56 Generalised tonic seizure
• 8A68.7/R56 Generalised atonic seizure
• 8A68/R56 Types of seizures
• 8A68.Y/R56.8 Other specified type of seizure
• 8A68.Z/R56 Type of seizure, unspecified
• 8A6Y/G40.8 Other specified epilepsy or seizures
• 8A6Z/G40 Epilepsy or seizures, unspecified
• 8A80.0/G43.0 Migraine without aura
• 8A80.1/G43.1 Migraine with aura
• 8A80.10/G43.1 Hemiplegic migraine
• 8A80.1Y/G43.1 Other specified migraine with aura
• 8A80.1Z/G43.1 Migraine with aura, unspecified
• 8A80.2/G43 Chronic migraine
• 8A80.3/G43.8 Complications related to migraine
• 8A80.30/G43.2 Status migrainosus
• 8A80.3Y/G43.8 Other specified complications related to migraine
• 8A80.4/G43 Cyclic vomiting syndrome
• 8A80/G43 Migraine
• 8A80.Y/G43.8 Other specified migraine
• 8A80.Z/G43 Migraine, unspecified
• 8A81.0/G44.0 Infrequent episodic tension-type headache
• 8A81.1/G44 Frequent episodic tension-type headache
• 8A81.2/G44 Chronic tension-type headache
• 8A81/G44 Tension-type headache
• 8A81.Y/G44.8 Other specified tension-type headache
• 8A81.Z/G44 Tension-type headache, unspecified
• 8A82/G44.1 Trigeminal autonomic cephalalgias
• 8A83/G44.2 Other primary headache disorder
• 8A84.0/G44.3 Acute headache associated with traumatic injury to the head
• 8A84.1/G44.3 Persistent headache associated with traumatic injury to the head
• 8A84/G44 Secondary headache
• 8A84.Y/G44.8 Other specified secondary headache
• 8A84.Z/G44 Secondary headache, unspecified
• 8A85/No Mapping Painful cranial neuropathies or other facial pains
• 8A8Y/No Mapping Other specified headache disorders
• 8A8Z/No Mapping Headache disorders, unspecified
• 8B00.0/I61.0 Deep hemispheric haemorrhage
• 8B00.1/I61.1 Lobar haemorrhage
• 8B00.2/I61.3 Brainstem haemorrhage
• 8B00.3/I61.4 Cerebellar haemorrhage
• 8B00.4/I61.5 Intraventricular haemorrhage without parenchymal haemorrhage
• 8B00.5/I61.6 Haemorrhage of multiple sites
• 8B00/I61 Intracerebral haemorrhage
• 8B00.Z/I61 Intracerebral haemorrhage, site unspecified
• 8B01.0/I60 Aneurysmal subarachnoid haemorrhage
• 8B01.1/I60.8 Non-aneurysmal subarachnoid haemorrhage
• 8B01.2/I60 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal
• 8B01/I60 Subarachnoid haemorrhage
• 8B02/I62.0 Nontraumatic subdural haemorrhage
• 8B03/I62.1 Nontraumatic epidural haemorrhage
• 8B0Z/I60-I69 Intracranial haemorrhage, unspecified
• 8B10.0/G45.3 Amaurosis fugax
• 8B10/G45 Transient ischaemic attack
• 8B10.Y/G45.8 Other specified transient ischaemic attack
• 8B10.Z/G45 Transient ischaemic attack, unspecified
• 8B11.0/I63.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis
• 8B11.1/I63.3 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis
• 8B11.2/I63 Cerebral ischaemic stroke due to embolic occlusion
• 8B11.20/I63 Cerebral ischaemic stroke due to cardiac embolism
• 8B11.21/I63 Cerebral ischaemic stroke due to aortic arch embolism
• 8B11.22/I63 Cerebral ischaemic stroke due to paradoxical embolism
• 8B11.2Y/I63 Cerebral ischaemic stroke due to other specified embolic occlusion
• 8B11.2Z/I63 Cerebral ischaemic stroke due to embolic occlusion, unspecified
• 8B11.3/I63 Cerebral ischaemic stroke due to small artery occlusion
• 8B11.4/I63 Cerebral ischaemic stroke due to other known cause
• 8B11.40/I63 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct
• 8B11.41/I63.6 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy
• 8B11.42/I63 Cerebral ischaemic stroke due to hypercoagulable state
• 8B11.43/I63 Cerebral ischaemic stroke in association with subarachnoid haemorrhage
• 8B11.44/I63 Cerebral ischemic stroke from dissection
• 8B11.5/I63 Cerebral ischaemic stroke of unknown cause
• 8B11.50/I63.2 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery
• 8B11.51/I63.5 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery
• 8B11.5Z/I63 Cerebral ischaemic stroke, unspecified
• 8B11/I63 Cerebral ischaemic stroke
• 8B1Y/I67.8 Other specified cerebral ischaemia
• 8B1Z/I67.8 Cerebral ischaemia, unspecified
• 8B20/I64 Stroke not known if ischaemic or haemorrhagic
• 8B21.0/I60-I69 Silent cerebral infarct
• 8B21.1/I60-I69 Silent cerebral microbleed
• 8B21/I60-I69 Cerebrovascular disease with no acute cerebral symptom
• 8B21.Y/I60-I69 Other specified cerebrovascular disease with no acute cerebral symptom
• 8B21.Z/I60-I69 Cerebrovascular disease with no acute cerebral symptom, unspecified
• 8B22.0/I67.0 Dissection of cerebral arteries
• 8B22.1/I67.6 Cerebral venous thrombosis
• 8B22.2/I67 Cerebral vasoconstriction syndromes
• 8B22.3/I67 Isolated cerebral amyloid angiopathy
• 8B22.4/I67 Intracranial vascular malformation
• 8B22.40/Q28.2 Arteriovenous malformation of cerebral vessels
• 8B22.41/I67 Cerebral cavernous malformation
• 8B22.42/I67 Dural arteriovenous fistula
• 8B22.43/I67 Carotid cavernous fistula
• 8B22.4Y/I67 Other specified intracranial vascular malformation
• 8B22.4Z/I67 Intracranial vascular malformation, unspecified
• 8B22.5/I67.1 Cerebral aneurysm, nonruptured
• 8B22.6/I67 Familial cerebral saccular aneurysm
• 8B22.7/I67.7 Cerebral arteritis, not elsewhere classified
• 8B22.70/I67.7 Primary cerebral arteritis
• 8B22.7Y/I67.7 Other specified cerebral arteritis, not elsewhere classified
• 8B22.7Z/I67.7 Cerebral arteritis, not elsewhere classified, unspecified
• 8B22.8/I67.4 Hypertensive encephalopathy
• 8B22.9/I67 Migraine-induced stroke
• 8B22.A/I67 Subclavian steal syndrome
• 8B22.B/I67 Moyamoya syndrome
• 8B22.C/I67 Hereditary cerebrovascular diseases
• 8B22.C0/I67 [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome
• 8B22.C1/I67 [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome
• 8B22.CY/I67 Other specified hereditary cerebrovascular diseases
• 8B22.CZ/I67 Hereditary cerebrovascular diseases, unspecified
• 8B22/I67 Certain specified cerebrovascular diseases
• 8B22.Y/I67.8 Other specified cerebrovascular disease
• 8B23/I68 Cerebrovascular abnormalities
• 8B24/G93.1 Hypoxic-ischaemic encephalopathy
• 8B25.0/I69.3 Late effects of cerebral ischemic stroke
• 8B25.1/I69.1 Late effects of intracerebral haemorrhage
• 8B25.2/I69.0 Late effects of subarachnoid haemorrhage
• 8B25.3/I69.2 Late effects of other nontraumatic intracranial haemorrhage
• 8B25.4/I69.4 Late effects of stroke not known if ischaemic or haemorrhagic
• 8B25/I69 Late effects of cerebrovascular disease
• 8B25.Y/I69.8 Late effects of other specified cerebrovascular disease
• 8B25.Z/I69 Late effects of cerebrovascular disease, unspecified
• 8B26.0/G46.3 Brainstem stroke syndrome
• 8B26.1/G46.4 Cerebellar stroke syndrome
• 8B26.2/G46.0 Middle cerebral artery syndrome
• 8B26.3/G46.1 Anterior cerebral artery syndrome
• 8B26.4/G46.2 Posterior cerebral artery syndrome
• 8B26.5/G46 Lacunar syndromes
• 8B26.50/G46.5 Pure motor lacunar syndrome
• 8B26.51/G46.6 Pure sensory lacunar syndrome
• 8B26.5Y/G46 Other specified lacunar syndromes
• 8B26.5Z/G46 Lacunar syndromes, unspecified
• 8B26/G46 Vascular syndromes of brain in cerebrovascular diseases
• 8B26.Y/G46.8 Other specified vascular syndromes of brain in cerebrovascular diseases
• 8B26.Z/G46 Vascular syndromes of brain in cerebrovascular diseases, unspecified
• 8B2Z/I60-I69 Cerebrovascular diseases, unspecified
• 8B40/G83.4 Cauda equina syndrome
• 8B41/G04 Myelitis
• 8B42/G99.2 Myelopathy
• 8B43.0/G95.1 Acute arterial infarction of the spinal cord
• 8B43.1/G95.1 Acute venous infarction of the spinal cord
• 8B43.2/G95.1 Chronic venous infarction of the spinal cord
• 8B43/G95.9 Non-compressive vascular myelopathies
• 8B43.Y/G95.9 Other specified non-compressive vascular myelopathies
• 8B43.Z/G95.9 Non-compressive vascular myelopathies, unspecified
• 8B44.0/G11.4 Hereditary spastic paraplegia
• 8B44.00/G11.4 Autosomal dominant hereditary spastic paraplegia
• 8B44.01/G11.4 Autosomal recessive hereditary spastic paraplegia
• 8B44.02/G11.4 X-linked hereditary spastic paraplegia
• 8B44.0Y/G11.4 Other specified hereditary spastic paraplegia
• 8B44.0Z/G11.4 Hereditary spastic paraplegia, unspecified
• 8B44/G95.9 Degenerative myelopathic disorders
• 8B44.Y/G95.9 Other specified degenerative myelopathic disorders
• 8B44.Z/G95.9 Degenerative myelopathic disorders, unspecified
• 8B4Y/G95.9 Other specified spinal cord disorders excluding trauma
• 8B4Z/G95.9 Spinal cord disorders excluding trauma, unspecified
• 8B60.0/G12.2 Amyotrophic lateral sclerosis
• 8B60.1/G12.2 Progressive bulbar palsy
• 8B60.2/G12.2 Progressive pseudobulbar palsy
• 8B60.3/G12.2 Progressive muscular atrophy
• 8B60.4/G12.2 Primary lateral sclerosis
• 8B60.5/G12.2 Amyotrophic lateral sclerosis-Plus
• 8B60.6/G12.2 Monomelic amyotrophy
• 8B60.7/G12.2 Madras type motor neuron disease
• 8B60/G12.2 Motor neuron disease
• 8B60.Y/G12.2 Other specified motor neuron disease
• 8B60.Z/G12.2 Motor neuron disease, unspecified
• 8B61.0/G12.0 Infantile spinal muscular atrophy, Type I
• 8B61.1/G12 Late infantile spinal muscular atrophy, Type II
• 8B61.2/G12 Juvenile form spinal muscular dystrophy, Type III
• 8B61.3/G12 Adult onset spinal muscular atrophy, Type IV
• 8B61.4/G12 Localised spinal muscular atrophy
• 8B61/G12 Spinal muscular atrophy
• 8B61.Y/G12.8 Other specified spinal muscular atrophy
• 8B61.Z/G12 Spinal muscular atrophy, unspecified
• 8B62/G14 Post polio progressive muscular atrophy
• 8B6Y/VI Other specified motor neuron diseases or related disorders
• 8B6Z/VI Motor neuron diseases or related disorders, unspecified
• 8B80/G52.0 Disorders of olfactory nerve
• 8B81.0/G50-G59 Brainstem lesion
• 8B81/G50-G59 Disorders of vestibulocochlear nerve
• 8B81.Y/G50-G59 Other specified disorders of vestibulocochlear nerve
• 8B81.Z/G50-G59 Disorders of vestibulocochlear nerve, unspecified
• 8B82.0/G50.0 Trigeminal neuralgia
• 8B82.1/G50.1 Atypical facial pain
• 8B82/G50 Disorders of trigeminal nerve
• 8B82.Z/G50 Disorders of trigeminal nerve, unspecified
• 8B83/G50-G59 Disorders of spinal accessory nerve
• 8B84/G52.3 Disorders of hypoglossal nerve
• 8B85/G52.7 Disorders of multiple cranial nerves
• 8B86/G52.2 Disorders of vagus nerve
• 8B87/G52.1 Disorders of glossopharyngeal nerve
• 8B88.0/G51.0 Bell palsy
• 8B88.1/G51.4 Facial myokymia
• 8B88.2/G51.3 Hemifacial spasm
• 8B88.3/G51 Facial neuritis
• 8B88/G51 Disorders of facial nerve
• 8B88.Y/G51.8 Other specified disorders of facial nerve
• 8B88.Z/G51 Disorders of facial nerve, unspecified
• 8B8Y/G50-G59 Other specified disorders of cranial nerves
• 8B8Z/G50-G59 Disorders of cranial nerves, unspecified
• 8B90/G55 Nerve root and plexus compressions
• 8B91.0/G54.5 Neuralgic shoulder amyotrophy
• 8B91.1/G54.0 Thoracic outlet syndrome due to cervical rib
• 8B91/G54.0 Brachial plexus disorders
• 8B91.Y/G54.0 Other specified brachial plexus disorders
• 8B91.Z/G54.0 Brachial plexus disorders, unspecified
• 8B92.0/G54.1 Post radiation lumbosacral plexopathy
• 8B92.1/G54.1 Vasculitic lumbosacral plexopathy
• 8B92.2/G54.1 Diabetic lumbosacral plexopathy
• 8B92.3/G54.1 Lumbosacral radiculoplexopathy
• 8B92/G54.1 Lumbosacral plexus disorders
• 8B92.Y/G54.1 Other specified lumbosacral plexus disorders
• 8B92.Z/G54.1 Lumbosacral plexus disorders, unspecified
• 8B93.0/M54.1 Radiculopathy due to compression
• 8B93.1/M54.1 Radiculopathy due to metabolic disorders
• 8B93.2/M54.1 Radiculopathy due to electric shock or lightning
• 8B93.3/M54.1 Radiculopathy due to radiation injury
• 8B93.4/M54.1 Radiculopathy due to nutritional deficiencies
• 8B93.5/M54.1 Radiculopathy due to toxicity
• 8B93.6/M54.1 Radiculopathy due to intervertebral disc disorders
• 8B93.7/M54.1 Radiculopathy due to neoplastic disease
• 8B93.8/M54.1 Radiculopathy due to spondylosis
• 8B93/M54.1 Radiculopathy
• 8B93.Y/M54.1 Other specified radiculopathy
• 8B93.Z/M54.1 Radiculopathy, unspecified
• 8B94/G54.8 Diabetic radiculoplexoneuropathy
• 8B95/G54 Secondary brachial plexus lesion due to certain specified disorders
• 8B9Y/G54.8 Other specified nerve root or plexus disorders
• 8B9Z/G54 Nerve root or plexus disorders, unspecified
• 8C00/G60.3 Idiopathic progressive neuropathy
• 8C01.0/G61.0 Acute inflammatory demyelinating polyneuropathy
• 8C01.1/G61 Post vaccinal neuropathy
• 8C01.2/G61 Subacute inflammatory demyelinating polyneuropathy
• 8C01.3/G61 Chronic inflammatory demyelinating polyneuropathy
• 8C01/G61 Inflammatory polyneuropathy
• 8C01.Y/G61.8 Other specified inflammatory polyneuropathy
• 8C01.Z/G61 Inflammatory polyneuropathy, unspecified
• 8C03.0/G63.2 Diabetic polyneuropathy
• 8C03.1/G63.0 Polyneuropathy due to infectious diseases
• 8C03.2/G63.1 Polyneuropathy in neoplastic disease
• 8C03.3/G63.4 Polyneuropathy in nutritional deficiency
• 8C03.4/G63.5 Polyneuropathy in systemic connective tissue disorders
• 8C03/G50-G59 Other secondary polyneuropathy
• 8C03.Y/G50-G59 Other specified secondary polyneuropathy
• 8C03.Z/G50-G59 Other secondary polyneuropathy, unspecified
• 8C0Y/G50-G59 Other specified polyneuropathy
• 8C0Z/G50-G59 Polyneuropathy, unspecified
• 8C10.0/G56.0 Carpal tunnel syndrome
• 8C10.1/G56.2 Lesion of ulnar nerve
• 8C10.2/G56.3 Lesion of radial nerve
• 8C10/G56 Mononeuropathies of upper limb
• 8C10.Y/G56.8 Other specified mononeuropathies of upper limb
• 8C10.Z/G56 Mononeuropathies of upper limb, unspecified
• 8C11.0/G57.0 Lesion of sciatic nerve
• 8C11.00/G57.0 Sciatic nerve piriformis syndrome
• 8C11.0Y/G57.0 Other specified lesion of sciatic nerve
• 8C11.0Z/G57.0 Lesion of sciatic nerve, unspecified
• 8C11.1/G57.1 Meralgia paraesthetica
• 8C11.2/G57.2 Lesion of femoral nerve
• 8C11.3/G57.3 Lesion of common peroneal nerve
• 8C11.4/G57.4 Lesion of tibial nerve
• 8C11.5/G57.5 Tarsal tunnel syndrome
• 8C11.6/G57.6 Lesion of plantar nerve
• 8C11/G57 Mononeuropathies of lower limb
• 8C11.Y/G57.8 Other specified mononeuropathies of lower limb
• 8C11.Z/G57 Mononeuropathies of lower limb, unspecified
• 8C12.0/G58.0 Intercostal neuropathy
• 8C12.1/G58.7 Mononeuritis multiplex
• 8C12.2/G58 Lesion of suprascapular nerve
• 8C12.3/G58 Lesion of axillary nerve
• 8C12.4/G58 Lesion of long thoracic nerve
• 8C12.5/G58 Traumatic neuroma, not otherwise specified
• 8C12/G58 Certain specified mononeuropathies
• 8C12.Y/G58.8 Mononeuropathy of other specified nerve
• 8C1Y/G59.8 Mononeuropathy of other specified site
• 8C1Z/G59 Mononeuropathy of unspecified site
• 8C20.0/G60.0 Charcot-Marie-Tooth disease 1 demyelinating
• 8C20.1/G60.0 Charcot-Marie-Tooth disease 2 axonal
• 8C20.2/G60.0 Intermediate Charcot-Marie-Tooth disease
• 8C20/G60.0 Hereditary motor and sensory neuropathy
• 8C20.Y/G60.0 Other specified hereditary motor and sensory neuropathy
• 8C20.Z/G60.0 Hereditary motor and sensory neuropathy, unspecified
• 8C21.0/G60.8 Hereditary sensory and autonomic neuropathy type I
• 8C21.1/G90.1 Hereditary sensory and autonomic neuropathy type III
• 8C21.2/G60 Hereditary sensory and autonomic neuropathy type IV
• 8C21.3/G60.8 Hereditary sensory and autonomic neuropathy type V
• 8C21/G50-G59 Hereditary sensory or autonomic neuropathy
• 8C21.Y/G50-G59 Other specified hereditary sensory or autonomic neuropathy
• 8C21.Z/G50-G59 Hereditary sensory or autonomic neuropathy, unspecified
• 8C2Y/G50-G59 Other specified hereditary neuropathy
• 8C2Z/G50-G59 Hereditary neuropathy, unspecified
• 8C4Y/G50-G59 Other specified disorders of nerve root, plexus or peripheral nerves
• 8C4Z/G50-G59 Disorders of nerve root, plexus or peripheral nerves, unspecified
• 8C60.0/G70.0 Drug-induced myasthenia gravis
• 8C60/G70.0 Myasthenia gravis
• 8C60.Y/G70.0 Other specified myasthenia gravis
• 8C60.Z/G70.0 Myasthenia gravis, unspecified
• 8C61/G70.2 Congenital myasthenic syndromes
• 8C62/G73.1 Lambert-Eaton syndrome
• 8C6Y/G70.8 Other specified myasthenia gravis and neuromuscular junction disorders
• 8C6Z/G70 Unspecified myasthenia gravis or neuromuscular junction disorders
• 8C70.0/G71.0 Becker muscular dystrophy
• 8C70.1/G71.0 Duchenne muscular dystrophy
• 8C70.2/G71.0 Emery-Dreifuss muscular dystrophy
• 8C70.3/G71.0 Facioscapulohumeral muscular dystrophy
• 8C70.4/G71.0 Limb-girdle muscular dystrophy
• 8C70.40/G71.0 Dominant limb-girdle muscular dystrophy
• 8C70.41/G71.0 Recessive limb-girdle muscular dystrophy
• 8C70.4Y/G71.0 Other specified limb-girdle muscular dystrophy
• 8C70.4Z/G71.0 Limb-girdle muscular dystrophy, unspecified
• 8C70.5/G71.0 Scapuloperoneal muscular dystrophy
• 8C70.6/G71.0 Congenital muscular dystrophy
• 8C70/G71.0 Muscular dystrophy
• 8C70.Y/G71.0 Other specified muscular dystrophy
• 8C70.Z/G71.0 Muscular dystrophy, unspecified
• 8C71.0/G71.1 Myotonic dystrophy
• 8C71.1/G71.1 Chondrodystrophic myotonia
• 8C71.2/G71.1 Myotonia congenita
• 8C71.3/G71.1 Drug-induced myotonia
• 8C71.4/G71.1 Neuromyotonia
• 8C71.5/G71.1 Pseudomyotonia
• 8C71/G71.1 Myotonic disorders
• 8C71.Y/G71.1 Other specified myotonic disorders
• 8C71.Z/G71.1 Myotonic disorders, unspecified
• 8C72.0/G71.2 Congenital myopathy with structural abnormalities
• 8C72.00/G71.2 Nemaline myopathy
• 8C72.01/G71.2 Centronuclear myopathy
• 8C72.02/G71.2 Central core disease
• 8C72.0Y/G71.2 Other specified congenital myopathy with structural abnormalities
• 8C72.0Z/G71.2 Congenital myopathy with structural abnormalities, unspecified
• 8C72.1/G71.2 Congenital myopathy with no structural abnormalities
• 8C72/G71.2 Congenital myopathies
• 8C72.Y/G71.2 Other specified congenital myopathies
• 8C72.Z/G71.2 Congenital myopathies, unspecified
• 8C73.0/G71.3 Autosomal recessive cardiomyopathy or ophthalmoplegia
• 8C73.1/G71.3 Neuropathy, ataxia, and retinitis pigmentosa
• 8C73/G71.3 Mitochondrial myopathies
• 8C73.Y/G71.3 Other specified mitochondrial myopathies
• 8C73.Z/G71.3 Mitochondrial myopathies, unspecified
• 8C74.0/G71 Paramyotonia congenita
• 8C74.1/G72.3 Periodic paralysis
• 8C74.10/G72.3 Hypokalaemic periodic paralysis
• 8C74.11/G72.3 Hyperkalaemic periodic paralysis
• 8C74.1Y/G72.3 Other specified periodic paralysis
• 8C74.1Z/G72.3 Periodic paralysis, unspecified
• 8C74/G71 Periodic paralyses or disorders of muscle membrane excitability
• 8C74.Y/G71 Other specified periodic paralyses or disorders of muscle membrane excitability
• 8C74.Z/G71 Periodic paralyses or disorders of muscle membrane excitability, unspecified
• 8C75/G71 Distal myopathies
• 8C76/G71 Myofibrillar myopathy
• 8C77/G71.8 Ocular myopathy
• 8C78/G71.8 Malignant hyperthermia or hyperpyrexia
• 8C7Y/G71.8 Other specified primary disorders of muscles
• 8C7Z/G71 Primary disorders of muscles, unspecified
• 8C80/G72.0 Drug-induced myopathy
• 8C81/G72 Autoimmune myopathy
• 8C82/G72 Myopathy in certain specified infectious or parasitic disease
• 8C83/G72 Myopathy in certain specified endocrine disease
• 8C84/G72 Secondary rhabdomyolysis
• 8C8Y/G72.8 Other specified secondary myopathies
• 8C8Z/G72 Secondary myopathies, unspecified
• 8D0Y/G70-G73 Other specified diseases of neuromuscular junction or muscle
• 8D0Z/G70-G73 Diseases of neuromuscular junction or muscle, unspecified
• 8D20.0/G80.2 Spastic unilateral cerebral palsy
• 8D20.1/G80 Spastic bilateral cerebral palsy
• 8D20.10/G80.0 Spastic quadriplegic cerebral palsy
• 8D20.11/G80.1 Spastic diplegic cerebral palsy
• 8D20.1Z/G80 Spastic bilateral cerebral palsy, unspecified
• 8D20/G80 Spastic cerebral palsy
• 8D20.Y/G80 Other specified spastic cerebral palsy
• 8D20.Z/G80 Spastic cerebral palsy, unspecified
• 8D21/G80.3 Dyskinetic cerebral palsy
• 8D22/G80.4 Ataxic cerebral palsy
• 8D23/G80 Worster-Drought syndrome
• 8D2Y/G80.8 Other specified cerebral palsy
• 8D2Z/G80 Cerebral palsy, unspecified
• 8D40.0/E63.9 Encephalopathy due to nutritional deficiency
• 8D40.1/E63.9 Neuropathy due to nutritional deficiency
• 8D40.2/E63.9 Myopathy due to nutritional deficiency
• 8D40.3/E63.9 Intellectual developmental disorder due to nutritional deficiency
• 8D40/VI Neurological disorders due to nutrient deficiency
• 8D40.Y/VI Other specified neurological disorders due to nutrient deficiency
• 8D40.Z/VI Neurological disorders due to nutrient deficiency, unspecified
• 8D41.0/VI Peripheral neuropathy due to vitamin B6 hyperalimentation
• 8D41.1/VI Myopathy due to hypercalcaemia
• 8D41.2/VI Pseudotumour Cerebri related to Hypervitaminosis A
• 8D41/VI Neurological disorders due to an excess of micro or macro nutrients
• 8D41.Y/VI Other specified neurological disorders due to an excess of micro or macro nutrients
• 8D41.Z/VI Neurological disorders due to an excess of micro or macro nutrients, unspecified
• 8D42/VI Neurological disorders due to overweight or obesity in adults or children
• 8D43.0/G92 Encephalopathy due to toxicity
• 8D43.00/G92 Encephalopathy due to ammonia
• 8D43.0Y/G92 Other specified encephalopathy due to toxicity
• 8D43.0Z/G92 Encephalopathy due to toxicity, unspecified
• 8D43.1/T65.9 Cognitive impairment due to toxicity
• 8D43.2/T65.9 Neuropathy due to toxicity
• 8D43.20/G62.0 Drug-induced polyneuropathy
• 8D43.21/T65.9 Post radiation polyneuropathy
• 8D43.2Y/T65.9 Other specified neuropathy due to toxicity
• 8D43.2Z/T65.9 Neuropathy due to toxicity, unspecified
• 8D43.3/T65.9 Myopathy due to toxicity
• 8D43.4/T65.9 Movement disorders due to toxicity
• 8D43.5/T62.2 Cassava poisoning
• 8D43/VI Neurological disorders due to toxicity
• 8D43.Y/VI Other specified neurological disorders due to toxicity
• 8D43.Z/VI Neurological disorders due to toxicity, unspecified
• 8D44.0/G62.1 Alcoholic polyneuropathy
• 8D44.1/G72.1 Alcoholic myopathy
• 8D44/VI Alcohol-related neurological disorders
• 8D44.Y/VI Other specified alcohol-related neurological disorders
• 8D44.Z/VI Alcohol-related neurological disorders, unspecified
• 8D4Y/VI Other specified nutritional or toxic disorders of the nervous system
• 8D4Z/VI Nutritional or toxic disorders of the nervous system, unspecified
• 8D60.0/G93.2 Brain herniation syndromes
• 8D60.1/G93.6 Cerebral oedema
• 8D60/G93.2 Increased intracranial pressure
• 8D60.Y/G93.2 Other specified increased intracranial pressure
• 8D60.Z/G93.2 Increased intracranial pressure, unspecified
• 8D61.0/VI Spontaneous intracranial hypotension
• 8D61.1/VI Secondary intracranial hypotension
• 8D61/VI Intracranial hypotension
• 8D61.Y/VI Other specified intracranial hypotension
• 8D61.Z/VI Intracranial hypotension, unspecified
• 8D62/G96.0 Cerebrospinal fluid rhinorrhoea
• 8D63/G96.0 Cerebrospinal fluid otorrhoea
• 8D64.0/G91.0 Communicating hydrocephalus
• 8D64.00/G91.0 Increased cerebrospinal fluid production
• 8D64.01/G91.0 Congenital agenesis of arachnoid villi
• 8D64.02/G91.0 Post haemorrhagic hydrocephalus
• 8D64.03/G91.0 Post traumatic hydrocephalus
• 8D64.04/G91.2 Normal-pressure hydrocephalus
• 8D64.0Y/G91.0 Other specified communicating hydrocephalus
• 8D64.0Z/G91.0 Communicating hydrocephalus, unspecified
• 8D64.1/G91.1 Non-communicating hydrocephalus
• 8D64.10/G91.1 Hydrocephalus due to structural malformations
• 8D64.1Y/G91.1 Other specified non-communicating hydrocephalus
• 8D64.1Z/G91.1 Non-communicating hydrocephalus, unspecified
• 8D64.2/G94 Ex-vacuo hydrocephalus
• 8D64/G94 Hydrocephalus
• 8D64.Z/G94 Hydrocephalus, unspecified
• 8D65/G96.0 Cerebrospinal fluid fistula
• 8D66.0/G95.0 Idiopathic syringomyelia
• 8D66.1/G95.0 Syringomyelia due to certain specified cause
• 8D66.2/G95.0 Syringobulbia
• 8D66/G95.0 Syringomyelia or syringobulbia
• 8D66.Y/G95.0 Other specified syringomyelia or syringobulbia
• 8D66.Z/G95.0 Syringomyelia or syringobulbia, unspecified
• 8D67/G93.0 Intracranial arachnoid cyst
• 8D68/G93.0 Porencephalic cyst
• 8D6Y/VI Other specified disorders of cerebrospinal fluid pressure or flow
• 8D6Z/VI Disorders of cerebrospinal fluid pressure or flow, unspecified
• 8D80/G90 Congenital malformations of the autonomic nervous system
• 8D81/G90 Inherited autonomic nervous system disorders
• 8D82/G90 Autoimmune disorders involving the autonomic nervous system
• 8D83/G90 Autonomic nervous system disorder due to infection
• 8D84/G90 Pure autonomic nervous system failure
• 8D85/G90 Autonomic nervous system disorder due to substances
• 8D86/G90 Autonomic nervous system hyperactivity
• 8D87.0/G90 Multiple system atrophy
• 8D87.00/G23.3 Multiple system atrophy, Cerebellar type
• 8D87.01/G23.2 Multiple system atrophy, Parkinsonism
• 8D87.0Y/G90 Other specified multiple system atrophy
• 8D87.0Z/G90 Multiple system atrophy, unspecified
• 8D87/G90 Autonomic nervous system disorder due to certain specified neurodegenerative disorder
• 8D87.Y/G90 Other specified autonomic nervous system disorder due to specified neurodegenerative disorder
• 8D88.0/G99.1 Autonomic neuropathy due to sodium channelopathies
• 8D88.1/G90 Autonomic neuropathy due to diabetes mellitus
• 8D88.2/G99.1 Immune mediated autonomic neuropathy
• 8D88.3/G90 Autonomic disorder due to toxins
• 8D88.4/G99.0 Autonomic neuropathy in endocrine and metabolic diseases
• 8D88/G90 Autonomic neuropathies
• 8D88.Y/G90 Other specified autonomic neuropathies
• 8D88.Z/G90 Autonomic neuropathies, unspecified
• 8D89.0/G90 Reflex syncope
• 8D89.1/G90 Syncope due to autonomic failure
• 8D89.2/G90 Postural orthostatic tachycardia syndrome
• 8D89.3/G90 Baroreflex failure
• 8D89/G90 Disorders of orthostatic tolerance
• 8D89.Y/G90 Other specified disorders of orthostatic tolerance
• 8D89.Z/G90 Disorders of orthostatic tolerance, unspecified
• 8D8A.1/G90 Horner syndrome
• 8D8A.2/G90 Episodic anisocoria
• 8D8A/G90 Focal or segmental autonomic disorders
• 8D8A.Y/G90 Other specified focal or segmental autonomic disorders
• 8D8A.Z/G90 Focal or segmental autonomic disorders, unspecified
• 8D8B/G90 Disorders affecting autonomic synaptic neurotransmission
• 8D8C/G90.4 Autonomic dysreflexia
• 8D8D/G90 Hypoglycaemia unawareness
• 8D8Y/G90.8 Other specified disorders of autonomic nervous system
• 8D8Z/G90 Disorders of autonomic nervous system, unspecified
• 8E00/A81.9 Sporadic Creutzfeldt-Jakob Disease
• 8E01.0/A81.9 Iatrogenically acquired Creutzfeldt-Jakob Disease
• 8E01.1/A81.8 Kuru
• 8E01.2/A81.9 Variant Creutzfeldt-Jakob Disease
• 8E01.3/A81.9 Other acquired Creutzfeldt-Jakob Disease
• 8E01/A81.9 Acquired prion disease
• 8E02.0/A81.0 Genetic Creutzfeldt-Jakob disease
• 8E02.1/A81.9 Gerstmann-Straussler-Scheinker syndrome
• 8E02.2/A81.9 Fatal familial insomnia
• 8E02.3/A81.9 Other genetic prion diseases
• 8E02/A81.9 Genetic prion diseases
• 8E02.Y/A81.9 Other specified Creutzfeldt-Jakob disease
• 8E02.Z/A81.9 Creutzfeldt-Jakob disease, unspecified
• 8E03/A81.9 Variably protease sensitive prionopathy
• 8E0Y/A81.9 Other specified human prion diseases
• 8E0Z/A81.9 Human prion diseases, unspecified
• 8E20/VI Persistent vegetative state
• 8E21/VI Permanent vegetative state
• 8E22.0/R40.1 Minimally conscious state plus
• 8E22.1/R40.1 Minimally conscious state minus
• 8E22/R40.1 Minimally conscious state
• 8E22.Y/R40.1 Other specified minimally conscious state
• 8E22.Z/R40.1 Minimally conscious state, unspecified
• 8E2Y/VI Other specified disorders of consciousness
• 8E2Z/VI Disorders of consciousness, unspecified
• 8E40.0/G03.8 Neoplastic meningitis
• 8E40.1/G03.8 Chemical meningitis
• 8E40.2/G03.8 Inflammatory meningitis
• 8E40.3/G03 Arachnoiditis
• 8E40/G90-G99 Disorders of the meninges excluding infection
• 8E40.Y/G90-G99 Other specified disorders of the meninges excluding infection
• 8E40.Z/G90-G99 Disorders of the meninges excluding infection, unspecified
• 8E41.0/G90-G99 Pachymeningitis due to infection
• 8E41.1/G90-G99 Idiopathic hypertrophic pachymeningitis
• 8E41/G90-G99 Pachymeningitis
• 8E41.Y/G90-G99 Other specified pachymeningitis
• 8E41.Z/G90-G99 Pachymeningitis, unspecified
• 8E42/G90-G99 Superficial siderosis of the nervous system
• 8E43.0/G90-G99 Neuropathic pain
• 8E43.00/G90-G99 Phantom limb syndrome
• 8E43.0Y/G90-G99 Other specified neuropathic pain
• 8E43.0Z/G90-G99 Neuropathic pain, unspecified
• 8E43/G90-G99 Pain disorders
• 8E43.Y/G90-G99 Other specified pain disorders
• 8E43.Z/G90-G99 Pain disorders, unspecified
• 8E44/G90-G99 Post anoxic brain damage
• 8E45/G83.5 Locked-in syndrome
• 8E46/G93.7 Reye syndrome
• 8E47/G93.4 Encephalopathy, not elsewhere classified
• 8E48/G04.8 Encephalitis, not elsewhere classified
• 8E49/G93.3 Postviral fatigue syndrome
• 8E4A.0/G90-G99 Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord
• 8E4A.1/G90-G99 Paraneoplastic or autoimmune disorders of the peripheral or autonomic nervous system
• 8E4A.2/G90-G99 Paraneoplastic or autoimmune neuromuscular transmission disorders
• 8E4A.3/G13 Paraneoplastic or autoimmune disorders of the muscle
• 8E4A/G90-G99 Paraneoplastic or autoimmune disorders of the nervous system
• 8E4A.Y/G90-G99 Other specified paraneoplastic or autoimmune disorders of the nervous system
• 8E4Y/G90-G99 Other specified disorders of the nervous system
• 8E60/G97.2 Post ventricular shunting leak
• 8E61.0/T66 Brain irradiation
• 8E61.1/T66 Spinal cord irradiation
• 8E61/G97 Post radiation injury of the nervous system
• 8E62/G03.8 Postprocedural meningitis
• 8E63/G93.4 Post pump encephalopathy
• 8E64/G97.8 Multifocal cerebral infarctions
• 8E65/G93.1 Anoxic-ischaemic encephalopathy
• 8E66/G97 Intracranial hypotension due to lumbar puncture
• 8E7Y/VII Other specified diseases of the nervous system
• 8E7Z/VII Diseases of the nervous system, unspecified
• 9A00.0/Q15.8 Dystopia canthorum
• 9A00.1/Q15.8 Telecanthus
• 9A00/Q10.3 Congenital malposition of eyelids
• 9A00.Y/Q10.3 Other specified congenital malposition of eyelids
• 9A00.Z/Q10.3 Congenital malposition of eyelids, unspecified
• 9A01.0/H00.0 Preseptal cellulitis
• 9A01.1/H00.0 Abscess of eyelid
• 9A01.2/H00.0 Hordeolum
• 9A01.20/H00.0 Hordeolum externum
• 9A01.21/H00.0 Hordeolum internum
• 9A01.2Z/H00.0 Hordeolum, unspecified
• 9A01.3/H01.0 Infectious blepharitis
• 9A01.4/H03.0 Infestation of eyelid
• 9A01/H01.9 Infectious disorders of eyelid
• 9A01.Y/H01.9 Other specified infectious disorders of eyelid
• 9A02.0/H00.1 Chalazion
• 9A02.00/H00.1 Chalazion externum
• 9A02.01/H00.1 Chalazion internum
• 9A02.0Y/H00.1 Other specified chalazion
• 9A02.0Z/H00.1 Chalazion, unspecified
• 9A02.1/H01.9 Posterior blepharitis
• 9A02.2/H01.9 Ligneous conjunctivitis
• 9A02.4/H01.9 Meibomian gland dysfunction
• 9A02/H01.9 Inflammatory disorders of eyelid
• 9A02.Y/H01.9 Other specified inflammatory disorders of eyelid
• 9A03.0/H02.4 Blepharoptosis
• 9A03.00/H02.4 Marcus-Gunn syndrome
• 9A03.01/H02.4 Mechanical ptosis of eyelid
• 9A03.02/H02.4 Myogenic ptosis of eyelid
• 9A03.03/H02.4 Paralytic ptosis of eyelid
• 9A03.0Y/H02.4 Other specified blepharoptosis
• 9A03.0Z/H02.4 Blepharoptosis, unspecified
• 9A03.1/H02.0 Entropion of eyelid
• 9A03.10/H02.0 Cicatricial entropion of eyelid
• 9A03.11/H02.0 Mechanical entropion of eyelid
• 9A03.12/H02.0 Senile entropion of eyelid
• 9A03.13/H02.0 Spastic entropion of eyelid
• 9A03.1Y/H02.0 Other specified entropion of eyelid
• 9A03.1Z/H02.0 Entropion of eyelid, unspecified
• 9A03.2/H02.1 Ectropion of eyelid
• 9A03.20/H02.1 Cicatricial ectropion of eyelid
• 9A03.21/H02.1 Mechanical ectropion of eyelid
• 9A03.22/H02.1 Senile ectropion of eyelid
• 9A03.23/H02.1 Spastic ectropion of eyelid
• 9A03.24/H02.1 Floppy eyelid syndrome
• 9A03.2Y/H02.1 Other specified ectropion of eyelid
• 9A03.2Z/H02.1 Ectropion of eyelid, unspecified
• 9A03.3/H02.5 Eyelid retraction
• 9A03.4/H02.2 Lagophthalmos
• 9A03.40/H02.2 Cicatricial lagophthalmos
• 9A03.41/H02.2 Mechanical lagophthalmos
• 9A03.42/H02.2 Paralytic lagophthalmos
• 9A03.4Y/H02.2 Other specified lagophthalmos
• 9A03.4Z/H02.2 Lagophthalmos, unspecified
• 9A03.5/H02.7 Dermatochalasis of eyelid
• 9A03/H02.8 Acquired malposition of eyelid
• 9A03.Y/H02.8 Other specified acquired malposition of eyelid
• 9A03.Z/H02.8 Acquired malposition of eyelid, unspecified
• 9A04.0/H02.0 Trichiasis without entropion
• 9A04.1/H02.7 Madarosis of eyelid or periocular area
• 9A04/H02.8 Acquired disorders of eyelashes
• 9A04.Y/H02.8 Other specified acquired disorders of eyelashes
• 9A05.0/G51.4 Myokymia of eyelid
• 9A05.1/H51.8 Eyelid apraxia
• 9A05/H02.8 Movement disorders of eyelid
• 9A05.Y/H02.8 Other specified movement disorders of eyelid
• 9A05.Z/H02.8 Movement disorders of eyelid, unspecified
• 9A06.0/H02 Involvement of eyelid by dermatosis classified elsewhere
• 9A06.1/H02 Vitiligo of eyelid or periocular area
• 9A06.2/H02 Symblepharon, acquired
• 9A06.3/H02 Traumatic scar of eyelid
• 9A06.4/H02.6 Xanthelasma of eyelid
• 9A06.5/H02 Tear Trough Deformity
• 9A06.6/H02 Sunken Sulcus Deformity
• 9A06.7/H02 Dermatitis or eczema of eyelids
• 9A06.70/L20.8 Atopic eczema of eyelids
• 9A06.71/H02 Seborrhoeic dermatitis of eyelids
• 9A06.72/H02 Allergic contact blepharoconjunctivitis
• 9A06.7Y/H02 Other specified dermatitis or eczema of eyelids
• 9A06.7Z/H02 Dermatitis or eczema of eyelids, type unspecified
• 9A06.8/H02.3 Blepharochalasis
• 9A06/H02 Certain specified disorders of eyelid
• 9A06.Y/H02.8 Other specified disorders of eyelid
• 9A0Y/H02.8 Other specified disorders of eyelid or peri-ocular area
• 9A0Z/H02 Disorders of eyelid or peri-ocular area, unspecified
• 9A10.0/H04 Infections of the lacrimal gland
• 9A10.1/H04 Orbital inflammatory syndrome
• 9A10.2/H04 Benign lymphoepithelial lesion of lacrimal gland
• 9A10.3/H04 Hyperlacrimation
• 9A10.4/H04 Underproduction of tears
• 9A10/H04 Disorders of lacrimal gland
• 9A10.Y/H04 Other specified disorders of lacrimal gland
• 9A10.Z/H04 Disorders of lacrimal gland, unspecified
• 9A11.0/H04 Eversion of lacrimal punctum
• 9A11.1/H04.3 Canaliculitis
• 9A11.2/H04.3 Dacryocystitis
• 9A11.3/H04.5 Conjunctivochalasis
• 9A11.4/H04.5 Punctal stenosis
• 9A11.5/H04.5 Nasolacrimal canalicular stenosis
• 9A11.6/H04.5 Dacryolith
• 9A11.7/H04.5 Nasolacrimal sac stenosis
• 9A11.8/H04.5 Nasolacrimal duct obstruction
• 9A11/H04 Disorders of lacrimal drainage system
• 9A11.Y/H04 Other specified disorders of lacrimal drainage system
• 9A11.Z/H04 Disorders of lacrimal drainage system, unspecified
• 9A1Y/H04.8 Other specified disorders of lacrimal apparatus
• 9A1Z/H04 Disorders of lacrimal apparatus, unspecified